primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
107026833,10702683,3,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Anaemia,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107026833,10702683,3,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107026833,10702683,4,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Anaemia,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107026833,10702683,4,SS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
108752645,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Cellulitis,,2016,Q1,5,F,20140701.0,20150902.0,20150227,20160127,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20160127.0,,MD,US,US,2016,Q1,Elderly
108752645,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Hyponatraemia,,2016,Q1,5,F,20140701.0,20150902.0,20150227,20160127,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20160127.0,,MD,US,US,2016,Q1,Elderly
108752645,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Respiratory failure,,2016,Q1,5,F,20140701.0,20150902.0,20150227,20160127,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20160127.0,,MD,US,US,2016,Q1,Elderly
109351433,10935143,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,600.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Angina unstable,,2016,Q1,3,F,20141109.0,20160210.0,20150320,20160218,EXP,,US-ASTRAZENECA-2015SE24455,ASTRAZENECA,,17741.0,DY,,F,Y,,,20160218.0,,MD,US,US,2016,Q1,Elderly
109509555,10950955,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,PLACEBO RUN IN PHASE,,,,,,,,,,TABLET,,2016,Q1,Death,,2016,Q1,5,F,20150228.0,20160105.0,20150324,20160118,EXP,,PL-ASTRAZENECA-2015SE25796,ASTRAZENECA,,30157.0,DY,,F,Y,,,20160118.0,,MD,PL,PL,2016,Q1,Elderly
109509555,10950955,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,DAILY,,,,,,,,,,TABLET,,2016,Q1,Death,,2016,Q1,5,F,20150228.0,20160105.0,20150324,20160118,EXP,,PL-ASTRAZENECA-2015SE25796,ASTRAZENECA,,30157.0,DY,,F,Y,,,20160118.0,,MD,PL,PL,2016,Q1,Elderly
1117939913,11179399,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Basal cell carcinoma,,2016,Q1,13,F,20130514.0,20160122.0,20150611,20160128,EXP,,PHHO2015IT009351,NOVARTIS,,79.0,YR,,M,Y,50.0,KG,20160128.0,,MD,IT,IT,2016,Q1,Elderly
1117939913,11179399,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Pneumonia,,2016,Q1,13,F,20130514.0,20160122.0,20150611,20160128,EXP,,PHHO2015IT009351,NOVARTIS,,79.0,YR,,M,Y,50.0,KG,20160128.0,,MD,IT,IT,2016,Q1,Elderly
1117939913,11179399,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Squamous cell carcinoma of lung,,2016,Q1,13,F,20130514.0,20160122.0,20150611,20160128,EXP,,PHHO2015IT009351,NOVARTIS,,79.0,YR,,M,Y,50.0,KG,20160128.0,,MD,IT,IT,2016,Q1,Elderly
114914702,11491470,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Dehydration,,2016,Q1,2,F,,20160215.0,20150910,20160226,EXP,,DK-TEVA-591498ISR,TEVA,"RUNGBY J,STORGAARD H,BAGGER J,KNOP F,VILSBOLL T.",44.0,YR,,M,Y,,,20160226.0,,OT,DK,DK,2016,Q1,Adult
114914702,11491470,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,2,F,,20160215.0,20150910,20160226,EXP,,DK-TEVA-591498ISR,TEVA,"RUNGBY J,STORGAARD H,BAGGER J,KNOP F,VILSBOLL T.",44.0,YR,,M,Y,,,20160226.0,,OT,DK,DK,2016,Q1,Adult
114914702,11491470,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM DAILY;,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Lactic acidosis,,2016,Q1,2,F,,20160215.0,20150910,20160226,EXP,,DK-TEVA-591498ISR,TEVA,"RUNGBY J,STORGAARD H,BAGGER J,KNOP F,VILSBOLL T.",44.0,YR,,M,Y,,,20160226.0,,OT,DK,DK,2016,Q1,Adult
114914702,11491470,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2016,Q1,Dehydration,,2016,Q1,2,F,,20160215.0,20150910,20160226,EXP,,DK-TEVA-591498ISR,TEVA,"RUNGBY J,STORGAARD H,BAGGER J,KNOP F,VILSBOLL T.",44.0,YR,,M,Y,,,20160226.0,,OT,DK,DK,2016,Q1,Adult
114914702,11491470,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,2,F,,20160215.0,20150910,20160226,EXP,,DK-TEVA-591498ISR,TEVA,"RUNGBY J,STORGAARD H,BAGGER J,KNOP F,VILSBOLL T.",44.0,YR,,M,Y,,,20160226.0,,OT,DK,DK,2016,Q1,Adult
114914702,11491470,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2016,Q1,Lactic acidosis,,2016,Q1,2,F,,20160215.0,20150910,20160226,EXP,,DK-TEVA-591498ISR,TEVA,"RUNGBY J,STORGAARD H,BAGGER J,KNOP F,VILSBOLL T.",44.0,YR,,M,Y,,,20160226.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Abdominal pain,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Dehydration,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Dizziness,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Headache,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Hypophagia,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Lactic acidosis,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Malaise,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Nausea,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115055583,11505558,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, ONCE A DAY",,,,U,,,,10.0,MG,,QD,2016,Q1,Vomiting,,2016,Q1,3,F,,20160310.0,20150915,20160322,EXP,,DK-AUROBINDO-AUR-APL-2015-08236,AUROBINDO,,44.0,YR,,M,Y,,,20160322.0,,OT,DK,DK,2016,Q1,Adult
115874872,11587487,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Exposure during pregnancy,,2016,Q1,2,F,,20160307.0,20151001,20160315,EXP,,GB-ASTRAZENECA-2015SE93339,ASTRAZENECA,,34.0,YR,,F,Y,73.0,KG,20160315.0,,MD,GB,GB,2016,Q1,Young Adult
115940652,11594065,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,,,,,U,,,,10.0,MG,TRANSDERMAL PATCH,,2016,Q1,Encephalocele,,2016,Q1,2,F,20150807.0,20160307.0,20151005,20160317,EXP,GB-MHRA-EYC 00128190,GB-TEVA-597171ACC,TEVA,,15.0,HR,,,Y,,,20160317.0,,MD,GB,GB,2016,Q1,Youth
116162614,11616261,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2650.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Coronary artery disease,,2016,Q1,4,F,20150707.0,20151230.0,20151009,20160101,EXP,,TR-ASTRAZENECA-2015SE96851,ASTRAZENECA,,21460.0,DY,,M,Y,,,20160101.0,,MD,TR,TR,2016,Q1,Elderly
117837382,11783738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,8090.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Prostate cancer,,2016,Q1,2,F,20151030.0,20160303.0,20151127,20160311,EXP,,US-ASTRAZENECA-2015SF18406,ASTRAZENECA,,25350.0,DY,,M,Y,,,20160311.0,,MD,US,US,2016,Q1,Elderly
118679123,11867912,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5330.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Lumbar spinal stenosis,,2016,Q1,3,F,20150818.0,20160228.0,20151224,20160307,EXP,,AU-ASTRAZENECA-2015SF23141,ASTRAZENECA,,23257.0,DY,,M,Y,,,20160307.0,,MD,AU,AU,2016,Q1,Elderly
118824454,11882445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Exposure during pregnancy,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Off label use,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Product use issue,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Stress,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118836111,11883611,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Orchitis,,2016,Q1,1,I,20151106.0,20151224.0,20160101,20160101,EXP,,GB-ASTRAZENECA-2015SF30703,ASTRAZENECA,,65.0,YR,,M,Y,113.0,KG,20160101.0,,MD,GB,GB,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetes mellitus inadequate control,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Fluid intake reduced,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Gastrointestinal motility disorder,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Hypokalaemia,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Klebsiella bacteraemia,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Lung infection,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Metabolic acidosis,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Pyelonephritis acute,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
118838402,11883840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2120.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Renal tubular disorder,,2016,Q1,2,F,20151114.0,20160215.0,20160101,20160223,EXP,,IT-ASTRAZENECA-2015SF31283,ASTRAZENECA,,19799.0,DY,,F,Y,,,20160223.0,,MD,IT,IT,2016,Q1,Elderly
119114811,11911481,1,PS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Deep vein thrombosis,,2016,Q1,1,I,20140310.0,20140624.0,20160112,20160112,PER,,US-ASTRAZENECA-2014SE48826,ASTRAZENECA,,17096.0,DY,,M,Y,,,20160112.0,,CN,US,US,2016,Q1,Elderly
119114811,11911481,1,PS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Viral infection,,2016,Q1,1,I,20140310.0,20140624.0,20160112,20160112,PER,,US-ASTRAZENECA-2014SE48826,ASTRAZENECA,,17096.0,DY,,M,Y,,,20160112.0,,CN,US,US,2016,Q1,Elderly
119177031,11917703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Dizziness,,2016,Q1,1,I,20151231.0,20160107.0,20160114,20160114,EXP,,GB-ASTRAZENECA-2016SE01754,ASTRAZENECA,,63.0,YR,,M,Y,97.0,KG,20160114.0,,OT,GB,GB,2016,Q1,Adult
119264151,11926415,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160106.0,20160114.0,20160119,20160119,EXP,,GB-ASTRAZENECA-2016SE04439,ASTRAZENECA,,59.0,YR,,F,Y,,,20160119.0,,PH,GB,GB,2016,Q1,Adult
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Blood glucose decreased,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Chronic kidney disease,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Glycosylated haemoglobin increased,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Hypertension,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Lipid metabolism disorder,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Obesity,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119305371,11930537,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNKNOWN",,,,,,,,10.0,MG,,,2016,Q1,Polyneuropathy,,2016,Q1,1,I,,20160107.0,20160120,20160120,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201601006564,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20160119.0,,OT,PL,PL,2016,Q1,Elderly
119321612,11932161,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1 /DAY",,,,,,,,10.0,MG,,QD,2016,Q1,Decreased insulin requirement,,2016,Q1,2,F,,20160223.0,20160120,20160304,EXP,,"GB-IMPAX LABORATORIES, INC-2016-IPXL-00022",IMPAX,"REDFORD C, DOHERTY L, SMITH J. SGLT2 INHIBITORS AND THE RISK OF DIABETIC KETOACIDOSIS. PRACTICAL DIABETES. 2015?32(7):263-4A",58.0,YR,,F,Y,85.0,KG,20160304.0,,MD,GB,GB,2016,Q1,Adult
119321612,11932161,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1 /DAY",,,,,,,,10.0,MG,,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,2,F,,20160223.0,20160120,20160304,EXP,,"GB-IMPAX LABORATORIES, INC-2016-IPXL-00022",IMPAX,"REDFORD C, DOHERTY L, SMITH J. SGLT2 INHIBITORS AND THE RISK OF DIABETIC KETOACIDOSIS. PRACTICAL DIABETES. 2015?32(7):263-4A",58.0,YR,,F,Y,85.0,KG,20160304.0,,MD,GB,GB,2016,Q1,Adult
119321612,11932161,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1 /DAY",,,,,,,,10.0,MG,,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,,20160223.0,20160120,20160304,EXP,,"GB-IMPAX LABORATORIES, INC-2016-IPXL-00022",IMPAX,"REDFORD C, DOHERTY L, SMITH J. SGLT2 INHIBITORS AND THE RISK OF DIABETIC KETOACIDOSIS. PRACTICAL DIABETES. 2015?32(7):263-4A",58.0,YR,,F,Y,85.0,KG,20160304.0,,MD,GB,GB,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Abdominal pain,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Asthenia,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Dyspnoea,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Ketoacidosis,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Lethargy,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Mental status changes,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Metabolic acidosis,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Nausea,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Unresponsive to stimuli,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119332131,11933213,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Vomiting,,2016,Q1,1,I,,20160113.0,20160121,20160121,EXP,,US-ASTRAZENECA-2016SE04096,ASTRAZENECA,,44.0,YR,,M,Y,,,20160121.0,,PH,US,US,2016,Q1,Adult
119375591,11937559,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Hepatic enzyme increased,,2016,Q1,1,I,20131210.0,20140718.0,20160122,20160122,EXP,,US-ASTRAZENECA-2014SE54702,ASTRAZENECA,,24054.0,DY,,M,Y,,,20160122.0,,MD,US,US,2016,Q1,Elderly
119375591,11937559,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Hepatic enzyme increased,,2016,Q1,1,I,20131210.0,20140718.0,20160122,20160122,EXP,,US-ASTRAZENECA-2014SE54702,ASTRAZENECA,,24054.0,DY,,M,Y,,,20160122.0,,MD,US,US,2016,Q1,Elderly
119386462,11938646,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3630.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Myelodysplastic syndrome,,2016,Q1,2,F,20150622.0,20160126.0,20160122,20160203,EXP,,NL-ASTRAZENECA-2016SE05140,ASTRAZENECA,,784.0,MON,,F,Y,,,20160203.0,,MD,NL,NL,2016,Q1,Elderly
119406982,11940698,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Hypokalaemia,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Klebsiella infection,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Lung consolidation,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Metabolic acidosis,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119406982,11940698,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q1,Pyelonephritis acute,,2016,Q1,2,F,20151114.0,20160224.0,20160122,20160309,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093492,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20160309.0,,CN,IT,IT,2016,Q1,Adult
119413461,11941346,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7300.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Staphylococcal infection,,2016,Q1,1,I,20151009.0,20160114.0,20160122,20160122,EXP,,US-ASTRAZENECA-2016SE05115,ASTRAZENECA,,25493.0,DY,,F,Y,,,20160122.0,,MD,US,US,2016,Q1,Elderly
119414411,11941441,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Dysuria,,2016,Q1,1,I,20140126.0,20140127.0,20160122,20160122,PER,,US-ASTRAZENECA-2014SE09673,ASTRAZENECA,,71.0,YR,,F,Y,,,20160123.0,,CN,US,CA,2016,Q1,Elderly
119414881,11941488,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,8070.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Hydronephrosis,,2016,Q1,1,I,20151225.0,20160115.0,20160122,20160122,EXP,,US-ASTRAZENECA-2016SE05988,ASTRAZENECA,,25570.0,DY,,F,Y,,,20160123.0,,MD,US,US,2016,Q1,Elderly
119445872,11944587,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Gastroenteritis,,2016,Q1,2,F,20160118.0,20160322.0,20160125,20160325,EXP,,IN-ASTRAZENECA-2016SE07525,ASTRAZENECA,,23971.0,DY,,M,Y,,,20160326.0,,MD,IN,IN,2016,Q1,Elderly
119445872,11944587,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Gastroenteritis,,2016,Q1,2,F,20160118.0,20160322.0,20160125,20160325,EXP,,IN-ASTRAZENECA-2016SE07525,ASTRAZENECA,,23971.0,DY,,M,Y,,,20160326.0,,MD,IN,IN,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Blood pressure decreased,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Body temperature increased,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Dysuria,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Feeding disorder,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Malaise,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Oxygen saturation decreased,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119652281,11965228,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q1,Pyelonephritis,,2016,Q1,1,I,20151203.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05798,ASTRAZENECA,,65.0,YR,,M,Y,120.0,KG,20160127.0,,PH,GB,GB,2016,Q1,Elderly
119658171,11965817,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Hyperkalaemia,,2016,Q1,1,I,20140921.0,20160119.0,20160127,20160127,EXP,,GB-ASTRAZENECA-2016SE05894,ASTRAZENECA,,75.0,YR,,M,Y,104.5,KG,20160127.0,,MD,GB,GB,2016,Q1,Elderly
119672372,11967237,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q1,Drug hypersensitivity,,2016,Q1,2,F,20151221.0,20160309.0,20160127,20160317,EXP,,GB-ASTRAZENECA-2016SE06069,ASTRAZENECA,,35.0,YR,,M,Y,100.5,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
119672372,11967237,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q1,Eye swelling,,2016,Q1,2,F,20151221.0,20160309.0,20160127,20160317,EXP,,GB-ASTRAZENECA-2016SE06069,ASTRAZENECA,,35.0,YR,,M,Y,100.5,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
119672372,11967237,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q1,Lip swelling,,2016,Q1,2,F,20151221.0,20160309.0,20160127,20160317,EXP,,GB-ASTRAZENECA-2016SE06069,ASTRAZENECA,,35.0,YR,,M,Y,100.5,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
119672372,11967237,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q1,Pharyngeal oedema,,2016,Q1,2,F,20151221.0,20160309.0,20160127,20160317,EXP,,GB-ASTRAZENECA-2016SE06069,ASTRAZENECA,,35.0,YR,,M,Y,100.5,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
119672372,11967237,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q1,Rash generalised,,2016,Q1,2,F,20151221.0,20160309.0,20160127,20160317,EXP,,GB-ASTRAZENECA-2016SE06069,ASTRAZENECA,,35.0,YR,,M,Y,100.5,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
119672372,11967237,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q1,Vomiting,,2016,Q1,2,F,20151221.0,20160309.0,20160127,20160317,EXP,,GB-ASTRAZENECA-2016SE06069,ASTRAZENECA,,35.0,YR,,M,Y,100.5,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
119755951,11975595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5090.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Chronic kidney disease,,2016,Q1,1,I,20150820.0,20150917.0,20160129,20160129,EXP,,US-ASTRAZENECA-2015SE90854,ASTRAZENECA,,25090.0,DY,,M,Y,,,20160129.0,,MD,US,US,2016,Q1,Elderly
119755951,11975595,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5090.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Chronic kidney disease,,2016,Q1,1,I,20150820.0,20150917.0,20160129,20160129,EXP,,US-ASTRAZENECA-2015SE90854,ASTRAZENECA,,25090.0,DY,,M,Y,,,20160129.0,,MD,US,US,2016,Q1,Elderly
119767681,11976768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160111.0,20160122.0,20160129,20160129,EXP,,GB-ASTRAZENECA-2016SE07505,ASTRAZENECA,,61.0,YR,,M,Y,,,20160129.0,,PH,GB,GB,2016,Q1,Adult
120012441,12001244,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Pancreatitis acute,,2016,Q1,1,I,20160112.0,20160129.0,20160204,20160204,EXP,,GB-ASTRAZENECA-2016SE10238,ASTRAZENECA,,51.0,YR,,M,Y,119.0,KG,20160204.0,,MD,GB,GB,2016,Q1,Adult
120107561,12010756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160127.0,20160129.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE10317,ASTRAZENECA,,24750.0,DY,,M,Y,71.6,KG,20160205.0,,MD,GB,GB,2016,Q1,Elderly
120111651,12011165,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160128.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE09705,ASTRAZENECA,,50.0,YR,,F,Y,,,20160205.0,,PH,GB,GB,2016,Q1,Adult
120116521,12011652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,20160119.0,20160128.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE09699,ASTRAZENECA,,56.0,YR,,M,Y,130.0,KG,20160205.0,,OT,GB,GB,2016,Q1,Adult
120116521,12011652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Amylase increased,,2016,Q1,1,I,20160119.0,20160128.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE09699,ASTRAZENECA,,56.0,YR,,M,Y,130.0,KG,20160205.0,,OT,GB,GB,2016,Q1,Adult
120116521,12011652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160119.0,20160128.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE09699,ASTRAZENECA,,56.0,YR,,M,Y,130.0,KG,20160205.0,,OT,GB,GB,2016,Q1,Adult
120116521,12011652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Malaise,,2016,Q1,1,I,20160119.0,20160128.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE09699,ASTRAZENECA,,56.0,YR,,M,Y,130.0,KG,20160205.0,,OT,GB,GB,2016,Q1,Adult
120146301,12014630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Sepsis,,2016,Q1,1,I,,20160129.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE10217,ASTRAZENECA,,71.0,YR,,F,Y,,,20160205.0,,PH,GB,GB,2016,Q1,Elderly
120146301,12014630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Urinary tract infection,,2016,Q1,1,I,,20160129.0,20160205,20160205,EXP,,GB-ASTRAZENECA-2016SE10217,ASTRAZENECA,,71.0,YR,,F,Y,,,20160205.0,,PH,GB,GB,2016,Q1,Elderly
120224002,12022400,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q1,Device related infection,,2016,Q1,2,F,20150406.0,20160217.0,20160206,20160224,EXP,,GB-ABBVIE-16K-167-1549987-00,ABBVIE,,71.0,YR,,M,Y,101.0,KG,20160224.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q1,Elderly
120224002,12022400,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q1,Osteoarthritis,,2016,Q1,2,F,20150406.0,20160217.0,20160206,20160224,EXP,,GB-ABBVIE-16K-167-1549987-00,ABBVIE,,71.0,YR,,M,Y,101.0,KG,20160224.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q1,Elderly
120370902,12037090,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q1,Metastases to lung,,2016,Q1,2,F,201511.0,20160322.0,20160208,20160330,EXP,,US-009507513-1602USA003120,MERCK,,52.0,YR,,M,Y,,,20160330.0,,CN,US,US,2016,Q1,Adult
120370902,12037090,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q1,Pancreatic carcinoma,,2016,Q1,2,F,201511.0,20160322.0,20160208,20160330,EXP,,US-009507513-1602USA003120,MERCK,,52.0,YR,,M,Y,,,20160330.0,,CN,US,US,2016,Q1,Adult
120429761,12042976,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,200805.0,20080908.0,20160208,20160208,PER,,US-ASTRAZENECA-2008BM12807,ASTRAZENECA,,676.0,MON,,F,Y,,,20160208.0,,,US,US,2016,Q1,Elderly
120429761,12042976,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Decreased appetite,,2016,Q1,1,I,200805.0,20080908.0,20160208,20160208,PER,,US-ASTRAZENECA-2008BM12807,ASTRAZENECA,,676.0,MON,,F,Y,,,20160208.0,,,US,US,2016,Q1,Elderly
120429761,12042976,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Fungal infection,,2016,Q1,1,I,200805.0,20080908.0,20160208,20160208,PER,,US-ASTRAZENECA-2008BM12807,ASTRAZENECA,,676.0,MON,,F,Y,,,20160208.0,,,US,US,2016,Q1,Elderly
120429761,12042976,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Nausea,,2016,Q1,1,I,200805.0,20080908.0,20160208,20160208,PER,,US-ASTRAZENECA-2008BM12807,ASTRAZENECA,,676.0,MON,,F,Y,,,20160208.0,,,US,US,2016,Q1,Elderly
120429761,12042976,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Pruritus,,2016,Q1,1,I,200805.0,20080908.0,20160208,20160208,PER,,US-ASTRAZENECA-2008BM12807,ASTRAZENECA,,676.0,MON,,F,Y,,,20160208.0,,,US,US,2016,Q1,Elderly
120429761,12042976,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Weight decreased,,2016,Q1,1,I,200805.0,20080908.0,20160208,20160208,PER,,US-ASTRAZENECA-2008BM12807,ASTRAZENECA,,676.0,MON,,F,Y,,,20160208.0,,,US,US,2016,Q1,Elderly
120467891,12046789,1,PS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Prostate cancer,,2016,Q1,1,I,20140601.0,20140703.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE52304,ASTRAZENECA,,26699.0,DY,,M,Y,,,20160209.0,,CN,US,US,2016,Q1,Elderly
120467891,12046789,1,PS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Transitional cell carcinoma,,2016,Q1,1,I,20140601.0,20140703.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE52304,ASTRAZENECA,,26699.0,DY,,M,Y,,,20160209.0,,CN,US,US,2016,Q1,Elderly
120469281,12046928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, 4D80140A,,202293.0,5.0,MG,TABLET,QD,2016,Q1,Bladder irritation,,2016,Q1,1,I,2015.0,20141008.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE78578,ASTRAZENECA,,65.0,YR,,F,Y,100.2,KG,20160209.0,,CN,US,US,2016,Q1,Elderly
120469281,12046928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, 4D80140A,,202293.0,5.0,MG,TABLET,QD,2016,Q1,Bladder pain,,2016,Q1,1,I,2015.0,20141008.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE78578,ASTRAZENECA,,65.0,YR,,F,Y,100.2,KG,20160209.0,,CN,US,US,2016,Q1,Elderly
120469281,12046928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, 4D80140A,,202293.0,5.0,MG,TABLET,QD,2016,Q1,Blood glucose increased,,2016,Q1,1,I,2015.0,20141008.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE78578,ASTRAZENECA,,65.0,YR,,F,Y,100.2,KG,20160209.0,,CN,US,US,2016,Q1,Elderly
120469281,12046928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, 4D80140A,,202293.0,5.0,MG,TABLET,QD,2016,Q1,Fungal infection,,2016,Q1,1,I,2015.0,20141008.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE78578,ASTRAZENECA,,65.0,YR,,F,Y,100.2,KG,20160209.0,,CN,US,US,2016,Q1,Elderly
120469281,12046928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, 4D80140A,,202293.0,5.0,MG,TABLET,QD,2016,Q1,Oropharyngeal pain,,2016,Q1,1,I,2015.0,20141008.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE78578,ASTRAZENECA,,65.0,YR,,F,Y,100.2,KG,20160209.0,,CN,US,US,2016,Q1,Elderly
120469281,12046928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, 4D80140A,,202293.0,5.0,MG,TABLET,QD,2016,Q1,Rhinorrhoea,,2016,Q1,1,I,2015.0,20141008.0,20160209,20160209,PER,,US-ASTRAZENECA-2014SE78578,ASTRAZENECA,,65.0,YR,,F,Y,100.2,KG,20160209.0,,CN,US,US,2016,Q1,Elderly
120473242,12047324,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6270.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Pneumonia,,2016,Q1,2,F,20160111.0,20160209.0,20160208,20160217,EXP,,RU-ASTRAZENECA-2016SE10885,ASTRAZENECA,,21665.0,DY,,M,Y,,,20160217.0,,MD,RU,RU,2016,Q1,Elderly
120520761,12052076,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, -,,202293.0,5.0,MG,TABLET,,2016,Q1,Arterial stenosis,,2016,Q1,1,I,20151201.0,20160201.0,20160209,20160209,EXP,,GB-ASTRAZENECA-2016SE10711,ASTRAZENECA,,58.0,YR,,F,Y,80.0,KG,20160209.0,,MD,GB,GB,2016,Q1,Adult
120520761,12052076,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, -,,202293.0,5.0,MG,TABLET,,2016,Q1,Cerebral infarction,,2016,Q1,1,I,20151201.0,20160201.0,20160209,20160209,EXP,,GB-ASTRAZENECA-2016SE10711,ASTRAZENECA,,58.0,YR,,F,Y,80.0,KG,20160209.0,,MD,GB,GB,2016,Q1,Adult
120520761,12052076,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, -,,202293.0,5.0,MG,TABLET,,2016,Q1,Cerebrovascular disorder,,2016,Q1,1,I,20151201.0,20160201.0,20160209,20160209,EXP,,GB-ASTRAZENECA-2016SE10711,ASTRAZENECA,,58.0,YR,,F,Y,80.0,KG,20160209.0,,MD,GB,GB,2016,Q1,Adult
120520761,12052076,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, -,,202293.0,5.0,MG,TABLET,,2016,Q1,Circulatory collapse,,2016,Q1,1,I,20151201.0,20160201.0,20160209,20160209,EXP,,GB-ASTRAZENECA-2016SE10711,ASTRAZENECA,,58.0,YR,,F,Y,80.0,KG,20160209.0,,MD,GB,GB,2016,Q1,Adult
120520761,12052076,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, -,,202293.0,5.0,MG,TABLET,,2016,Q1,Dizziness,,2016,Q1,1,I,20151201.0,20160201.0,20160209,20160209,EXP,,GB-ASTRAZENECA-2016SE10711,ASTRAZENECA,,58.0,YR,,F,Y,80.0,KG,20160209.0,,MD,GB,GB,2016,Q1,Adult
120520761,12052076,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, -,,202293.0,5.0,MG,TABLET,,2016,Q1,Orthostatic hypotension,,2016,Q1,1,I,20151201.0,20160201.0,20160209,20160209,EXP,,GB-ASTRAZENECA-2016SE10711,ASTRAZENECA,,58.0,YR,,F,Y,80.0,KG,20160209.0,,MD,GB,GB,2016,Q1,Adult
120698151,12069815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diarrhoea,,2016,Q1,1,I,,20160203.0,20160211,20160211,EXP,,GB-ASTRAZENECA-2016SE11818,ASTRAZENECA,,45.0,YR,,F,Y,60.0,KG,20160211.0,,MD,GB,GB,2016,Q1,Adult
120698151,12069815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Ketoacidosis,,2016,Q1,1,I,,20160203.0,20160211,20160211,EXP,,GB-ASTRAZENECA-2016SE11818,ASTRAZENECA,,45.0,YR,,F,Y,60.0,KG,20160211.0,,MD,GB,GB,2016,Q1,Adult
120698151,12069815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Lethargy,,2016,Q1,1,I,,20160203.0,20160211,20160211,EXP,,GB-ASTRAZENECA-2016SE11818,ASTRAZENECA,,45.0,YR,,F,Y,60.0,KG,20160211.0,,MD,GB,GB,2016,Q1,Adult
120698151,12069815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Somnolence,,2016,Q1,1,I,,20160203.0,20160211,20160211,EXP,,GB-ASTRAZENECA-2016SE11818,ASTRAZENECA,,45.0,YR,,F,Y,60.0,KG,20160211.0,,MD,GB,GB,2016,Q1,Adult
120698151,12069815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Vomiting,,2016,Q1,1,I,,20160203.0,20160211,20160211,EXP,,GB-ASTRAZENECA-2016SE11818,ASTRAZENECA,,45.0,YR,,F,Y,60.0,KG,20160211.0,,MD,GB,GB,2016,Q1,Adult
120774062,12077406,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,315.0,MG,,,,,,5.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,2,F,20160209.0,20160315.0,20160215,20160318,EXP,,US-ASTRAZENECA-2016SE15531,ASTRAZENECA,,22763.0,DY,,,Y,,,20160318.0,,MD,US,US,2016,Q1,Elderly
120785101,12078510,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160208.0,20160216,20160216,EXP,,US-ASTRAZENECA-2016SE13876,ASTRAZENECA,,34.0,YR,,F,Y,,,20160216.0,,OT,US,US,2016,Q1,Young Adult
120804351,12080435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Brain stem stroke,,2016,Q1,1,I,,20160208.0,20160216,20160216,EXP,,US-ASTRAZENECA-2016SE13814,ASTRAZENECA,,60.0,YR,,M,Y,,,20160216.0,,MD,US,US,2016,Q1,Adult
120804351,12080435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Cerebellar ischaemia,,2016,Q1,1,I,,20160208.0,20160216,20160216,EXP,,US-ASTRAZENECA-2016SE13814,ASTRAZENECA,,60.0,YR,,M,Y,,,20160216.0,,MD,US,US,2016,Q1,Adult
120804831,12080483,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Basal ganglia infarction,,2016,Q1,1,I,,20160208.0,20160216,20160216,EXP,,US-ASTRAZENECA-2016SE13847,ASTRAZENECA,,60.0,YR,,F,Y,,,20160216.0,,MD,US,US,2016,Q1,Adult
120804831,12080483,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Hemiplegia,,2016,Q1,1,I,,20160208.0,20160216,20160216,EXP,,US-ASTRAZENECA-2016SE13847,ASTRAZENECA,,60.0,YR,,F,Y,,,20160216.0,,MD,US,US,2016,Q1,Adult
120894601,12089460,7,C,DAPAGLIFLOZIN W/METFORMIN,,2,Oral,UNK,,,,, UNKNOWN,,,,,,,2016,Q1,Epistaxis,,2016,Q1,1,I,201510.0,20151021.0,20160218,20160218,PER,,US-PERRIGO-15US011131,PERRIGO,,32.0,YR,,F,Y,86.17,KG,20160218.0,,CN,US,US,2016,Q1,Young Adult
120894601,12089460,7,C,DAPAGLIFLOZIN W/METFORMIN,,2,Oral,UNK,,,,, UNKNOWN,,,,,,,2016,Q1,Nasal dryness,,2016,Q1,1,I,201510.0,20151021.0,20160218,20160218,PER,,US-PERRIGO-15US011131,PERRIGO,,32.0,YR,,F,Y,86.17,KG,20160218.0,,CN,US,US,2016,Q1,Young Adult
120898061,12089806,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,8390.417,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160128.0,20160210.0,20160218,20160218,EXP,,GB-ASTRAZENECA-2016SE14424,ASTRAZENECA,,59.0,YR,,M,Y,115.0,KG,20160218.0,,MD,GB,GB,2016,Q1,Adult
120898061,12089806,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,8390.417,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Lower respiratory tract infection,,2016,Q1,1,I,20160128.0,20160210.0,20160218,20160218,EXP,,GB-ASTRAZENECA-2016SE14424,ASTRAZENECA,,59.0,YR,,M,Y,115.0,KG,20160218.0,,MD,GB,GB,2016,Q1,Adult
120913181,12091318,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2016,Q1,Acute myocardial infarction,,2016,Q1,1,I,,20151014.0,20160218,20160218,EXP,,BR-ASTRAZENECA-2016SE17022,ASTRAZENECA,,63.0,YR,,M,Y,91.0,KG,20160218.0,,MD,BR,BR,2016,Q1,Adult
120913181,12091318,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2016,Q1,Blood cholesterol increased,,2016,Q1,1,I,,20151014.0,20160218,20160218,EXP,,BR-ASTRAZENECA-2016SE17022,ASTRAZENECA,,63.0,YR,,M,Y,91.0,KG,20160218.0,,MD,BR,BR,2016,Q1,Adult
120913181,12091318,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,,20151014.0,20160218,20160218,EXP,,BR-ASTRAZENECA-2016SE17022,ASTRAZENECA,,63.0,YR,,M,Y,91.0,KG,20160218.0,,MD,BR,BR,2016,Q1,Adult
120913181,12091318,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2016,Q1,Low density lipoprotein increased,,2016,Q1,1,I,,20151014.0,20160218,20160218,EXP,,BR-ASTRAZENECA-2016SE17022,ASTRAZENECA,,63.0,YR,,M,Y,91.0,KG,20160218.0,,MD,BR,BR,2016,Q1,Adult
120913181,12091318,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2016,Q1,Weight decreased,,2016,Q1,1,I,,20151014.0,20160218,20160218,EXP,,BR-ASTRAZENECA-2016SE17022,ASTRAZENECA,,63.0,YR,,M,Y,91.0,KG,20160218.0,,MD,BR,BR,2016,Q1,Adult
120942821,12094282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160118.0,20160212.0,20160219,20160219,EXP,,GB-ASTRAZENECA-2016SE15451,ASTRAZENECA,,56.0,YR,,M,Y,,,20160219.0,,MD,GB,GB,2016,Q1,Adult
120942821,12094282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Fatigue,,2016,Q1,1,I,20160118.0,20160212.0,20160219,20160219,EXP,,GB-ASTRAZENECA-2016SE15451,ASTRAZENECA,,56.0,YR,,M,Y,,,20160219.0,,MD,GB,GB,2016,Q1,Adult
120942821,12094282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Malaise,,2016,Q1,1,I,20160118.0,20160212.0,20160219,20160219,EXP,,GB-ASTRAZENECA-2016SE15451,ASTRAZENECA,,56.0,YR,,M,Y,,,20160219.0,,MD,GB,GB,2016,Q1,Adult
120942821,12094282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Thirst,,2016,Q1,1,I,20160118.0,20160212.0,20160219,20160219,EXP,,GB-ASTRAZENECA-2016SE15451,ASTRAZENECA,,56.0,YR,,M,Y,,,20160219.0,,MD,GB,GB,2016,Q1,Adult
121114761,12111476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Decreased appetite,,2016,Q1,1,I,,20160216.0,20160224,20160224,EXP,,KR-ASTRAZENECA-2016SE17669,ASTRAZENECA,A CASE OF DIABETIC KETOACIDOSIS INDUCED BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR. J KOREAN DIABETES 2015? 16:310-314.,73.0,YR,,F,Y,70.0,KG,20160224.0,,MD,KR,KR,2016,Q1,Elderly
121114761,12111476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160216.0,20160224,20160224,EXP,,KR-ASTRAZENECA-2016SE17669,ASTRAZENECA,A CASE OF DIABETIC KETOACIDOSIS INDUCED BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR. J KOREAN DIABETES 2015? 16:310-314.,73.0,YR,,F,Y,70.0,KG,20160224.0,,MD,KR,KR,2016,Q1,Elderly
121114761,12111476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Diarrhoea,,2016,Q1,1,I,,20160216.0,20160224,20160224,EXP,,KR-ASTRAZENECA-2016SE17669,ASTRAZENECA,A CASE OF DIABETIC KETOACIDOSIS INDUCED BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR. J KOREAN DIABETES 2015? 16:310-314.,73.0,YR,,F,Y,70.0,KG,20160224.0,,MD,KR,KR,2016,Q1,Elderly
121114761,12111476,2,SS,METFORMIN + DAPAGLIFLOZIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Decreased appetite,,2016,Q1,1,I,,20160216.0,20160224,20160224,EXP,,KR-ASTRAZENECA-2016SE17669,ASTRAZENECA,A CASE OF DIABETIC KETOACIDOSIS INDUCED BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR. J KOREAN DIABETES 2015? 16:310-314.,73.0,YR,,F,Y,70.0,KG,20160224.0,,MD,KR,KR,2016,Q1,Elderly
121114761,12111476,2,SS,METFORMIN + DAPAGLIFLOZIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160216.0,20160224,20160224,EXP,,KR-ASTRAZENECA-2016SE17669,ASTRAZENECA,A CASE OF DIABETIC KETOACIDOSIS INDUCED BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR. J KOREAN DIABETES 2015? 16:310-314.,73.0,YR,,F,Y,70.0,KG,20160224.0,,MD,KR,KR,2016,Q1,Elderly
121114761,12111476,2,SS,METFORMIN + DAPAGLIFLOZIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Diarrhoea,,2016,Q1,1,I,,20160216.0,20160224,20160224,EXP,,KR-ASTRAZENECA-2016SE17669,ASTRAZENECA,A CASE OF DIABETIC KETOACIDOSIS INDUCED BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR. J KOREAN DIABETES 2015? 16:310-314.,73.0,YR,,F,Y,70.0,KG,20160224.0,,MD,KR,KR,2016,Q1,Elderly
121282103,12128210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,3,F,20160212.0,20160304.0,20160229,20160308,EXP,,PL-ASTRAZENECA-2016SE20852,ASTRAZENECA,,25442.0,DY,,M,Y,,,20160308.0,,MD,PL,PL,2016,Q1,Elderly
121282103,12128210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic metabolic decompensation,,2016,Q1,3,F,20160212.0,20160304.0,20160229,20160308,EXP,,PL-ASTRAZENECA-2016SE20852,ASTRAZENECA,,25442.0,DY,,M,Y,,,20160308.0,,MD,PL,PL,2016,Q1,Elderly
121282103,12128210,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,3,F,20160212.0,20160304.0,20160229,20160308,EXP,,PL-ASTRAZENECA-2016SE20852,ASTRAZENECA,,25442.0,DY,,M,Y,,,20160308.0,,MD,PL,PL,2016,Q1,Elderly
121282103,12128210,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic metabolic decompensation,,2016,Q1,3,F,20160212.0,20160304.0,20160229,20160308,EXP,,PL-ASTRAZENECA-2016SE20852,ASTRAZENECA,,25442.0,DY,,M,Y,,,20160308.0,,MD,PL,PL,2016,Q1,Elderly
121282461,12128246,3,SS,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,,N,,,,10.0,MG,,QD,2016,Q1,Dehydration,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,3,SS,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,,N,,,,10.0,MG,,QD,2016,Q1,Ketoacidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121282461,12128246,3,SS,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,,N,,,,10.0,MG,,QD,2016,Q1,Lactic acidosis,,2016,Q1,1,I,,20160215.0,20160229,20160229,EXP,,DK-IPCA LABORATORIES LIMITED-IPC201602-000284,IPCA,"STORGAARD H,BAGGER J,KNOP F,VILSBOLL T,RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC CLIN PHARMACOL TOXICOL 2016 FEB?118(2):168-70.",44.0,YR,,M,Y,,,20160229.0,,OT,DK,DK,2016,Q1,Adult
121336521,12133652,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,,U,,,,10.0,MG,,,2016,Q1,Congenital hydrocephalus,,2016,Q1,1,I,,20160223.0,20160301,20160301,EXP,GB-MHRA-ADR 23357992,PHHY2016GB024615,SANDOZ,,20.0,WK,,,Y,,,20160301.0,,OT,GB,GB,2016,Q1,Youth
121336521,12133652,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, UNK",,,,U,,,,10.0,MG,,,2016,Q1,Foetal exposure during pregnancy,,2016,Q1,1,I,,20160223.0,20160301,20160301,EXP,GB-MHRA-ADR 23357992,PHHY2016GB024615,SANDOZ,,20.0,WK,,,Y,,,20160301.0,,OT,GB,GB,2016,Q1,Youth
121398881,12139888,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,2016.0,20160225.0,20160303,20160303,EXP,GB-MHRA-EYC 00135508,GB-009507513-1603GBR000777,MERCK,,53.0,YR,,M,Y,82.0,KG,20160303.0,,CN,CH,GB,2016,Q1,Adult
121398881,12139888,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q1,Blood creatine phosphokinase increased,,2016,Q1,1,I,2016.0,20160225.0,20160303,20160303,EXP,GB-MHRA-EYC 00135508,GB-009507513-1603GBR000777,MERCK,,53.0,YR,,M,Y,82.0,KG,20160303.0,,CN,CH,GB,2016,Q1,Adult
121398881,12139888,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q1,Rhabdomyolysis,,2016,Q1,1,I,2016.0,20160225.0,20160303,20160303,EXP,GB-MHRA-EYC 00135508,GB-009507513-1603GBR000777,MERCK,,53.0,YR,,M,Y,82.0,KG,20160303.0,,CN,CH,GB,2016,Q1,Adult
121406511,12140651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160213.0,20160224.0,20160303,20160303,EXP,,GB-ASTRAZENECA-2016SE20046,ASTRAZENECA,,58.0,YR,,M,Y,103.0,KG,20160303.0,,PH,GB,GB,2016,Q1,Adult
121406731,12140673,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160213.0,20160224.0,20160303,20160303,EXP,,GB-ASTRAZENECA-2016SE19711,ASTRAZENECA,,25.0,YR,,M,Y,85.8,KG,20160303.0,,OT,GB,GB,2016,Q1,Young Adult
121418591,12141859,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160210.0,20160224.0,20160303,20160303,EXP,,GB-ASTRAZENECA-2016SE19687,ASTRAZENECA,,68.0,YR,,M,Y,90.0,KG,20160303.0,,MD,GB,GB,2016,Q1,Elderly
121471341,12147134,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, A958A,,202293.0,10.0,MG,TABLET,,2016,Q1,Abdominal pain,,2016,Q1,1,I,20160217.0,20160226.0,20160304,20160304,EXP,,GB-ASTRAZENECA-2016SE20781,ASTRAZENECA,,70.0,YR,,M,Y,80.0,KG,20160304.0,,MD,GB,GB,2016,Q1,Elderly
121471341,12147134,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, A958A,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160217.0,20160226.0,20160304,20160304,EXP,,GB-ASTRAZENECA-2016SE20781,ASTRAZENECA,,70.0,YR,,M,Y,80.0,KG,20160304.0,,MD,GB,GB,2016,Q1,Elderly
121471341,12147134,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, A958A,,202293.0,10.0,MG,TABLET,,2016,Q1,Metabolic acidosis,,2016,Q1,1,I,20160217.0,20160226.0,20160304,20160304,EXP,,GB-ASTRAZENECA-2016SE20781,ASTRAZENECA,,70.0,YR,,M,Y,80.0,KG,20160304.0,,MD,GB,GB,2016,Q1,Elderly
121560991,12156099,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",221.042,DF,,,,,,1.0,DF,,QD,2016,Q1,Neutropenia,,2016,Q1,1,I,20160223.0,20160302.0,20160307,20160307,EXP,GB-MHRA-TPP5724859C3366081YC1456251754719,GB-ELI_LILLY_AND_COMPANY-GB201603000736,ELI LILLY AND CO,,33.0,YR,,M,Y,102.0,KG,20160303.0,,CN,GB,GB,2016,Q1,Young Adult
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Blood cholesterol increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Blood creatinine increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Blood triglycerides increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Blood urea increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Blood uric acid increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Fatigue,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,High density lipoprotein decreased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Low density lipoprotein increased,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Prostate cancer,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121611261,12161126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Weight fluctuation,,2016,Q1,1,I,20150707.0,20151030.0,20160308,20160308,EXP,,BR-ASTRAZENECA-2016SE25863,ASTRAZENECA,,84.0,YR,,M,Y,74.5,KG,20160308.0,,MD,BR,BR,2016,Q1,Elderly
121613522,12161352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,,,,,,5.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,2,F,20160228.0,20160309.0,20160308,20160311,EXP,,US-ASTRAZENECA-2016SE21864,ASTRAZENECA,,14437.0,DY,,,Y,,,20160311.0,,MD,US,US,2016,Q1,Elderly
121655221,12165522,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,,U, UKNOWN,,202293.0,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160219.0,20160302.0,20160309,20160309,EXP,,GB-ASTRAZENECA-2016SE22778,ASTRAZENECA,,46.0,YR,,F,Y,,,20160309.0,,OT,GB,GB,2016,Q1,Adult
121685281,12168528,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160206.0,20160302.0,20160310,20160310,EXP,,GB-ASTRAZENECA-2016SE22825,ASTRAZENECA,,72.0,YR,,M,Y,91.8,KG,20160310.0,,MD,GB,GB,2016,Q1,Elderly
121824571,12182457,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,,20151027.0,20160316,20160316,EXP,,BR-ASTRAZENECA-2016SE28593,ASTRAZENECA,,64.0,YR,,F,Y,60.1,KG,20160316.0,,MD,BR,BR,2016,Q1,Adult
121824571,12182457,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Weight decreased,,2016,Q1,1,I,,20151027.0,20160316,20160316,EXP,,BR-ASTRAZENECA-2016SE28593,ASTRAZENECA,,64.0,YR,,F,Y,60.1,KG,20160316.0,,MD,BR,BR,2016,Q1,Adult
121881651,12188165,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160309.0,20160317,20160317,EXP,,GB-ASTRAZENECA-2016SE26575,ASTRAZENECA,,60.0,YR,,F,Y,65.0,KG,20160317.0,,MD,GB,GB,2016,Q1,Adult
121895521,12189552,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160311.0,20160318,20160318,EXP,,GB-ASTRAZENECA-2016SE28084,ASTRAZENECA,,59.0,YR,,F,Y,,,20160318.0,,OT,GB,GB,2016,Q1,Adult
121916021,12191602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160311.0,20160318,20160318,EXP,,GB-ASTRAZENECA-2016SE27627,ASTRAZENECA,,46.0,YR,,F,Y,,,20160318.0,,PH,GB,GB,2016,Q1,Adult
121919131,12191913,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160311.0,20160318,20160318,EXP,,GB-ASTRAZENECA-2016SE28077,ASTRAZENECA,,51.0,YR,,F,Y,,,20160318.0,,OT,GB,GB,2016,Q1,Adult
121922531,12192253,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q1,Eye swelling,,2016,Q1,1,I,20151016.0,20160311.0,20160318,20160318,EXP,,DE-ASTRAZENECA-2016SE28561,ASTRAZENECA,,66.0,YR,,M,Y,98.0,KG,20160318.0,,MD,DE,DE,2016,Q1,Elderly
121929782,12192978,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Acute kidney injury,,2016,Q1,2,F,,20160311.0,20160318,20160322,EXP,,GB-ASTRAZENECA-2016SE28087,ASTRAZENECA,,56.0,YR,,F,Y,,,20160318.0,,OT,GB,GB,2016,Q1,Adult
121929782,12192978,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,2,F,,20160311.0,20160318,20160322,EXP,,GB-ASTRAZENECA-2016SE28087,ASTRAZENECA,,56.0,YR,,F,Y,,,20160318.0,,OT,GB,GB,2016,Q1,Adult
121929782,12192978,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Gastroenteritis,,2016,Q1,2,F,,20160311.0,20160318,20160322,EXP,,GB-ASTRAZENECA-2016SE28087,ASTRAZENECA,,56.0,YR,,F,Y,,,20160318.0,,OT,GB,GB,2016,Q1,Adult
121929782,12192978,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Weight decreased,,2016,Q1,2,F,,20160311.0,20160318,20160322,EXP,,GB-ASTRAZENECA-2016SE28087,ASTRAZENECA,,56.0,YR,,F,Y,,,20160318.0,,OT,GB,GB,2016,Q1,Adult
121950501,12195050,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,5.0,MG,,QD,2016,Q1,Fungal infection,,2016,Q1,1,I,20151005.0,,20160318,20160318,DIR,,,,,42.0,YR,,F,N,76.6,KG,20151221.0,N,PH,US,,2016,Q1,Adult
121954451,12195445,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Hyperglycaemia,,2016,Q1,1,I,,20151027.0,20160321,20160321,EXP,,BR-PFIZER INC-2016161126,PFIZER,,64.0,YR,,F,Y,60.1,KG,20160321.0,,MD,BR,BR,2016,Q1,Adult
121954451,12195445,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,TABLET,QD,2016,Q1,Weight decreased,,2016,Q1,1,I,,20151027.0,20160321,20160321,EXP,,BR-PFIZER INC-2016161126,PFIZER,,64.0,YR,,F,Y,60.1,KG,20160321.0,,MD,BR,BR,2016,Q1,Adult
121995771,12199577,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DF, UNK",,,,U,,,,2.0,DF,,QD,2016,Q1,Abdominal discomfort,,2016,Q1,1,I,20160225.0,20160315.0,20160322,20160322,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201603005724,ELI LILLY AND CO,,46.0,YR,,M,Y,88.0,KG,20160321.0,,CN,DE,DE,2016,Q1,Adult
121995771,12199577,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DF, UNK",,,,U,,,,2.0,DF,,QD,2016,Q1,Faecaloma,,2016,Q1,1,I,20160225.0,20160315.0,20160322,20160322,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201603005724,ELI LILLY AND CO,,46.0,YR,,M,Y,88.0,KG,20160321.0,,CN,DE,DE,2016,Q1,Adult
121995771,12199577,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DF, UNK",,,,U,,,,2.0,DF,,QD,2016,Q1,Gastrooesophageal reflux disease,,2016,Q1,1,I,20160225.0,20160315.0,20160322,20160322,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201603005724,ELI LILLY AND CO,,46.0,YR,,M,Y,88.0,KG,20160321.0,,CN,DE,DE,2016,Q1,Adult
121995771,12199577,2,SS,DAPAGLIFLOZIN W/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DF, UNK",,,,U,,,,2.0,DF,,QD,2016,Q1,Haematemesis,,2016,Q1,1,I,20160225.0,20160315.0,20160322,20160322,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201603005724,ELI LILLY AND CO,,46.0,YR,,M,Y,88.0,KG,20160321.0,,CN,DE,DE,2016,Q1,Adult
121996861,12199686,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q1,Nasal congestion,,2016,Q1,1,I,,20160309.0,20160322,20160322,PER,,US-BAYER-2016-048215,BAYER,,65.0,YR,E,F,Y,,,20160322.0,,CN,US,US,2016,Q1,Elderly
122043671,12204367,1,PS,DAPAGLIFLOZIN + METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,U,,,205649.0,1.0,DF,TABLET,BID,2016,Q1,Abdominal discomfort,,2016,Q1,1,I,20160225.0,20160315.0,20160323,20160323,EXP,,DE-ASTRAZENECA-2016SE29707,ASTRAZENECA,,46.0,YR,,M,Y,88.0,KG,20160323.0,,,DE,DE,2016,Q1,Adult
122043671,12204367,1,PS,DAPAGLIFLOZIN + METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,U,,,205649.0,1.0,DF,TABLET,BID,2016,Q1,Faecaloma,,2016,Q1,1,I,20160225.0,20160315.0,20160323,20160323,EXP,,DE-ASTRAZENECA-2016SE29707,ASTRAZENECA,,46.0,YR,,M,Y,88.0,KG,20160323.0,,,DE,DE,2016,Q1,Adult
122043671,12204367,1,PS,DAPAGLIFLOZIN + METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,U,,,205649.0,1.0,DF,TABLET,BID,2016,Q1,Gastrooesophageal reflux disease,,2016,Q1,1,I,20160225.0,20160315.0,20160323,20160323,EXP,,DE-ASTRAZENECA-2016SE29707,ASTRAZENECA,,46.0,YR,,M,Y,88.0,KG,20160323.0,,,DE,DE,2016,Q1,Adult
122043671,12204367,1,PS,DAPAGLIFLOZIN + METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,U,,,205649.0,1.0,DF,TABLET,BID,2016,Q1,Haematemesis,,2016,Q1,1,I,20160225.0,20160315.0,20160323,20160323,EXP,,DE-ASTRAZENECA-2016SE29707,ASTRAZENECA,,46.0,YR,,M,Y,88.0,KG,20160323.0,,,DE,DE,2016,Q1,Adult
122050851,12205085,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Haemorrhoidal haemorrhage,,2016,Q1,1,I,201502.0,20160115.0,20160323,20160323,EXP,,US-BAYER-2016-013035,BAYER,,64.0,YR,A,F,Y,,,20160323.0,,CN,US,US,2016,Q1,Adult
122054141,12205414,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Ketonuria,,2016,Q1,1,I,20160129.0,20160315.0,20160323,20160323,EXP,,GB-ASTRAZENECA-2016SE28894,ASTRAZENECA,,59.0,YR,,M,Y,,,20160323.0,,MD,GB,GB,2016,Q1,Adult
122054141,12205414,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Malaise,,2016,Q1,1,I,20160129.0,20160315.0,20160323,20160323,EXP,,GB-ASTRAZENECA-2016SE28894,ASTRAZENECA,,59.0,YR,,M,Y,,,20160323.0,,MD,GB,GB,2016,Q1,Adult
122054141,12205414,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Polyuria,,2016,Q1,1,I,20160129.0,20160315.0,20160323,20160323,EXP,,GB-ASTRAZENECA-2016SE28894,ASTRAZENECA,,59.0,YR,,M,Y,,,20160323.0,,MD,GB,GB,2016,Q1,Adult
122054141,12205414,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Thirst,,2016,Q1,1,I,20160129.0,20160315.0,20160323,20160323,EXP,,GB-ASTRAZENECA-2016SE28894,ASTRAZENECA,,59.0,YR,,M,Y,,,20160323.0,,MD,GB,GB,2016,Q1,Adult
122163151,12216315,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6200.417,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160306.0,20160321.0,20160329,20160329,EXP,,GB-ASTRAZENECA-2016SE30991,ASTRAZENECA,,53.0,YR,,F,Y,,,20160329.0,,PH,GB,GB,2016,Q1,Adult
122163151,12216315,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6200.417,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q1,Loss of consciousness,,2016,Q1,1,I,20160306.0,20160321.0,20160329,20160329,EXP,,GB-ASTRAZENECA-2016SE30991,ASTRAZENECA,,53.0,YR,,F,Y,,,20160329.0,,PH,GB,GB,2016,Q1,Adult
122244791,12224479,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,340.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160314.0,20160324.0,20160331,20160331,EXP,,GB-ASTRAZENECA-2016SE32434,ASTRAZENECA,,52.0,YR,,F,Y,,,20160331.0,,PH,GB,GB,2016,Q1,Adult
122263881,12226388,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q1,Ketoacidosis,,2016,Q1,1,I,20160214.0,20160323.0,20160331,20160331,EXP,,GB-ASTRAZENECA-2016SE32210,ASTRAZENECA,,49.0,YR,,F,Y,,,20160331.0,,MD,GB,GB,2016,Q1,Adult
122273001,12227300,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160211.0,20160324.0,20160331,20160331,EXP,,GB-ASTRAZENECA-2016SE32407,ASTRAZENECA,,67.0,YR,,M,Y,,,20160331.0,,MD,GB,GB,2016,Q1,Elderly
110114525,11011452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1550.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q2,Metastatic neoplasm,,2016,Q2,5,F,20150402.0,20160407.0,20150410,20160411,EXP,,RU-ASTRAZENECA-2015SE31924,ASTRAZENECA,,23037.0,DY,,F,Y,,,20160411.0,,MD,RU,RU,2016,Q2,Elderly
110114525,11011452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1550.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q2,Ovarian cancer,,2016,Q2,5,F,20150402.0,20160407.0,20150410,20160411,EXP,,RU-ASTRAZENECA-2015SE31924,ASTRAZENECA,,23037.0,DY,,F,Y,,,20160411.0,,MD,RU,RU,2016,Q2,Elderly
110116767,11011676,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1810.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Intervertebral disc protrusion,,2016,Q2,7,F,20150119.0,20151110.0,20150410,20160425,EXP,,RU-ASTRAZENECA-2015SE17912,ASTRAZENECA,,23089.0,DY,,M,Y,,,20160425.0,,MD,RU,RU,2016,Q2,Elderly
110116767,11011676,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1810.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Spinal cord neoplasm,,2016,Q2,7,F,20150119.0,20151110.0,20150410,20160425,EXP,,RU-ASTRAZENECA-2015SE17912,ASTRAZENECA,,23089.0,DY,,M,Y,,,20160425.0,,MD,RU,RU,2016,Q2,Elderly
1107992712,11079927,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5330.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Acute kidney injury,,2016,Q2,12,F,20150322.0,20160331.0,20150430,20160405,EXP,,US-ASTRAZENECA-2015SE40169,ASTRAZENECA,,22484.0,DY,,M,Y,,,20160405.0,,MD,US,US,2016,Q2,Elderly
1107992712,11079927,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5330.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Clostridium difficile colitis,,2016,Q2,12,F,20150322.0,20160331.0,20150430,20160405,EXP,,US-ASTRAZENECA-2015SE40169,ASTRAZENECA,,22484.0,DY,,M,Y,,,20160405.0,,MD,US,US,2016,Q2,Elderly
1107992712,11079927,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5330.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Pleural effusion,,2016,Q2,12,F,20150322.0,20160331.0,20150430,20160405,EXP,,US-ASTRAZENECA-2015SE40169,ASTRAZENECA,,22484.0,DY,,M,Y,,,20160405.0,,MD,US,US,2016,Q2,Elderly
1107992712,11079927,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5330.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Pneumonia,,2016,Q2,12,F,20150322.0,20160331.0,20150430,20160405,EXP,,US-ASTRAZENECA-2015SE40169,ASTRAZENECA,,22484.0,DY,,M,Y,,,20160405.0,,MD,US,US,2016,Q2,Elderly
1107992712,11079927,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5330.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Septic shock,,2016,Q2,12,F,20150322.0,20160331.0,20150430,20160405,EXP,,US-ASTRAZENECA-2015SE40169,ASTRAZENECA,,22484.0,DY,,M,Y,,,20160405.0,,MD,US,US,2016,Q2,Elderly
111237203,11123720,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Purpura,,2016,Q2,3,F,20140614.0,20160622.0,20150519,20160630,EXP,,CA-ASTRAZENECA-2015SE45036,ASTRAZENECA,,68.0,YR,,F,Y,,,20160630.0,,MD,CA,CA,2016,Q2,Elderly
111237203,11123720,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Purpura,,2016,Q2,3,F,20140614.0,20160622.0,20150519,20160630,EXP,,CA-ASTRAZENECA-2015SE45036,ASTRAZENECA,,68.0,YR,,F,Y,,,20160630.0,,MD,CA,CA,2016,Q2,Elderly
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Decreased appetite,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidotic hyperglycaemic coma,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Dyspnoea,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Hyperglycaemia,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Nausea,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Pancreatitis,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Prerenal failure,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Shock,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112194342,11219434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Staphylococcus test positive,,2016,Q2,2,F,,20160428.0,20150625,20160506,EXP,,AT-ASTRAZENECA-2015SE62482,ASTRAZENECA,,50.0,YR,,F,Y,,,20160507.0,,MD,AT,AT,2016,Q2,Adult
112774763,11277476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7160.0,MG,,U,,,,10.0,MG,TABLET,QD,2016,Q2,Bladder cancer,,2016,Q2,3,F,20150612.0,20160422.0,20150716,20160430,EXP,,US-ASTRAZENECA-2015SE67587,ASTRAZENECA,,28874.0,DY,,M,Y,,,20160430.0,,MD,US,US,2016,Q2,Elderly
112774763,11277476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7160.0,MG,,U,,,,10.0,MG,TABLET,QD,2016,Q2,Haematuria,,2016,Q2,3,F,20150612.0,20160422.0,20150716,20160430,EXP,,US-ASTRAZENECA-2015SE67587,ASTRAZENECA,,28874.0,DY,,M,Y,,,20160430.0,,MD,US,US,2016,Q2,Elderly
116204792,11620479,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Cardiac failure congestive,,2016,Q2,2,F,20150122.0,20150206.0,20151012,20160604,EXP,,US-ASTRAZENECA-2015SE09817,ASTRAZENECA,,27409.0,DY,,F,Y,,,20160604.0,,MD,US,US,2016,Q2,Elderly
116204792,11620479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Cardiac failure congestive,,2016,Q2,2,F,20150122.0,20150206.0,20151012,20160604,EXP,,US-ASTRAZENECA-2015SE09817,ASTRAZENECA,,27409.0,DY,,F,Y,,,20160604.0,,MD,US,US,2016,Q2,Elderly
116204792,11620479,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Cardiac failure congestive,,2016,Q2,2,F,20150122.0,20150206.0,20151012,20160604,EXP,,US-ASTRAZENECA-2015SE09817,ASTRAZENECA,,27409.0,DY,,F,Y,,,20160604.0,,MD,US,US,2016,Q2,Elderly
117206302,11720630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Hypercapnia,,2016,Q2,2,F,20151027.0,20160426.0,20151110,20160430,EXP,,CA-ASTRAZENECA-2015SF08356,ASTRAZENECA,,69.0,YR,,M,Y,,,20160430.0,,MD,CA,CA,2016,Q2,Elderly
117206302,11720630,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Hypercapnia,,2016,Q2,2,F,20151027.0,20160426.0,20151110,20160430,EXP,,CA-ASTRAZENECA-2015SF08356,ASTRAZENECA,,69.0,YR,,M,Y,,,20160430.0,,MD,CA,CA,2016,Q2,Elderly
117626412,11762641,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Dyspepsia,,2016,Q2,2,F,20141001.0,20160412.0,20151120,20160420,EXP,,BR-ASTRAZENECA-2015SF11572,ASTRAZENECA,,22829.0,DY,,M,Y,,,20160421.0,,MD,BR,BR,2016,Q2,Elderly
120107562,12010756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,2,F,20160127.0,20160528.0,20160205,20160604,EXP,,GB-ASTRAZENECA-2016SE10317,ASTRAZENECA,,24750.0,DY,,M,Y,71.6,KG,20160604.0,,MD,GB,GB,2016,Q2,Elderly
120949653,12094965,7,C,Dapagliflozin,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2016,Q2,Anaemia,,2016,Q2,3,F,20160211.0,20160426.0,20160219,20160505,EXP,,"AU-KADMON PHARMACEUTICALS, LLC-KAD201602-000568",KADMON,,58.0,YR,,F,Y,94.8,KG,20160505.0,,OT,AU,AU,2016,Q2,Adult
121224594,12122459,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,,,,,,5.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,4,F,20160214.0,20160330.0,20160226,20160407,EXP,,JM-ASTRAZENECA-2016SE17497,ASTRAZENECA,,15448.0,DY,,F,Y,,,20160407.0,,MD,JP,JP,2016,Q2,Elderly
121389016,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Alanine aminotransferase increased,,2016,Q2,6,F,201601.0,20160412.0,20160302,20160422,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160422.0,,MD,DE,DE,2016,Q2,Adult
121389016,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Aspartate aminotransferase increased,,2016,Q2,6,F,201601.0,20160412.0,20160302,20160422,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160422.0,,MD,DE,DE,2016,Q2,Adult
121389016,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Immune reconstitution inflammatory syndrome,,2016,Q2,6,F,201601.0,20160412.0,20160302,20160422,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160422.0,,MD,DE,DE,2016,Q2,Adult
121389016,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Pneumonia aspiration,,2016,Q2,6,F,201601.0,20160412.0,20160302,20160422,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160422.0,,MD,DE,DE,2016,Q2,Adult
121389016,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Progressive multifocal leukoencephalopathy,,2016,Q2,6,F,201601.0,20160412.0,20160302,20160422,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160422.0,,MD,DE,DE,2016,Q2,Adult
121389016,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Sepsis,,2016,Q2,6,F,201601.0,20160412.0,20160302,20160422,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160422.0,,MD,DE,DE,2016,Q2,Adult
121996862,12199686,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q2,Dry mouth,,2016,Q2,2,F,20160219.0,20160606.0,20160322,20160616,PER,,US-BAYER-2016-048215,BAYER,,65.0,YR,E,F,Y,,,20160616.0,,CN,US,US,2016,Q2,Elderly
121996862,12199686,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q2,Nasal congestion,,2016,Q2,2,F,20160219.0,20160606.0,20160322,20160616,PER,,US-BAYER-2016-048215,BAYER,,65.0,YR,E,F,Y,,,20160616.0,,CN,US,US,2016,Q2,Elderly
122050852,12205085,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Haemorrhoidal haemorrhage,,2016,Q2,2,F,201502.0,20160602.0,20160323,20160617,EXP,,US-BAYER-2016-013035,BAYER,,64.0,YR,A,F,Y,,,20160617.0,,CN,US,US,2016,Q2,Adult
122243862,12224386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6360.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q2,Transitional cell carcinoma,,2016,Q2,2,F,20160105.0,20160516.0,20160331,20160524,EXP,,US-ASTRAZENECA-2016SE32610,ASTRAZENECA,,26821.0,DY,,M,Y,,,20160524.0,,MD,US,US,2016,Q2,Elderly
122390861,12239086,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2016,Q2,Lip swelling,,2016,Q2,1,I,20160316.0,20160330.0,20160405,20160405,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-19891UK",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,115.0,KG,20160405.0,,OT,GB,GB,2016,Q2,Elderly
122390861,12239086,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,1,I,20160316.0,20160330.0,20160405,20160405,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-19891UK",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,115.0,KG,20160405.0,,OT,GB,GB,2016,Q2,Elderly
122390861,12239086,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2016,Q2,Rash erythematous,,2016,Q2,1,I,20160316.0,20160330.0,20160405,20160405,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-19891UK",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,115.0,KG,20160405.0,,OT,GB,GB,2016,Q2,Elderly
122403661,12240366,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,630.0,MG,,U,,,,5.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160326.0,20160328.0,20160405,20160405,EXP,,JP-ASTRAZENECA-2016SE34410,ASTRAZENECA,,14528.0,DY,,F,Y,,,20160405.0,,MD,JP,JP,2016,Q2,Elderly
122403661,12240366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,630.0,MG,,U,,,,5.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160326.0,20160328.0,20160405,20160405,EXP,,JP-ASTRAZENECA-2016SE34410,ASTRAZENECA,,14528.0,DY,,F,Y,,,20160405.0,,MD,JP,JP,2016,Q2,Elderly
122427911,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,,,,,5.0,MG,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160324.0,20160406,20160406,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,INOUE. A CASE OF TYPE 2 DIABETES MELLITUS IN WHICH DIABETIC KETOACIDOSIS DEVELOPED DURING THE ORAL USE OF DAPAGLIFLOZIN AND LEVOTHYROXINE. JAPANESE SOCIETY OF INTERNAL MEDICINE. 2016;36,41.0,YR,,M,Y,,,20160406.0,,MD,JP,JP,2016,Q2,Adult
122427911,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,,,,,5.0,MG,,,2016,Q2,Malaise,,2016,Q2,1,I,,20160324.0,20160406,20160406,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,INOUE. A CASE OF TYPE 2 DIABETES MELLITUS IN WHICH DIABETIC KETOACIDOSIS DEVELOPED DURING THE ORAL USE OF DAPAGLIFLOZIN AND LEVOTHYROXINE. JAPANESE SOCIETY OF INTERNAL MEDICINE. 2016;36,41.0,YR,,M,Y,,,20160406.0,,MD,JP,JP,2016,Q2,Adult
122427911,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,,,,,5.0,MG,,,2016,Q2,Nausea,,2016,Q2,1,I,,20160324.0,20160406,20160406,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,INOUE. A CASE OF TYPE 2 DIABETES MELLITUS IN WHICH DIABETIC KETOACIDOSIS DEVELOPED DURING THE ORAL USE OF DAPAGLIFLOZIN AND LEVOTHYROXINE. JAPANESE SOCIETY OF INTERNAL MEDICINE. 2016;36,41.0,YR,,M,Y,,,20160406.0,,MD,JP,JP,2016,Q2,Adult
122427911,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,,,,,5.0,MG,,,2016,Q2,Thirst,,2016,Q2,1,I,,20160324.0,20160406,20160406,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,INOUE. A CASE OF TYPE 2 DIABETES MELLITUS IN WHICH DIABETIC KETOACIDOSIS DEVELOPED DURING THE ORAL USE OF DAPAGLIFLOZIN AND LEVOTHYROXINE. JAPANESE SOCIETY OF INTERNAL MEDICINE. 2016;36,41.0,YR,,M,Y,,,20160406.0,,MD,JP,JP,2016,Q2,Adult
122480552,12248055,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Lactic acidosis,,2016,Q2,2,F,20160401.0,20160505.0,20160408,20160516,EXP,,US-ASTRAZENECA-2016SE36014,ASTRAZENECA,,27319.0,DY,,F,Y,,,20160514.0,,MD,US,US,2016,Q2,Elderly
122483452,12248345,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,2,F,20160326.0,20160422.0,20160408,20160429,EXP,,GB-ASTRAZENECA-2016SE34571,ASTRAZENECA,,8766.0,DY,,M,Y,88.4,KG,20160429.0,,MD,GB,GB,2016,Q2,Elderly
122491201,12249120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Chillblains,,2016,Q2,1,I,20160204.0,20160331.0,20160408,20160408,EXP,,GB-ASTRAZENECA-2016SE35011,ASTRAZENECA,,71.0,YR,,M,Y,111.0,KG,20160408.0,,MD,GB,GB,2016,Q2,Elderly
122491201,12249120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Pain in extremity,,2016,Q2,1,I,20160204.0,20160331.0,20160408,20160408,EXP,,GB-ASTRAZENECA-2016SE35011,ASTRAZENECA,,71.0,YR,,M,Y,111.0,KG,20160408.0,,MD,GB,GB,2016,Q2,Elderly
122491201,12249120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Peripheral coldness,,2016,Q2,1,I,20160204.0,20160331.0,20160408,20160408,EXP,,GB-ASTRAZENECA-2016SE35011,ASTRAZENECA,,71.0,YR,,M,Y,111.0,KG,20160408.0,,MD,GB,GB,2016,Q2,Elderly
122491201,12249120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Pulse abnormal,,2016,Q2,1,I,20160204.0,20160331.0,20160408,20160408,EXP,,GB-ASTRAZENECA-2016SE35011,ASTRAZENECA,,71.0,YR,,M,Y,111.0,KG,20160408.0,,MD,GB,GB,2016,Q2,Elderly
122491201,12249120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Vasoconstriction,,2016,Q2,1,I,20160204.0,20160331.0,20160408,20160408,EXP,,GB-ASTRAZENECA-2016SE35011,ASTRAZENECA,,71.0,YR,,M,Y,111.0,KG,20160408.0,,MD,GB,GB,2016,Q2,Elderly
122557171,12255717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,, NOT KNOWN,,,,,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160321.0,20160404.0,20160412,20160412,EXP,,GB-ASTRAZENECA-2016SE35936,ASTRAZENECA,,46.0,YR,,F,Y,75.0,KG,20160412.0,,MD,GB,GB,2016,Q2,Adult
122560551,12256055,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Atrial fibrillation,,2016,Q2,1,I,20160321.0,20160404.0,20160412,20160412,EXP,,GB-ASTRAZENECA-2016SE36297,ASTRAZENECA,,62.0,YR,,M,Y,120.0,KG,20160412.0,,MD,GB,GB,2016,Q2,Adult
122615442,12261544,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,510.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q2,Ketosis,,2016,Q2,2,F,20160402.0,20160428.0,20160412,20160506,EXP,,RO-ASTRAZENECA-2016SE35988,ASTRAZENECA,,11694.0,DY,,M,Y,88.8,KG,20160506.0,,MD,RO,RO,2016,Q2,Elderly
122615571,12261557,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, DO NOT  KNOW,,202293.0,10.0,MG,TABLET,,2016,Q2,Decreased appetite,,2016,Q2,1,I,20160309.0,20160404.0,20160412,20160412,EXP,,GB-ASTRAZENECA-2016SE35904,ASTRAZENECA,,55.0,YR,,F,Y,68.0,KG,20160413.0,,MD,GB,GB,2016,Q2,Adult
122615571,12261557,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, DO NOT  KNOW,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160309.0,20160404.0,20160412,20160412,EXP,,GB-ASTRAZENECA-2016SE35904,ASTRAZENECA,,55.0,YR,,F,Y,68.0,KG,20160413.0,,MD,GB,GB,2016,Q2,Adult
122615571,12261557,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, DO NOT  KNOW,,202293.0,10.0,MG,TABLET,,2016,Q2,Malaise,,2016,Q2,1,I,20160309.0,20160404.0,20160412,20160412,EXP,,GB-ASTRAZENECA-2016SE35904,ASTRAZENECA,,55.0,YR,,F,Y,68.0,KG,20160413.0,,MD,GB,GB,2016,Q2,Adult
122615571,12261557,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, DO NOT  KNOW,,202293.0,10.0,MG,TABLET,,2016,Q2,Vomiting,,2016,Q2,1,I,20160309.0,20160404.0,20160412,20160412,EXP,,GB-ASTRAZENECA-2016SE35904,ASTRAZENECA,,55.0,YR,,F,Y,68.0,KG,20160413.0,,MD,GB,GB,2016,Q2,Adult
122618971,12261897,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160313.0,20160405.0,20160413,20160413,EXP,,GB-ASTRAZENECA-2016SE36814,ASTRAZENECA,,63.0,YR,,F,Y,103.3,KG,20160413.0,,MD,GB,GB,2016,Q2,Adult
122618971,12261897,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Vomiting,,2016,Q2,1,I,20160313.0,20160405.0,20160413,20160413,EXP,,GB-ASTRAZENECA-2016SE36814,ASTRAZENECA,,63.0,YR,,F,Y,103.3,KG,20160413.0,,MD,GB,GB,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Body mass index increased,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Genital infection,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Glucose urine present,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Glycosylated haemoglobin increased,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Weight decreased,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122815021,12281502,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Weight increased,,2016,Q2,1,I,200912.0,20160406.0,20160419,20160419,EXP,,HU-ELI_LILLY_AND_COMPANY-HU201604003025,ELI LILLY AND CO,,52.0,YR,,,Y,,,20160418.0,,MD,HU,HU,2016,Q2,Adult
122823831,12282383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAMS ONE TABLET AFTER BREAKFAST,,,,U,,,202293.0,,,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160110.0,20160411.0,20160419,20160419,EXP,,TH-ASTRAZENECA-2016SE39845,ASTRAZENECA,,65.0,YR,,F,Y,57.7,KG,20160419.0,,MD,TH,TH,2016,Q2,Elderly
122852011,12285201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160412.0,20160420,20160420,EXP,,NL-ASTRAZENECA-2016SE40448,ASTRAZENECA,CITATION NOT PROVIDED,58.0,YR,,M,Y,,,20160420.0,,MD,NL,NL,2016,Q2,Adult
122852011,12285201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Off label use,,2016,Q2,1,I,,20160412.0,20160420,20160420,EXP,,NL-ASTRAZENECA-2016SE40448,ASTRAZENECA,CITATION NOT PROVIDED,58.0,YR,,M,Y,,,20160420.0,,MD,NL,NL,2016,Q2,Adult
122852011,12285201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Product use issue,,2016,Q2,1,I,,20160412.0,20160420,20160420,EXP,,NL-ASTRAZENECA-2016SE40448,ASTRAZENECA,CITATION NOT PROVIDED,58.0,YR,,M,Y,,,20160420.0,,MD,NL,NL,2016,Q2,Adult
122852011,12285201,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160412.0,20160420,20160420,EXP,,NL-ASTRAZENECA-2016SE40448,ASTRAZENECA,CITATION NOT PROVIDED,58.0,YR,,M,Y,,,20160420.0,,MD,NL,NL,2016,Q2,Adult
122852011,12285201,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Off label use,,2016,Q2,1,I,,20160412.0,20160420,20160420,EXP,,NL-ASTRAZENECA-2016SE40448,ASTRAZENECA,CITATION NOT PROVIDED,58.0,YR,,M,Y,,,20160420.0,,MD,NL,NL,2016,Q2,Adult
122852011,12285201,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Product use issue,,2016,Q2,1,I,,20160412.0,20160420,20160420,EXP,,NL-ASTRAZENECA-2016SE40448,ASTRAZENECA,CITATION NOT PROVIDED,58.0,YR,,M,Y,,,20160420.0,,MD,NL,NL,2016,Q2,Adult
122898961,12289896,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, DAILY (1-0-0-0)",,,,U,,,,5.0,MG,COATED TABLET,,2016,Q2,Altered state of consciousness,,2016,Q2,1,I,20160309.0,20160412.0,20160421,20160421,EXP,,CH-NAPPMUNDI-GBR-2016-0035433,PURDUE,,63.0,YR,,M,Y,,,20160421.0,,MD,CH,CH,2016,Q2,Adult
122898961,12289896,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, DAILY (1-0-0-0)",,,,U,,,,5.0,MG,COATED TABLET,,2016,Q2,Coma scale abnormal,,2016,Q2,1,I,20160309.0,20160412.0,20160421,20160421,EXP,,CH-NAPPMUNDI-GBR-2016-0035433,PURDUE,,63.0,YR,,M,Y,,,20160421.0,,MD,CH,CH,2016,Q2,Adult
122898961,12289896,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, DAILY (1-0-0-0)",,,,U,,,,5.0,MG,COATED TABLET,,2016,Q2,Respiratory depression,,2016,Q2,1,I,20160309.0,20160412.0,20160421,20160421,EXP,,CH-NAPPMUNDI-GBR-2016-0035433,PURDUE,,63.0,YR,,M,Y,,,20160421.0,,MD,CH,CH,2016,Q2,Adult
122944411,12294441,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Psoriasis,,2016,Q2,1,I,20150628.0,20160415.0,20160422,20160422,EXP,,GB-ASTRAZENECA-2016SE40630,ASTRAZENECA,,68.0,YR,,M,Y,140.0,KG,20160422.0,,MD,GB,GB,2016,Q2,Elderly
123082982,12308298,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Overdose,,2016,Q2,2,F,20160212.0,20160620.0,20160426,20160628,EXP,,US-ASTRAZENECA-2016SE25226,ASTRAZENECA,,14027.0,DY,,,Y,,,20160629.0,,MD,US,US,2016,Q2,Elderly
123082982,12308298,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Overdose,,2016,Q2,2,F,20160212.0,20160620.0,20160426,20160628,EXP,,US-ASTRAZENECA-2016SE25226,ASTRAZENECA,,14027.0,DY,,,Y,,,20160629.0,,MD,US,US,2016,Q2,Elderly
123088712,12308871,1,PS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Adenocarcinoma gastric,,2016,Q2,2,F,20160211.0,20160421.0,20160427,20160428,EXP,,BG-ASTRAZENECA-2016SE35827,ASTRAZENECA,,23412.0,DY,,M,Y,,,20160428.0,,MD,BG,BG,2016,Q2,Elderly
123088712,12308871,1,PS,BLINDED DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Sepsis,,2016,Q2,2,F,20160211.0,20160421.0,20160427,20160428,EXP,,BG-ASTRAZENECA-2016SE35827,ASTRAZENECA,,23412.0,DY,,M,Y,,,20160428.0,,MD,BG,BG,2016,Q2,Elderly
123098021,12309802,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Erythema,,2016,Q2,1,I,20160401.0,20160419.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE41783,ASTRAZENECA,,42.0,YR,,F,Y,76.0,KG,20160427.0,,MD,GB,GB,2016,Q2,Adult
123098021,12309802,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Rash macular,,2016,Q2,1,I,20160401.0,20160419.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE41783,ASTRAZENECA,,42.0,YR,,F,Y,76.0,KG,20160427.0,,MD,GB,GB,2016,Q2,Adult
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Cough,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Dizziness,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Fatigue,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Malaise,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Nasopharyngitis,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123103351,12310335,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Parosmia,,2016,Q2,1,I,,20160420.0,20160427,20160427,EXP,GB-MHRA-ADR 23433795,GB-NOVOPROD-488850,NOVO NORDISK,,70.0,YR,E,F,Y,80.0,KG,20160427.0,,CN,GB,GB,2016,Q2,Elderly
123110611,12311061,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160421.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE43049,ASTRAZENECA,,56.0,YR,,M,Y,,,20160427.0,,MD,GB,GB,2016,Q2,Adult
123110611,12311061,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2016,Q2,Haemoglobin decreased,,2016,Q2,1,I,,20160421.0,20160427,20160427,EXP,,GB-ASTRAZENECA-2016SE43049,ASTRAZENECA,,56.0,YR,,M,Y,,,20160427.0,,MD,GB,GB,2016,Q2,Adult
123230561,12323056,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNSPECIFIED,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20150416.0,20160330.0,20160502,20160502,PER,,US-JNJFOC-20160401536,JANSSEN,,62.0,YR,A,M,Y,,,20160502.0,,CN,US,US,2016,Q2,Adult
123548891,12354889,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,GENERIC,,,,U,,,202293.0,,,TABLET,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,,20160503.0,20160511,20160511,EXP,,BR-ASTRAZENECA-2016SE48361,ASTRAZENECA,,73.0,YR,,M,Y,,,20160511.0,,CN,BR,BR,2016,Q2,Elderly
123673372,12367337,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Sepsis,,2016,Q2,2,F,20160417.0,20160613.0,20160513,20160622,EXP,,US-ASTRAZENECA-2016SE49874,ASTRAZENECA,,23095.0,DY,,M,Y,,,20160622.0,,MD,US,US,2016,Q2,Elderly
123673372,12367337,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Sepsis,,2016,Q2,2,F,20160417.0,20160613.0,20160513,20160622,EXP,,US-ASTRAZENECA-2016SE49874,ASTRAZENECA,,23095.0,DY,,M,Y,,,20160622.0,,MD,US,US,2016,Q2,Elderly
123691591,12369159,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160506.0,20160513,20160513,EXP,,GB-ASTRAZENECA-2016SE49774,ASTRAZENECA,,45.0,YR,,,Y,96.0,KG,20160513.0,,OT,GB,GB,2016,Q2,Adult
123736051,12373605,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,202293.0,10.0,MG,TABLET,,2016,Q2,Haematuria,,2016,Q2,1,I,20160316.0,20160509.0,20160516,20160516,EXP,,GB-ASTRAZENECA-2016SE50539,ASTRAZENECA,,59.0,YR,,M,Y,99.0,KG,20160517.0,,OT,GB,GB,2016,Q2,Adult
123736051,12373605,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,202293.0,10.0,MG,TABLET,,2016,Q2,Hallucination,,2016,Q2,1,I,20160316.0,20160509.0,20160516,20160516,EXP,,GB-ASTRAZENECA-2016SE50539,ASTRAZENECA,,59.0,YR,,M,Y,99.0,KG,20160517.0,,OT,GB,GB,2016,Q2,Adult
123736051,12373605,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,202293.0,10.0,MG,TABLET,,2016,Q2,Malaise,,2016,Q2,1,I,20160316.0,20160509.0,20160516,20160516,EXP,,GB-ASTRAZENECA-2016SE50539,ASTRAZENECA,,59.0,YR,,M,Y,99.0,KG,20160517.0,,OT,GB,GB,2016,Q2,Adult
123879241,12387924,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160421.0,20160513.0,20160520,20160520,EXP,,GB-ASTRAZENECA-2016SE52655,ASTRAZENECA,,68.0,YR,,M,Y,71.0,KG,20160520.0,,MD,GB,GB,2016,Q2,Elderly
123879411,12387941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11904.167,MG,,U,,,202293.0,100.0,MG,TABLET,QD,2016,Q2,Contraindicated drug administered,,2016,Q2,1,I,20151124.0,20160513.0,20160520,20160520,EXP,,GB-ASTRAZENECA-2016SE52568,ASTRAZENECA,,53.0,YR,,F,Y,98.1,KG,20160520.0,,MD,GB,GB,2016,Q2,Adult
123879411,12387941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11904.167,MG,,U,,,202293.0,100.0,MG,TABLET,QD,2016,Q2,Urosepsis,,2016,Q2,1,I,20151124.0,20160513.0,20160520,20160520,EXP,,GB-ASTRAZENECA-2016SE52568,ASTRAZENECA,,53.0,YR,,F,Y,98.1,KG,20160520.0,,MD,GB,GB,2016,Q2,Adult
123882371,12388237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160512.0,20160520,20160520,EXP,,GB-ASTRAZENECA-2016SE52161,ASTRAZENECA,,70.0,YR,,F,Y,,,20160520.0,,OT,GB,GB,2016,Q2,Elderly
123910571,12391057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,201601.0,20160512.0,20160520,20160520,EXP,,GB-ASTRAZENECA-2016SE51937,ASTRAZENECA,,49.0,YR,,F,Y,71.0,KG,20160520.0,,MD,GB,GB,2016,Q2,Adult
123910571,12391057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,,2016,Q2,Pneumonia fungal,,2016,Q2,1,I,201601.0,20160512.0,20160520,20160520,EXP,,GB-ASTRAZENECA-2016SE51937,ASTRAZENECA,,49.0,YR,,F,Y,71.0,KG,20160520.0,,MD,GB,GB,2016,Q2,Adult
123939941,12393994,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Acute kidney injury,,2016,Q2,1,I,,20160512.0,20160523,20160523,EXP,,LV-NOVOPROD-492155,NOVO NORDISK,,46.0,YR,A,M,Y,142.0,KG,20160523.0,,MD,LV,LV,2016,Q2,Adult
123939941,12393994,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Pancreatitis,,2016,Q2,1,I,,20160512.0,20160523,20160523,EXP,,LV-NOVOPROD-492155,NOVO NORDISK,,46.0,YR,A,M,Y,142.0,KG,20160523.0,,MD,LV,LV,2016,Q2,Adult
123939941,12393994,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Rhabdomyolysis,,2016,Q2,1,I,,20160512.0,20160523,20160523,EXP,,LV-NOVOPROD-492155,NOVO NORDISK,,46.0,YR,A,M,Y,142.0,KG,20160523.0,,MD,LV,LV,2016,Q2,Adult
124037331,12403733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Acute kidney injury,,2016,Q2,1,I,20160207.0,20160518.0,20160525,20160525,EXP,,TH-ASTRAZENECA-2016SE54222,ASTRAZENECA,,67.0,YR,,F,Y,103.9,KG,20160525.0,,MD,TH,TH,2016,Q2,Elderly
124037331,12403733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Ketoacidosis,,2016,Q2,1,I,20160207.0,20160518.0,20160525,20160525,EXP,,TH-ASTRAZENECA-2016SE54222,ASTRAZENECA,,67.0,YR,,F,Y,103.9,KG,20160525.0,,MD,TH,TH,2016,Q2,Elderly
124037331,12403733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Shock,,2016,Q2,1,I,20160207.0,20160518.0,20160525,20160525,EXP,,TH-ASTRAZENECA-2016SE54222,ASTRAZENECA,,67.0,YR,,F,Y,103.9,KG,20160525.0,,MD,TH,TH,2016,Q2,Elderly
124105272,12410527,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Ketonuria,,2016,Q2,2,F,20160427.0,20160530.0,20160527,20160607,EXP,,GB-ASTRAZENECA-2016SE54852,ASTRAZENECA,,55.0,YR,,M,Y,90.0,KG,20160607.0,,MD,GB,GB,2016,Q2,Adult
124162091,12416209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG; UNK; 3 UNITS,,,,U,,,202293.0,,,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160503.0,20160519.0,20160530,20160530,EXP,,GB-ASTRAZENECA-2016SE54226,ASTRAZENECA,,51.0,YR,,F,Y,53.0,KG,20160530.0,,MD,GB,GB,2016,Q2,Adult
124291351,12429135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Abnormal loss of weight,,2016,Q2,1,I,20160115.0,20160525.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56497,ASTRAZENECA,,76.0,YR,,M,Y,80.0,KG,20160602.0,,MD,GB,GB,2016,Q2,Elderly
124291351,12429135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Change of bowel habit,,2016,Q2,1,I,20160115.0,20160525.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56497,ASTRAZENECA,,76.0,YR,,M,Y,80.0,KG,20160602.0,,MD,GB,GB,2016,Q2,Elderly
124291351,12429135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Colorectal cancer,,2016,Q2,1,I,20160115.0,20160525.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56497,ASTRAZENECA,,76.0,YR,,M,Y,80.0,KG,20160602.0,,MD,GB,GB,2016,Q2,Elderly
124291351,12429135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160115.0,20160525.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56497,ASTRAZENECA,,76.0,YR,,M,Y,80.0,KG,20160602.0,,MD,GB,GB,2016,Q2,Elderly
124291351,12429135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Dyspnoea,,2016,Q2,1,I,20160115.0,20160525.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56497,ASTRAZENECA,,76.0,YR,,M,Y,80.0,KG,20160602.0,,MD,GB,GB,2016,Q2,Elderly
124291351,12429135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Vomiting,,2016,Q2,1,I,20160115.0,20160525.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56497,ASTRAZENECA,,76.0,YR,,M,Y,80.0,KG,20160602.0,,MD,GB,GB,2016,Q2,Elderly
124292441,12429244,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5349.583,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Necrotising fasciitis,,2016,Q2,1,I,20160512.0,20160524.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE56342,ASTRAZENECA,,52.0,YR,,F,Y,,,20160601.0,,PH,GB,GB,2016,Q2,Adult
124292861,12429286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160418.0,20160524.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE55974,ASTRAZENECA,,56.0,YR,,F,Y,80.0,KG,20160601.0,,OT,GB,GB,2016,Q2,Adult
124292861,12429286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Gastroenteritis,,2016,Q2,1,I,20160418.0,20160524.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE55974,ASTRAZENECA,,56.0,YR,,F,Y,80.0,KG,20160601.0,,OT,GB,GB,2016,Q2,Adult
124292861,12429286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,,U,,,202293.0,5.0,MG,TABLET,,2016,Q2,Malaise,,2016,Q2,1,I,20160418.0,20160524.0,20160602,20160602,EXP,,GB-ASTRAZENECA-2016SE55974,ASTRAZENECA,,56.0,YR,,F,Y,80.0,KG,20160601.0,,OT,GB,GB,2016,Q2,Adult
124328981,12432898,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,U, NOT KNOWN,,,5.0,MG,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160418.0,20160526.0,20160603,20160603,EXP,GB-MHRA-EYC 00139848,GB-NOVOPROD-493939,NOVO NORDISK,,56.0,YR,A,F,Y,80.0,KG,20160603.0,,OT,GB,GB,2016,Q2,Adult
124328981,12432898,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,U, NOT KNOWN,,,5.0,MG,,,2016,Q2,Gastroenteritis,,2016,Q2,1,I,20160418.0,20160526.0,20160603,20160603,EXP,GB-MHRA-EYC 00139848,GB-NOVOPROD-493939,NOVO NORDISK,,56.0,YR,A,F,Y,80.0,KG,20160603.0,,OT,GB,GB,2016,Q2,Adult
124328981,12432898,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,,U, NOT KNOWN,,,5.0,MG,,,2016,Q2,Malaise,,2016,Q2,1,I,20160418.0,20160526.0,20160603,20160603,EXP,GB-MHRA-EYC 00139848,GB-NOVOPROD-493939,NOVO NORDISK,,56.0,YR,A,F,Y,80.0,KG,20160603.0,,OT,GB,GB,2016,Q2,Adult
124363111,12436311,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q2,Atrial flutter,,2016,Q2,1,I,20160311.0,20160525.0,20160605,20160605,EXP,,GB-ABBVIE-16K-167-1640350-00,ABBVIE,,54.0,YR,,,Y,138.0,KG,20160605.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q2,Adult
124363111,12436311,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q2,Haemoptysis,,2016,Q2,1,I,20160311.0,20160525.0,20160605,20160605,EXP,,GB-ABBVIE-16K-167-1640350-00,ABBVIE,,54.0,YR,,,Y,138.0,KG,20160605.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q2,Adult
124363111,12436311,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q2,Hypoxia,,2016,Q2,1,I,20160311.0,20160525.0,20160605,20160605,EXP,,GB-ABBVIE-16K-167-1640350-00,ABBVIE,,54.0,YR,,,Y,138.0,KG,20160605.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q2,Adult
124363111,12436311,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,1,I,20160311.0,20160525.0,20160605,20160605,EXP,,GB-ABBVIE-16K-167-1640350-00,ABBVIE,,54.0,YR,,,Y,138.0,KG,20160605.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q2,Adult
124406431,12440643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG,,,,U,,,,,,TABLET,,2016,Q2,Syncope,,2016,Q2,1,I,20160506.0,20160531.0,20160606,20160606,EXP,,IT-ASTRAZENECA-2016SE58762,ASTRAZENECA,,872.0,MON,,M,Y,,,20160607.0,,MD,IT,IT,2016,Q2,Elderly
124576851,12457685,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,MORNINGS,215.0,MG,,U,,,,5.0,MG,TABLET,QD,2016,Q2,Patella fracture,,2016,Q2,1,I,20151111.0,20160509.0,20160610,20160610,EXP,,JP-ASTRAZENECA-2016SE60757,ASTRAZENECA,,29762.0,DY,,F,Y,73.0,KG,20160611.0,,MD,JP,JP,2016,Q2,Elderly
124602611,12460261,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,1,I,,20160607.0,20160613,20160613,EXP,GB-MHRA-EYC 00140480,GB-TAKEDA-2016TEU003184,TAKEDA,,64.0,YR,,M,Y,83.91,KG,20160613.0,,OT,GB,GB,2016,Q2,Adult
124602611,12460261,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q2,Neuralgia,,2016,Q2,1,I,,20160607.0,20160613,20160613,EXP,GB-MHRA-EYC 00140480,GB-TAKEDA-2016TEU003184,TAKEDA,,64.0,YR,,M,Y,83.91,KG,20160613.0,,OT,GB,GB,2016,Q2,Adult
124602611,12460261,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q2,Paraesthesia,,2016,Q2,1,I,,20160607.0,20160613,20160613,EXP,GB-MHRA-EYC 00140480,GB-TAKEDA-2016TEU003184,TAKEDA,,64.0,YR,,M,Y,83.91,KG,20160613.0,,OT,GB,GB,2016,Q2,Adult
124602611,12460261,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q2,Pruritus,,2016,Q2,1,I,,20160607.0,20160613,20160613,EXP,GB-MHRA-EYC 00140480,GB-TAKEDA-2016TEU003184,TAKEDA,,64.0,YR,,M,Y,83.91,KG,20160613.0,,OT,GB,GB,2016,Q2,Adult
124602611,12460261,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q2,Rash,,2016,Q2,1,I,,20160607.0,20160613,20160613,EXP,GB-MHRA-EYC 00140480,GB-TAKEDA-2016TEU003184,TAKEDA,,64.0,YR,,M,Y,83.91,KG,20160613.0,,OT,GB,GB,2016,Q2,Adult
124602611,12460261,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,U,,,,,,,,2016,Q2,Rash macular,,2016,Q2,1,I,,20160607.0,20160613,20160613,EXP,GB-MHRA-EYC 00140480,GB-TAKEDA-2016TEU003184,TAKEDA,,64.0,YR,,M,Y,83.91,KG,20160613.0,,OT,GB,GB,2016,Q2,Adult
124670511,12467051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q2,Blood urea increased,,2016,Q2,1,I,20160526.0,20160607.0,20160615,20160615,EXP,,GB-ASTRAZENECA-2016SE61240,ASTRAZENECA,,71.0,YR,,M,Y,120.0,KG,20160615.0,,MD,GB,GB,2016,Q2,Elderly
124670511,12467051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q2,Renal impairment,,2016,Q2,1,I,20160526.0,20160607.0,20160615,20160615,EXP,,GB-ASTRAZENECA-2016SE61240,ASTRAZENECA,,71.0,YR,,M,Y,120.0,KG,20160615.0,,MD,GB,GB,2016,Q2,Elderly
124677731,12467773,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD, MORNING",,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,201603.0,20160610.0,20160615,20160615,EXP,GB-MHRA-ADR 23507031,GB-GLAXOSMITHKLINE-GB2016083498,GLAXOSMITHKLINE,,69.0,YR,,F,Y,,,20160615.0,,OT,GB,GB,2016,Q2,Elderly
124677731,12467773,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD, MORNING",,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,201603.0,20160610.0,20160615,20160615,EXP,GB-MHRA-ADR 23507031,GB-GLAXOSMITHKLINE-GB2016083498,GLAXOSMITHKLINE,,69.0,YR,,F,Y,,,20160615.0,,OT,GB,GB,2016,Q2,Elderly
124677731,12467773,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD, MORNING",,,,,,,,10.0,MG,,QD,2016,Q2,Liver function test abnormal,,2016,Q2,1,I,201603.0,20160610.0,20160615,20160615,EXP,GB-MHRA-ADR 23507031,GB-GLAXOSMITHKLINE-GB2016083498,GLAXOSMITHKLINE,,69.0,YR,,F,Y,,,20160615.0,,OT,GB,GB,2016,Q2,Elderly
124677731,12467773,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD, MORNING",,,,,,,,10.0,MG,,QD,2016,Q2,Malaise,,2016,Q2,1,I,201603.0,20160610.0,20160615,20160615,EXP,GB-MHRA-ADR 23507031,GB-GLAXOSMITHKLINE-GB2016083498,GLAXOSMITHKLINE,,69.0,YR,,F,Y,,,20160615.0,,OT,GB,GB,2016,Q2,Elderly
124677731,12467773,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, QD, MORNING",,,,,,,,10.0,MG,,QD,2016,Q2,Myalgia,,2016,Q2,1,I,201603.0,20160610.0,20160615,20160615,EXP,GB-MHRA-ADR 23507031,GB-GLAXOSMITHKLINE-GB2016083498,GLAXOSMITHKLINE,,69.0,YR,,F,Y,,,20160615.0,,OT,GB,GB,2016,Q2,Elderly
124722351,12472235,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD (MORNING)",,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,201603.0,20160610.0,20160616,20160616,EXP,GB-MHRA-ADR 23507031,PHFR2016GB004886,NOVARTIS,,69.0,YR,,F,Y,,,20160616.0,,OT,GB,GB,2016,Q2,Elderly
124722351,12472235,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD (MORNING)",,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,201603.0,20160610.0,20160616,20160616,EXP,GB-MHRA-ADR 23507031,PHFR2016GB004886,NOVARTIS,,69.0,YR,,F,Y,,,20160616.0,,OT,GB,GB,2016,Q2,Elderly
124722351,12472235,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD (MORNING)",,,,,,,,10.0,MG,,QD,2016,Q2,Liver function test abnormal,,2016,Q2,1,I,201603.0,20160610.0,20160616,20160616,EXP,GB-MHRA-ADR 23507031,PHFR2016GB004886,NOVARTIS,,69.0,YR,,F,Y,,,20160616.0,,OT,GB,GB,2016,Q2,Elderly
124722351,12472235,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD (MORNING)",,,,,,,,10.0,MG,,QD,2016,Q2,Malaise,,2016,Q2,1,I,201603.0,20160610.0,20160616,20160616,EXP,GB-MHRA-ADR 23507031,PHFR2016GB004886,NOVARTIS,,69.0,YR,,F,Y,,,20160616.0,,OT,GB,GB,2016,Q2,Elderly
124722351,12472235,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD (MORNING)",,,,,,,,10.0,MG,,QD,2016,Q2,Myalgia,,2016,Q2,1,I,201603.0,20160610.0,20160616,20160616,EXP,GB-MHRA-ADR 23507031,PHFR2016GB004886,NOVARTIS,,69.0,YR,,F,Y,,,20160616.0,,OT,GB,GB,2016,Q2,Elderly
124740531,12474053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q2,Colon cancer,,2016,Q2,1,I,20151216.0,20160608.0,20160616,20160616,EXP,,JP-ASTRAZENECA-2016SE64345,ASTRAZENECA,,23300.0,DY,,M,Y,61.0,KG,20160617.0,,MD,JP,JP,2016,Q2,Elderly
124740531,12474053,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q2,Colon cancer,,2016,Q2,1,I,20151216.0,20160608.0,20160616,20160616,EXP,,JP-ASTRAZENECA-2016SE64345,ASTRAZENECA,,23300.0,DY,,M,Y,61.0,KG,20160617.0,,MD,JP,JP,2016,Q2,Elderly
124763261,12476326,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,20160310.0,20160610.0,20160617,20160617,EXP,GB-MHRA-EYC 00140726,GB-PFIZER INC-2016298816,PFIZER,,74.0,YR,,M,Y,77.0,KG,20160617.0,,MD,GB,GB,2016,Q2,Elderly
124763261,12476326,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2016,Q2,Abnormal loss of weight,,2016,Q2,1,I,20160310.0,20160610.0,20160617,20160617,EXP,GB-MHRA-EYC 00140726,GB-PFIZER INC-2016298816,PFIZER,,74.0,YR,,M,Y,77.0,KG,20160617.0,,MD,GB,GB,2016,Q2,Elderly
124763261,12476326,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,20160310.0,20160610.0,20160617,20160617,EXP,GB-MHRA-EYC 00140726,GB-PFIZER INC-2016298816,PFIZER,,74.0,YR,,M,Y,77.0,KG,20160617.0,,MD,GB,GB,2016,Q2,Elderly
124763261,12476326,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2016,Q2,Pancreatitis acute,,2016,Q2,1,I,20160310.0,20160610.0,20160617,20160617,EXP,GB-MHRA-EYC 00140726,GB-PFIZER INC-2016298816,PFIZER,,74.0,YR,,M,Y,77.0,KG,20160617.0,,MD,GB,GB,2016,Q2,Elderly
124783551,12478355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5670.0,MG,,U,,,,10.0,MG,TABLET,QD,2016,Q2,Diabetic foot,,2016,Q2,1,I,20160511.0,20160609.0,20160618,20160618,EXP,,TR-ASTRAZENECA-2016SE64377,ASTRAZENECA,,26638.0,DY,,M,Y,,,20160618.0,,MD,TR,TR,2016,Q2,Elderly
124783551,12478355,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5670.0,MG,,U,,,,10.0,MG,TABLET,QD,2016,Q2,Diabetic foot,,2016,Q2,1,I,20160511.0,20160609.0,20160618,20160618,EXP,,TR-ASTRAZENECA-2016SE64377,ASTRAZENECA,,26638.0,DY,,M,Y,,,20160618.0,,MD,TR,TR,2016,Q2,Elderly
124796141,12479614,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,GB-DRREDDYS-GER/UKI/16/0080633,DR REDDYS,,74.0,YR,,M,Y,77.0,KG,20160620.0,,MD,GB,GB,2016,Q2,Elderly
124796141,12479614,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q2,Abnormal loss of weight,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,GB-DRREDDYS-GER/UKI/16/0080633,DR REDDYS,,74.0,YR,,M,Y,77.0,KG,20160620.0,,MD,GB,GB,2016,Q2,Elderly
124796141,12479614,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,GB-DRREDDYS-GER/UKI/16/0080633,DR REDDYS,,74.0,YR,,M,Y,77.0,KG,20160620.0,,MD,GB,GB,2016,Q2,Elderly
124796141,12479614,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q2,Pancreatitis acute,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,GB-DRREDDYS-GER/UKI/16/0080633,DR REDDYS,,74.0,YR,,M,Y,77.0,KG,20160620.0,,MD,GB,GB,2016,Q2,Elderly
124812001,12481200,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,MORNING,,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,201603.0,20160610.0,20160620,20160620,EXP,GB-MHRA-ADR 23507031,GB-DRREDDYS-GER/UKI/16/0080626,DR REDDYS,,69.0,YR,,F,Y,,,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124812001,12481200,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,MORNING,,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,201603.0,20160610.0,20160620,20160620,EXP,GB-MHRA-ADR 23507031,GB-DRREDDYS-GER/UKI/16/0080626,DR REDDYS,,69.0,YR,,F,Y,,,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124812001,12481200,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,MORNING,,,,,,,,10.0,MG,,QD,2016,Q2,Liver function test abnormal,,2016,Q2,1,I,201603.0,20160610.0,20160620,20160620,EXP,GB-MHRA-ADR 23507031,GB-DRREDDYS-GER/UKI/16/0080626,DR REDDYS,,69.0,YR,,F,Y,,,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124812001,12481200,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,MORNING,,,,,,,,10.0,MG,,QD,2016,Q2,Malaise,,2016,Q2,1,I,201603.0,20160610.0,20160620,20160620,EXP,GB-MHRA-ADR 23507031,GB-DRREDDYS-GER/UKI/16/0080626,DR REDDYS,,69.0,YR,,F,Y,,,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124812001,12481200,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,MORNING,,,,,,,,10.0,MG,,QD,2016,Q2,Myalgia,,2016,Q2,1,I,201603.0,20160610.0,20160620,20160620,EXP,GB-MHRA-ADR 23507031,GB-DRREDDYS-GER/UKI/16/0080626,DR REDDYS,,69.0,YR,,F,Y,,,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124816671,12481667,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,PHHY2016GB081206,SANDOZ,,74.0,YR,,M,Y,77.0,KG,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124816671,12481667,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Abnormal loss of weight,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,PHHY2016GB081206,SANDOZ,,74.0,YR,,M,Y,77.0,KG,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124816671,12481667,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,PHHY2016GB081206,SANDOZ,,74.0,YR,,M,Y,77.0,KG,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124816671,12481667,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2016,Q2,Pancreatitis acute,,2016,Q2,1,I,20160310.0,20160610.0,20160620,20160620,EXP,GB-MHRA-EYC 00140726,PHHY2016GB081206,SANDOZ,,74.0,YR,,M,Y,77.0,KG,20160620.0,,OT,GB,GB,2016,Q2,Elderly
124840211,12484021,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,,10.0,MG,,,2016,Q2,Anaphylactic reaction,,2016,Q2,1,I,20160513.0,20160613.0,20160621,20160621,EXP,,GB-ASTRAZENECA-2016SE65154,ASTRAZENECA,,42.0,YR,,M,Y,,,20160621.0,,OT,GB,GB,2016,Q2,Adult
124840211,12484021,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,,10.0,MG,,,2016,Q2,Pharyngeal oedema,,2016,Q2,1,I,20160513.0,20160613.0,20160621,20160621,EXP,,GB-ASTRAZENECA-2016SE65154,ASTRAZENECA,,42.0,YR,,M,Y,,,20160621.0,,OT,GB,GB,2016,Q2,Adult
124840211,12484021,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,,10.0,MG,,,2016,Q2,Swollen tongue,,2016,Q2,1,I,20160513.0,20160613.0,20160621,20160621,EXP,,GB-ASTRAZENECA-2016SE65154,ASTRAZENECA,,42.0,YR,,M,Y,,,20160621.0,,OT,GB,GB,2016,Q2,Adult
124881871,12488187,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q2,Generalised tonic-clonic seizure,,2016,Q2,1,I,20160602.0,20160614.0,20160622,20160622,EXP,,GB-ASTRAZENECA-2016SE65512,ASTRAZENECA,,53.0,YR,,M,Y,,,20160622.0,,PH,GB,GB,2016,Q2,Adult
124881871,12488187,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q2,Hyponatraemia,,2016,Q2,1,I,20160602.0,20160614.0,20160622,20160622,EXP,,GB-ASTRAZENECA-2016SE65512,ASTRAZENECA,,53.0,YR,,M,Y,,,20160622.0,,PH,GB,GB,2016,Q2,Adult
124882221,12488222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160426.0,20160613.0,20160622,20160622,EXP,,GB-ASTRAZENECA-2016SE65182,ASTRAZENECA,,43.0,YR,,M,Y,98.3,KG,20160622.0,,OT,GB,GB,2016,Q2,Adult
124882221,12488222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q2,Infection,,2016,Q2,1,I,20160426.0,20160613.0,20160622,20160622,EXP,,GB-ASTRAZENECA-2016SE65182,ASTRAZENECA,,43.0,YR,,M,Y,98.3,KG,20160622.0,,OT,GB,GB,2016,Q2,Adult
124886361,12488636,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2016,Q2,Abdominal pain upper,,2016,Q2,1,I,20160310.0,20160610.0,20160622,20160622,EXP,GB-MHRA-EYC 00140726,GB-TEVA-668563ACC,TEVA,,74.0,YR,,M,Y,77.0,KG,20160622.0,,MD,GB,GB,2016,Q2,Elderly
124886361,12488636,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2016,Q2,Abnormal loss of weight,,2016,Q2,1,I,20160310.0,20160610.0,20160622,20160622,EXP,GB-MHRA-EYC 00140726,GB-TEVA-668563ACC,TEVA,,74.0,YR,,M,Y,77.0,KG,20160622.0,,MD,GB,GB,2016,Q2,Elderly
124886361,12488636,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,20160310.0,20160610.0,20160622,20160622,EXP,GB-MHRA-EYC 00140726,GB-TEVA-668563ACC,TEVA,,74.0,YR,,M,Y,77.0,KG,20160622.0,,MD,GB,GB,2016,Q2,Elderly
124886361,12488636,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2016,Q2,Pancreatitis acute,,2016,Q2,1,I,20160310.0,20160610.0,20160622,20160622,EXP,GB-MHRA-EYC 00140726,GB-TEVA-668563ACC,TEVA,,74.0,YR,,M,Y,77.0,KG,20160622.0,,MD,GB,GB,2016,Q2,Elderly
124915561,12491556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Bacteriuria,,2016,Q2,1,I,20160517.0,20160615.0,20160623,20160623,EXP,,US-ASTRAZENECA-2016SE67379,ASTRAZENECA,,23125.0,DY,,M,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
124915561,12491556,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Bacteriuria,,2016,Q2,1,I,20160517.0,20160615.0,20160623,20160623,EXP,,US-ASTRAZENECA-2016SE67379,ASTRAZENECA,,23125.0,DY,,M,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
124916261,12491626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2016,Q2,Decreased appetite,,2016,Q2,1,I,20160607.0,,20160622,20160622,DIR,,,,,56.0,YR,,M,N,92.0,KG,20160621.0,N,PH,US,,2016,Q2,Adult
124916261,12491626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160607.0,,20160622,20160622,DIR,,,,,56.0,YR,,M,N,92.0,KG,20160621.0,N,PH,US,,2016,Q2,Adult
124916261,12491626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2016,Q2,Malaise,,2016,Q2,1,I,20160607.0,,20160622,20160622,DIR,,,,,56.0,YR,,M,N,92.0,KG,20160621.0,N,PH,US,,2016,Q2,Adult
124916261,12491626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2016,Q2,Nausea,,2016,Q2,1,I,20160607.0,,20160622,20160622,DIR,,,,,56.0,YR,,M,N,92.0,KG,20160621.0,N,PH,US,,2016,Q2,Adult
124916261,12491626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2016,Q2,Urinary tract infection,,2016,Q2,1,I,20160607.0,,20160622,20160622,DIR,,,,,56.0,YR,,M,N,92.0,KG,20160621.0,N,PH,US,,2016,Q2,Adult
124916261,12491626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2016,Q2,Vomiting,,2016,Q2,1,I,20160607.0,,20160622,20160622,DIR,,,,,56.0,YR,,M,N,92.0,KG,20160621.0,N,PH,US,,2016,Q2,Adult
124938561,12493856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Sepsis,,2016,Q2,1,I,20160524.0,20160615.0,20160623,20160623,EXP,,US-ASTRAZENECA-2016SE67135,ASTRAZENECA,,23132.0,DY,,M,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
124938561,12493856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Urinary tract infection,,2016,Q2,1,I,20160524.0,20160615.0,20160623,20160623,EXP,,US-ASTRAZENECA-2016SE67135,ASTRAZENECA,,23132.0,DY,,M,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
124938561,12493856,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Sepsis,,2016,Q2,1,I,20160524.0,20160615.0,20160623,20160623,EXP,,US-ASTRAZENECA-2016SE67135,ASTRAZENECA,,23132.0,DY,,M,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
124938561,12493856,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q2,Urinary tract infection,,2016,Q2,1,I,20160524.0,20160615.0,20160623,20160623,EXP,,US-ASTRAZENECA-2016SE67135,ASTRAZENECA,,23132.0,DY,,M,Y,,,20160623.0,,MD,US,US,2016,Q2,Elderly
124941881,12494188,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1.0,DF,,U,,,202293.0,1.0,DF,TABLET,QD,2016,Q2,Laziness,,2016,Q2,1,I,20160601.0,20160615.0,20160623,20160623,EXP,,GB-ASTRAZENECA-2016SE65957,ASTRAZENECA,,54.0,YR,,F,Y,,,20160623.0,,PH,GB,GB,2016,Q2,Adult
124941881,12494188,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1.0,DF,,U,,,202293.0,1.0,DF,TABLET,QD,2016,Q2,Lethargy,,2016,Q2,1,I,20160601.0,20160615.0,20160623,20160623,EXP,,GB-ASTRAZENECA-2016SE65957,ASTRAZENECA,,54.0,YR,,F,Y,,,20160623.0,,PH,GB,GB,2016,Q2,Adult
124941881,12494188,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1.0,DF,,U,,,202293.0,1.0,DF,TABLET,QD,2016,Q2,Somnolence,,2016,Q2,1,I,20160601.0,20160615.0,20160623,20160623,EXP,,GB-ASTRAZENECA-2016SE65957,ASTRAZENECA,,54.0,YR,,F,Y,,,20160623.0,,PH,GB,GB,2016,Q2,Adult
124998121,12499812,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,U,,,202293.0,10.0,MG,TABLET,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,,20160617.0,20160627,20160627,EXP,,IE-ASTRAZENECA-2016SE67415,ASTRAZENECA,,51.0,YR,,F,Y,,,20160627.0,,OT,IE,IE,2016,Q2,Adult
125007111,12500711,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,TABLET,,2016,Q2,Nausea,,2016,Q2,1,I,,20141204.0,20160627,20160627,PER,,US-ASTRAZENECA-2014SE99834,ASTRAZENECA,,69.0,YR,,M,Y,86.6,KG,20160627.0,,,US,US,2016,Q2,Elderly
125007111,12500711,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,TABLET,,2016,Q2,Vomiting,,2016,Q2,1,I,,20141204.0,20160627,20160627,PER,,US-ASTRAZENECA-2014SE99834,ASTRAZENECA,,69.0,YR,,M,Y,86.6,KG,20160627.0,,,US,US,2016,Q2,Elderly
125007111,12500711,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,TABLET,,2016,Q2,Weight decreased,,2016,Q2,1,I,,20141204.0,20160627,20160627,PER,,US-ASTRAZENECA-2014SE99834,ASTRAZENECA,,69.0,YR,,M,Y,86.6,KG,20160627.0,,,US,US,2016,Q2,Elderly
125201641,12520164,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q2,Disseminated intravascular coagulation,,2016,Q2,1,I,20140514.0,20140527.0,20160630,20160630,EXP,,US-ASTRAZENECA-2014SE40088,ASTRAZENECA,,70.0,YR,,F,Y,,,20160630.0,,CN,RO,RO,2016,Q2,Elderly
125201641,12520164,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,10.0,MG,TABLET,QD,2016,Q2,Sepsis,,2016,Q2,1,I,20140514.0,20140527.0,20160630,20160630,EXP,,US-ASTRAZENECA-2014SE40088,ASTRAZENECA,,70.0,YR,,F,Y,,,20160630.0,,CN,RO,RO,2016,Q2,Elderly
111653813,11165381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2016,Q3,Atrial tachycardia,,2016,Q3,3,F,201408.0,20160825.0,20150604,20160825,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-035308,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,112.0,KG,20160825.0,,CN,DE,SK,2016,Q3,Elderly
111653813,11165381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2016,Q3,Diarrhoea,,2016,Q3,3,F,201408.0,20160825.0,20150604,20160825,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-035308,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,112.0,KG,20160825.0,,CN,DE,SK,2016,Q3,Elderly
111653813,11165381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2016,Q3,Haematuria,,2016,Q3,3,F,201408.0,20160825.0,20150604,20160825,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-035308,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,112.0,KG,20160825.0,,CN,DE,SK,2016,Q3,Elderly
111653813,11165381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2016,Q3,Vomiting,,2016,Q3,3,F,201408.0,20160825.0,20150604,20160825,EXP,,SK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-035308,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,112.0,KG,20160825.0,,CN,DE,SK,2016,Q3,Elderly
114351696,11435169,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG DAILY (2 TABLETS),,,Y,,,,202293.0,,,TABLET,,2016,Q3,Ketoacidosis,,2016,Q3,6,F,20150822.0,20160722.0,20150831,20160728,EXP,,DE-ASTRAZENECA-2015SE81868,ASTRAZENECA,,22.0,YR,,F,Y,53.0,KG,20160728.0,,MD,DE,DE,2016,Q3,Youth
114351696,11435169,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG DAILY (2 TABLETS),,,Y,,,,202293.0,,,TABLET,,2016,Q3,Liver function test increased,,2016,Q3,6,F,20150822.0,20160722.0,20150831,20160728,EXP,,DE-ASTRAZENECA-2015SE81868,ASTRAZENECA,,22.0,YR,,F,Y,53.0,KG,20160728.0,,MD,DE,DE,2016,Q3,Youth
118528403,11852840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3650.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Prostate cancer,,2016,Q3,3,F,20150901.0,20160816.0,20151218,20160820,EXP,,DE-ASTRAZENECA-2015SF27547,ASTRAZENECA,,80.0,YR,,M,Y,,,20160820.0,,MD,DE,DE,2016,Q3,Elderly
119755952,11975595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5090.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Chronic kidney disease,,2016,Q3,2,F,20150820.0,20160908.0,20160129,20160915,EXP,,US-ASTRAZENECA-2015SE90854,ASTRAZENECA,,25090.0,DY,,M,Y,,,20160915.0,,MD,US,US,2016,Q3,Elderly
119755952,11975595,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5090.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Chronic kidney disease,,2016,Q3,2,F,20150820.0,20160908.0,20160129,20160915,EXP,,US-ASTRAZENECA-2015SE90854,ASTRAZENECA,,25090.0,DY,,M,Y,,,20160915.0,,MD,US,US,2016,Q3,Elderly
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Alanine aminotransferase increased,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Anaemia,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Aspartate aminotransferase increased,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Immune reconstitution inflammatory syndrome,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Pneumonia aspiration,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Progressive multifocal leukoencephalopathy,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Respiratory moniliasis,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Sepsis,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Staphylococcal infection,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121389017,12138901,8,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Toxoplasmosis,,2016,Q3,7,F,201601.0,20160830.0,20160302,20160913,EXP,,DE-BIOGEN-2016BI00191460,BIOGEN,,49.0,YR,,F,Y,,,20160913.0,,MD,DE,DE,2016,Q3,Adult
121922532,12192253,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,,,,TABLET,,2016,Q3,Eye swelling,,2016,Q3,2,F,20151016.0,20160902.0,20160318,20160908,EXP,,DE-ASTRAZENECA-2016SE28561,ASTRAZENECA,,66.0,YR,,M,Y,98.0,KG,20160908.0,,MD,DE,DE,2016,Q3,Elderly
122427912,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,U,,,,,5.0,MG,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,,20160826.0,20160406,20160826,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20160826.0,,MD,JP,JP,2016,Q3,Adult
122427912,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,U,,,,,5.0,MG,,,2016,Q3,Malaise,,2016,Q3,2,F,,20160826.0,20160406,20160826,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20160826.0,,MD,JP,JP,2016,Q3,Adult
122427912,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,U,,,,,5.0,MG,,,2016,Q3,Nausea,,2016,Q3,2,F,,20160826.0,20160406,20160826,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20160826.0,,MD,JP,JP,2016,Q3,Adult
122427912,12242791,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, UNK",,,U,,,,,5.0,MG,,,2016,Q3,Thirst,,2016,Q3,2,F,,20160826.0,20160406,20160826,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024514,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20160826.0,,MD,JP,JP,2016,Q3,Adult
122480553,12248055,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2016,Q3,Lactic acidosis,,2016,Q3,3,F,20160401.0,20160823.0,20160408,20160831,EXP,,US-ASTRAZENECA-2016SE36014,ASTRAZENECA,,27319.0,DY,,F,Y,,,20160831.0,,MD,US,US,2016,Q3,Elderly
124406432,12440643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,202293.0,,,TABLET,,2016,Q3,Syncope,,2016,Q3,2,F,20160506.0,20160908.0,20160606,20160915,EXP,,IT-ASTRAZENECA-2016SE58762,ASTRAZENECA,,872.0,MON,,M,Y,,,20160915.0,,MD,IT,IT,2016,Q3,Elderly
124741932,12474193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1430.0,MG,Y,,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Acute myocardial infarction,,2016,Q3,2,F,20160408.0,20160713.0,20160616,20160721,EXP,,JP-ASTRAZENECA-2016SE62506,ASTRAZENECA,,16306.0,DY,,M,Y,87.0,KG,20160721.0,,MD,JP,JP,2016,Q3,Elderly
124741932,12474193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1430.0,MG,Y,,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Dehydration,,2016,Q3,2,F,20160408.0,20160713.0,20160616,20160721,EXP,,JP-ASTRAZENECA-2016SE62506,ASTRAZENECA,,16306.0,DY,,M,Y,87.0,KG,20160721.0,,MD,JP,JP,2016,Q3,Elderly
124783552,12478355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5670.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Peripheral vascular disorder,,2016,Q3,2,F,20160511.0,20160902.0,20160618,20160909,EXP,,TR-ASTRAZENECA-2016SE64377,ASTRAZENECA,,26638.0,DY,,M,Y,,,20160909.0,,MD,TR,TR,2016,Q3,Elderly
124783552,12478355,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5670.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Peripheral vascular disorder,,2016,Q3,2,F,20160511.0,20160902.0,20160618,20160909,EXP,,TR-ASTRAZENECA-2016SE64377,ASTRAZENECA,,26638.0,DY,,M,Y,,,20160909.0,,MD,TR,TR,2016,Q3,Elderly
124783613,12478361,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,Y,,,,,5.0,MG,TABLET,QD,2016,Q3,Cerebral infarction,,2016,Q3,3,F,20160608.0,20160706.0,20160618,20160712,EXP,,JP-ASTRAZENECA-2016SE62295,ASTRAZENECA,,21217.0,DY,,M,Y,,,20160712.0,,MD,JP,JP,2016,Q3,Elderly
125215641,12521564,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20141103.0,20141110.0,20160701,20160701,EXP,,US-ASTRAZENECA-2014SE89825,ASTRAZENECA,,55.0,YR,,M,Y,,,20160701.0,,CN,CA,CA,2016,Q3,Adult
125215641,12521564,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20141103.0,20141110.0,20160701,20160701,EXP,,US-ASTRAZENECA-2014SE89825,ASTRAZENECA,,55.0,YR,,M,Y,,,20160701.0,,CN,CA,CA,2016,Q3,Adult
125215641,12521564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20141103.0,20141110.0,20160701,20160701,EXP,,US-ASTRAZENECA-2014SE89825,ASTRAZENECA,,55.0,YR,,M,Y,,,20160701.0,,CN,CA,CA,2016,Q3,Adult
125248981,12524898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20140514.0,20140515.0,20160704,20160704,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,70.0,YR,,F,Y,,,20160704.0,,MD,RO,RO,2016,Q3,Elderly
125248981,12524898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2016,Q3,Sepsis,,2016,Q3,1,I,20140514.0,20140515.0,20160704,20160704,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,70.0,YR,,F,Y,,,20160704.0,,MD,RO,RO,2016,Q3,Elderly
125248981,12524898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2016,Q3,Urinary tract infection,,2016,Q3,1,I,20140514.0,20140515.0,20160704,20160704,EXP,,US-ASTRAZENECA-2014SE36920,ASTRAZENECA,,70.0,YR,,F,Y,,,20160704.0,,MD,RO,RO,2016,Q3,Elderly
125272401,12527240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9280.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Diverticulitis,,2016,Q3,1,I,20160422.0,20160623.0,20160705,20160705,EXP,,CA-ASTRAZENECA-2016SE69808,ASTRAZENECA,,79.0,YR,,M,Y,,,20160705.0,,MD,CA,CA,2016,Q3,Elderly
125294511,12529451,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3990.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Peripheral ischaemia,,2016,Q3,1,I,,20160627.0,20160706,20160706,EXP,,GB-ASTRAZENECA-2016SE70350,ASTRAZENECA,,51.0,YR,,F,Y,,,20160706.0,,PH,GB,GB,2016,Q3,Adult
125377281,12537728,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.417,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,201512.0,20160629.0,20160707,20160707,EXP,,GB-ASTRAZENECA-2016SE71288,ASTRAZENECA,,54.0,YR,,F,Y,120.2,KG,20160707.0,,MD,GB,GB,2016,Q3,Adult
125377281,12537728,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.417,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Infection,,2016,Q3,1,I,201512.0,20160629.0,20160707,20160707,EXP,,GB-ASTRAZENECA-2016SE71288,ASTRAZENECA,,54.0,YR,,F,Y,120.2,KG,20160707.0,,MD,GB,GB,2016,Q3,Adult
125377631,12537763,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, QD",54.0,DF,,,,,,1.0,DF,,QD,2016,Q3,Peripheral swelling,,2016,Q3,1,I,20160622.0,20160701.0,20160707,20160707,EXP,GB-MHRA-TPP20101702C1144050YC1466605619173,GB-ELI_LILLY_AND_COMPANY-GB201607000567,ELI LILLY AND CO,,59.0,YR,,F,Y,82.0,KG,20160707.0,,CN,GB,GB,2016,Q3,Adult
125377631,12537763,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, QD",54.0,DF,,,,,,1.0,DF,,QD,2016,Q3,Swelling face,,2016,Q3,1,I,20160622.0,20160701.0,20160707,20160707,EXP,GB-MHRA-TPP20101702C1144050YC1466605619173,GB-ELI_LILLY_AND_COMPANY-GB201607000567,ELI LILLY AND CO,,59.0,YR,,F,Y,82.0,KG,20160707.0,,CN,GB,GB,2016,Q3,Adult
125388191,12538819,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2016,Q3,Bladder cancer,,2016,Q3,1,I,20160512.0,20160630.0,20160708,20160708,EXP,,GB-ASTRAZENECA-2016SE71953,ASTRAZENECA,,63.0,YR,,M,Y,132.9,KG,20160708.0,,MD,GB,GB,2016,Q3,Adult
125388191,12538819,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2016,Q3,Haematuria,,2016,Q3,1,I,20160512.0,20160630.0,20160708,20160708,EXP,,GB-ASTRAZENECA-2016SE71953,ASTRAZENECA,,63.0,YR,,M,Y,132.9,KG,20160708.0,,MD,GB,GB,2016,Q3,Adult
125388191,12538819,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 UNIT3,,,Y,U,,,202293.0,,,TABLET,,2016,Q3,Bladder cancer,,2016,Q3,1,I,20160512.0,20160630.0,20160708,20160708,EXP,,GB-ASTRAZENECA-2016SE71953,ASTRAZENECA,,63.0,YR,,M,Y,132.9,KG,20160708.0,,MD,GB,GB,2016,Q3,Adult
125388191,12538819,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 UNIT3,,,Y,U,,,202293.0,,,TABLET,,2016,Q3,Haematuria,,2016,Q3,1,I,20160512.0,20160630.0,20160708,20160708,EXP,,GB-ASTRAZENECA-2016SE71953,ASTRAZENECA,,63.0,YR,,M,Y,132.9,KG,20160708.0,,MD,GB,GB,2016,Q3,Adult
125392101,12539210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,N,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Constipation,,2016,Q3,1,I,2015.0,20160630.0,20160708,20160708,EXP,,GB-ASTRAZENECA-2016SE71967,ASTRAZENECA,,46.0,YR,,M,Y,,,20160708.0,,OT,GB,GB,2016,Q3,Adult
125392101,12539210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,N,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Faecaloma,,2016,Q3,1,I,2015.0,20160630.0,20160708,20160708,EXP,,GB-ASTRAZENECA-2016SE71967,ASTRAZENECA,,46.0,YR,,M,Y,,,20160708.0,,OT,GB,GB,2016,Q3,Adult
125424192,12542419,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1485.0,MG,Y,U,,,,5.0,MG,TABLET,QD,2016,Q3,Angina pectoris,,2016,Q3,2,F,20151225.0,20160905.0,20160708,20160914,EXP,,JP-ASTRAZENECA-2016SE72935,ASTRAZENECA,,68.0,YR,,F,Y,64.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
125424192,12542419,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1485.0,MG,Y,U,,,,5.0,MG,TABLET,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20151225.0,20160905.0,20160708,20160914,EXP,,JP-ASTRAZENECA-2016SE72935,ASTRAZENECA,,68.0,YR,,F,Y,64.0,KG,20160914.0,,MD,JP,JP,2016,Q3,Elderly
125455361,12545536,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2016,Q3,Diabetes mellitus inadequate control,,2016,Q3,1,I,201602.0,20160308.0,20160711,20160711,EXP,,GB-JNJFOC-20160311662,JANSSEN,,76.0,YR,E,F,Y,,,20160711.0,,CN,GB,GB,2016,Q3,Elderly
125455361,12545536,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2016,Q3,Impetigo,,2016,Q3,1,I,201602.0,20160308.0,20160711,20160711,EXP,,GB-JNJFOC-20160311662,JANSSEN,,76.0,YR,E,F,Y,,,20160711.0,,CN,GB,GB,2016,Q3,Elderly
125455361,12545536,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2016,Q3,Rash,,2016,Q3,1,I,201602.0,20160308.0,20160711,20160711,EXP,,GB-JNJFOC-20160311662,JANSSEN,,76.0,YR,E,F,Y,,,20160711.0,,CN,GB,GB,2016,Q3,Elderly
125491471,12549147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q3,Back pain,,2016,Q3,1,I,20160624.0,20160704.0,20160712,20160712,EXP,,GB-ASTRAZENECA-2016SE72860,ASTRAZENECA,,65.0,YR,,M,Y,63.0,KG,20160712.0,,MD,GB,GB,2016,Q3,Elderly
125491471,12549147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q3,Penile pain,,2016,Q3,1,I,20160624.0,20160704.0,20160712,20160712,EXP,,GB-ASTRAZENECA-2016SE72860,ASTRAZENECA,,65.0,YR,,M,Y,63.0,KG,20160712.0,,MD,GB,GB,2016,Q3,Elderly
125491471,12549147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q3,Urinary tract infection,,2016,Q3,1,I,20160624.0,20160704.0,20160712,20160712,EXP,,GB-ASTRAZENECA-2016SE72860,ASTRAZENECA,,65.0,YR,,M,Y,63.0,KG,20160712.0,,MD,GB,GB,2016,Q3,Elderly
125501922,12550192,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q3,Demyelination,,2016,Q3,2,F,20081224.0,20160715.0,20160712,20160726,EXP,,GB-ABBVIE-16K-167-1669458-00,ABBVIE,,40.0,YR,,F,Y,,,20160726.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q3,Adult
125501922,12550192,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q3,Lumbar puncture,,2016,Q3,2,F,20081224.0,20160715.0,20160712,20160726,EXP,,GB-ABBVIE-16K-167-1669458-00,ABBVIE,,40.0,YR,,F,Y,,,20160726.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q3,Adult
125501922,12550192,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q3,Myelitis transverse,,2016,Q3,2,F,20081224.0,20160715.0,20160712,20160726,EXP,,GB-ABBVIE-16K-167-1669458-00,ABBVIE,,40.0,YR,,F,Y,,,20160726.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q3,Adult
125501922,12550192,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2016,Q3,Peripheral paralysis,,2016,Q3,2,F,20081224.0,20160715.0,20160712,20160726,EXP,,GB-ABBVIE-16K-167-1669458-00,ABBVIE,,40.0,YR,,F,Y,,,20160726.0,,OT,COUNTRY NOT SPECIFIED,GB,2016,Q3,Adult
125527901,12552790,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160705.0,20160713,20160713,EXP,,IL-ASTRAZENECA-2016SE73243,ASTRAZENECA,,57.0,YR,,M,Y,,,20160713.0,,PH,IL,IL,2016,Q3,Adult
125527901,12552790,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q3,Diarrhoea,,2016,Q3,1,I,,20160705.0,20160713,20160713,EXP,,IL-ASTRAZENECA-2016SE73243,ASTRAZENECA,,57.0,YR,,M,Y,,,20160713.0,,PH,IL,IL,2016,Q3,Adult
125581022,12558102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q3,Angina pectoris,,2016,Q3,2,F,20160110.0,20160725.0,20160714,20160802,EXP,,PL-ASTRAZENECA-2016SE74100,ASTRAZENECA,,25272.0,DY,,M,Y,,,20160803.0,,MD,PL,PL,2016,Q3,Elderly
126014722,12601472,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6490.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Pneumonia,,2016,Q3,2,F,20160702.0,20160821.0,20160728,20160829,EXP,,PL-ASTRAZENECA-2016SE79217,ASTRAZENECA,,23468.0,DY,,F,Y,,,20160829.0,,MD,PL,PL,2016,Q3,Elderly
126014722,12601472,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6490.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Renal neoplasm,,2016,Q3,2,F,20160702.0,20160821.0,20160728,20160829,EXP,,PL-ASTRAZENECA-2016SE79217,ASTRAZENECA,,23468.0,DY,,F,Y,,,20160829.0,,MD,PL,PL,2016,Q3,Elderly
126030241,12603024,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Hypersomnia,,2016,Q3,1,I,20160418.0,20160720.0,20160728,20160728,EXP,,GB-ASTRAZENECA-2016SE79110,ASTRAZENECA,,71.0,YR,,M,Y,135.0,KG,20160728.0,,MD,GB,GB,2016,Q3,Elderly
126030241,12603024,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Sleep apnoea syndrome,,2016,Q3,1,I,20160418.0,20160720.0,20160728,20160728,EXP,,GB-ASTRAZENECA-2016SE79110,ASTRAZENECA,,71.0,YR,,M,Y,135.0,KG,20160728.0,,MD,GB,GB,2016,Q3,Elderly
126064771,12606477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2016,Q3,Anti-GAD antibody positive,,2016,Q3,1,I,20160721.0,,20160728,20160728,DIR,,,,,41.0,YR,,M,N,99.8,KG,20160727.0,N,PH,US,,2016,Q3,Adult
126064771,12606477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160721.0,,20160728,20160728,DIR,,,,,41.0,YR,,M,N,99.8,KG,20160727.0,N,PH,US,,2016,Q3,Adult
126064771,12606477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2016,Q3,Type 1 diabetes mellitus,,2016,Q3,1,I,20160721.0,,20160728,20160728,DIR,,,,,41.0,YR,,M,N,99.8,KG,20160727.0,N,PH,US,,2016,Q3,Adult
126084951,12608495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,420.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Accident,,2016,Q3,1,I,20160712.0,20160721.0,20160729,20160729,EXP,,GB-ASTRAZENECA-2016SE79234,ASTRAZENECA,,62.0,YR,,M,Y,68.0,KG,20160729.0,,PH,GB,GB,2016,Q3,Adult
126084951,12608495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,420.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160712.0,20160721.0,20160729,20160729,EXP,,GB-ASTRAZENECA-2016SE79234,ASTRAZENECA,,62.0,YR,,M,Y,68.0,KG,20160729.0,,PH,GB,GB,2016,Q3,Adult
126084951,12608495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,420.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Hypophagia,,2016,Q3,1,I,20160712.0,20160721.0,20160729,20160729,EXP,,GB-ASTRAZENECA-2016SE79234,ASTRAZENECA,,62.0,YR,,M,Y,68.0,KG,20160729.0,,PH,GB,GB,2016,Q3,Adult
126114321,12611432,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MCG, 1 IN 1 D",,,,,,,,100.0,UG,,QD,2016,Q3,General physical health deterioration,,2016,Q3,1,I,20160702.0,20160725.0,20160801,20160801,EXP,,AU-PFIZER INC-2016361117,PFIZER,,63.0,YR,,F,Y,,,20160801.0,,MD,AU,AU,2016,Q3,Adult
126114321,12611432,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MCG, 1 IN 1 D",,,,,,,,100.0,UG,,QD,2016,Q3,Pain,,2016,Q3,1,I,20160702.0,20160725.0,20160801,20160801,EXP,,AU-PFIZER INC-2016361117,PFIZER,,63.0,YR,,F,Y,,,20160801.0,,MD,AU,AU,2016,Q3,Adult
126130322,12613032,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,UG,,QD,2016,Q3,Liver function test abnormal,,2016,Q3,2,F,20160329.0,20160823.0,20160802,20160824,EXP,,AU-ROCHE-1803145,ROCHE,,63.0,YR,,F,Y,,,20160824.0,,MD,AU,AU,2016,Q3,Adult
126134411,12613441,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, DAILY",,,U,U,,,,10.0,MG,,,2016,Q3,Abdominal pain upper,,2016,Q3,1,I,20160310.0,20160610.0,20160802,20160802,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119109,RANBAXY,,74.0,YR,,M,Y,77.0,KG,20160802.0,,CN,ES,GB,2016,Q3,Elderly
126134411,12613441,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, DAILY",,,U,U,,,,10.0,MG,,,2016,Q3,Abnormal loss of weight,,2016,Q3,1,I,20160310.0,20160610.0,20160802,20160802,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119109,RANBAXY,,74.0,YR,,M,Y,77.0,KG,20160802.0,,CN,ES,GB,2016,Q3,Elderly
126134411,12613441,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, DAILY",,,U,U,,,,10.0,MG,,,2016,Q3,Decreased appetite,,2016,Q3,1,I,20160310.0,20160610.0,20160802,20160802,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119109,RANBAXY,,74.0,YR,,M,Y,77.0,KG,20160802.0,,CN,ES,GB,2016,Q3,Elderly
126134411,12613441,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 MG, DAILY",,,U,U,,,,10.0,MG,,,2016,Q3,Pancreatitis acute,,2016,Q3,1,I,20160310.0,20160610.0,20160802,20160802,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119109,RANBAXY,,74.0,YR,,M,Y,77.0,KG,20160802.0,,CN,ES,GB,2016,Q3,Elderly
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Abnormal loss of weight,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Accident,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Arthralgia,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Blood creatine phosphokinase decreased,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Chromaturia,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Cranial nerve disorder,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Diarrhoea,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Dysphagia,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Dyspnoea,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Eczema,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Forced expiratory volume decreased,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Mobility decreased,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Muscular weakness,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Myositis,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Pulmonary function test decreased,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126183521,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Respiratory failure,,2016,Q3,1,I,20160514.0,20160726.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20160803.0,,PH,GB,GB,2016,Q3,Adult
126203751,12620375,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2016,Q3,Vision blurred,,2016,Q3,1,I,20160721.0,20160729.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE82638,ASTRAZENECA,,57.0,YR,,M,Y,148.0,KG,20160804.0,,MD,GB,GB,2016,Q3,Adult
126203751,12620375,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,20160721.0,20160729.0,20160803,20160803,EXP,,GB-ASTRAZENECA-2016SE82638,ASTRAZENECA,,57.0,YR,,M,Y,148.0,KG,20160804.0,,MD,GB,GB,2016,Q3,Adult
126240203,12624020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,36600.0,MG,Y,,,,202293.0,100.0,MG,TABLET,QD,2016,Q3,Hyperkalaemia,,2016,Q3,3,F,20160726.0,20160919.0,20160804,20160927,EXP,,US-ASTRAZENECA-2016SE82351,ASTRAZENECA,,24212.0,DY,,M,Y,,,20160927.0,,MD,US,US,2016,Q3,Elderly
126240203,12624020,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,36600.0,MG,Y,,,,202293.0,100.0,MG,TABLET,QD,2016,Q3,Hyperkalaemia,,2016,Q3,3,F,20160726.0,20160919.0,20160804,20160927,EXP,,US-ASTRAZENECA-2016SE82351,ASTRAZENECA,,24212.0,DY,,M,Y,,,20160927.0,,MD,US,US,2016,Q3,Elderly
126342111,12634211,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,,2016,Q3,Erythema,,2016,Q3,1,I,,20160802.0,20160808,20160808,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50827UK",BOEHRINGER INGELHEIM,,68.0,YR,,F,Y,,,20160808.0,,OT,GB,GB,2016,Q3,Elderly
126342111,12634211,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,,2016,Q3,Pruritus,,2016,Q3,1,I,,20160802.0,20160808,20160808,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50827UK",BOEHRINGER INGELHEIM,,68.0,YR,,F,Y,,,20160808.0,,OT,GB,GB,2016,Q3,Elderly
126368071,12636807,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MCG (10 MCG,1 IN 1 D)",,,,,,,,10.0,UG,,,2016,Q3,Liver function test abnormal,,2016,Q3,1,I,20160329.0,20160726.0,20160809,20160809,EXP,,AU-PFIZER INC-2016362912,PFIZER,,63.0,YR,,F,Y,,,20160809.0,,MD,AU,AU,2016,Q3,Adult
126404462,12640446,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5110.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Coronary artery disease,,2016,Q3,2,F,20160804.0,20160919.0,20160810,20160922,EXP,,IN-ASTRAZENECA-2016SE85612,ASTRAZENECA,,23365.0,DY,,M,Y,,,20160922.0,,MD,IN,IN,2016,Q3,Elderly
126404462,12640446,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5110.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Coronary artery disease,,2016,Q3,2,F,20160804.0,20160919.0,20160810,20160922,EXP,,IN-ASTRAZENECA-2016SE85612,ASTRAZENECA,,23365.0,DY,,M,Y,,,20160922.0,,MD,IN,IN,2016,Q3,Elderly
126460661,12646066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Abdominal pain,,2016,Q3,1,I,20160705.0,20160803.0,20160811,20160811,EXP,,GB-ASTRAZENECA-2016SE84222,ASTRAZENECA,,58.0,YR,,F,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126460661,12646066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160705.0,20160803.0,20160811,20160811,EXP,,GB-ASTRAZENECA-2016SE84222,ASTRAZENECA,,58.0,YR,,F,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126460661,12646066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Vomiting,,2016,Q3,1,I,20160705.0,20160803.0,20160811,20160811,EXP,,GB-ASTRAZENECA-2016SE84222,ASTRAZENECA,,58.0,YR,,F,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126483161,12648316,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,U,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,,20160803.0,20160812,20160812,PER,,US-TAKEDA-2016TUS013765,TAKEDA,,60.0,YR,,F,Y,102.4,KG,20160812.0,,MD,US,US,2016,Q3,Adult
126483161,12648316,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,U,,,,,,,,2016,Q3,Weight fluctuation,,2016,Q3,1,I,,20160803.0,20160812,20160812,PER,,US-TAKEDA-2016TUS013765,TAKEDA,,60.0,YR,,F,Y,102.4,KG,20160812.0,,MD,US,US,2016,Q3,Adult
126498001,12649800,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2069.583,MG,Y,U,,,202293.0,5.0,MG,TABLET,BID,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160726.0,20160806.0,20160812,20160812,EXP,,GB-ASTRAZENECA-2016SE85387,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20160813.0,,MD,GB,GB,2016,Q3,Adult
126498001,12649800,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2069.583,MG,Y,U,,,202293.0,5.0,MG,TABLET,BID,2016,Q3,Pancreatitis acute,,2016,Q3,1,I,20160726.0,20160806.0,20160812,20160812,EXP,,GB-ASTRAZENECA-2016SE85387,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20160813.0,,MD,GB,GB,2016,Q3,Adult
126515071,12651507,2,SS,dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2016,Q3,Blood bicarbonate decreased,,2016,Q3,1,I,,20160805.0,20160815,20160815,EXP,,IT-TEVA-683825ACC,TEVA,"CASTELLINI M,DAFFINI L. DIABETIC KETOACIDOSIS AND SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS A CLINICAL CASE. ITALIAN JOURNAL OF MEDICINE. 2016 MAY 01;10(S2):22-22.",61.0,YR,,M,Y,,,20160815.0,,MD,IT,IT,2016,Q3,Adult
126515071,12651507,2,SS,dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2016,Q3,Blood lactic acid increased,,2016,Q3,1,I,,20160805.0,20160815,20160815,EXP,,IT-TEVA-683825ACC,TEVA,"CASTELLINI M,DAFFINI L. DIABETIC KETOACIDOSIS AND SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS A CLINICAL CASE. ITALIAN JOURNAL OF MEDICINE. 2016 MAY 01;10(S2):22-22.",61.0,YR,,M,Y,,,20160815.0,,MD,IT,IT,2016,Q3,Adult
126515071,12651507,2,SS,dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2016,Q3,Ketonuria,,2016,Q3,1,I,,20160805.0,20160815,20160815,EXP,,IT-TEVA-683825ACC,TEVA,"CASTELLINI M,DAFFINI L. DIABETIC KETOACIDOSIS AND SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS A CLINICAL CASE. ITALIAN JOURNAL OF MEDICINE. 2016 MAY 01;10(S2):22-22.",61.0,YR,,M,Y,,,20160815.0,,MD,IT,IT,2016,Q3,Adult
126515071,12651507,2,SS,dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2016,Q3,Metabolic acidosis,,2016,Q3,1,I,,20160805.0,20160815,20160815,EXP,,IT-TEVA-683825ACC,TEVA,"CASTELLINI M,DAFFINI L. DIABETIC KETOACIDOSIS AND SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS A CLINICAL CASE. ITALIAN JOURNAL OF MEDICINE. 2016 MAY 01;10(S2):22-22.",61.0,YR,,M,Y,,,20160815.0,,MD,IT,IT,2016,Q3,Adult
126638211,12663821,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160717.0,20160811.0,20160818,20160818,EXP,,GB-ASTRAZENECA-2016SE86894,ASTRAZENECA,,62.0,YR,,M,Y,,,20160818.0,,OT,GB,GB,2016,Q3,Adult
126638211,12663821,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Sepsis,,2016,Q3,1,I,20160717.0,20160811.0,20160818,20160818,EXP,,GB-ASTRAZENECA-2016SE86894,ASTRAZENECA,,62.0,YR,,M,Y,,,20160818.0,,OT,GB,GB,2016,Q3,Adult
126662241,12666224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,DAILY,660.0,MG,Y,,,,,5.0,MG,TABLET,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,1,I,20160808.0,20160810.0,20160818,20160818,EXP,,JP-ASTRAZENECA-2016SE86515,ASTRAZENECA,,19647.0,DY,,F,Y,,,20160819.0,,MD,JP,JP,2016,Q3,Elderly
126696791,12669679,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2016,Q3,Pancreatitis acute,,2016,Q3,1,I,20160613.0,20160811.0,20160819,20160819,EXP,,GB-ASTRAZENECA-2016SE86888,ASTRAZENECA,,57.0,YR,,F,Y,97.0,KG,20160819.0,,MD,GB,GB,2016,Q3,Adult
126696791,12669679,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,TABLET,,2016,Q3,Peripancreatic fluid collection,,2016,Q3,1,I,20160613.0,20160811.0,20160819,20160819,EXP,,GB-ASTRAZENECA-2016SE86888,ASTRAZENECA,,57.0,YR,,F,Y,97.0,KG,20160819.0,,MD,GB,GB,2016,Q3,Adult
126700141,12670014,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1120.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160802.0,20160812.0,20160821,20160821,EXP,,GB-ASTRAZENECA-2016SE87519,ASTRAZENECA,,62.0,YR,,M,Y,87.0,KG,20160821.0,,CN,GB,GB,2016,Q3,Adult
126761673,12676167,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,,QD,2016,Q3,Acute myocardial infarction,,2016,Q3,3,F,,20160920.0,20160823,20160922,EXP,,JP-009507513-1608JPN010700,MERCK,,86.0,YR,,F,Y,40.0,KG,20160922.0,,OT,JP,JP,2016,Q3,Elderly
126761673,12676167,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,3,F,,20160920.0,20160823,20160922,EXP,,JP-009507513-1608JPN010700,MERCK,,86.0,YR,,F,Y,40.0,KG,20160922.0,,OT,JP,JP,2016,Q3,Elderly
126761673,12676167,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,,QD,2016,Q3,Mallory-Weiss syndrome,,2016,Q3,3,F,,20160920.0,20160823,20160922,EXP,,JP-009507513-1608JPN010700,MERCK,,86.0,YR,,F,Y,40.0,KG,20160922.0,,OT,JP,JP,2016,Q3,Elderly
126761673,12676167,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,U,,,,,5.0,MG,,QD,2016,Q3,Urinary tract infection,,2016,Q3,3,F,,20160920.0,20160823,20160922,EXP,,JP-009507513-1608JPN010700,MERCK,,86.0,YR,,F,Y,40.0,KG,20160922.0,,OT,JP,JP,2016,Q3,Elderly
126815781,12681578,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 ANZ,,,,,,,,,,,QD,2016,Q3,Abdominal discomfort,Abdominal discomfort,2016,Q3,1,I,20160808.0,20160818.0,20160824,20160824,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54520UK",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,110.0,KG,20160824.0,,MD,GB,GB,2016,Q3,Adult
126815781,12681578,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 ANZ,,,,,,,,,,,QD,2016,Q3,Drug intolerance,Drug intolerance,2016,Q3,1,I,20160808.0,20160818.0,20160824,20160824,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54520UK",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,110.0,KG,20160824.0,,MD,GB,GB,2016,Q3,Adult
126815781,12681578,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 ANZ,,,,,,,,,,,QD,2016,Q3,Headache,Headache,2016,Q3,1,I,20160808.0,20160818.0,20160824,20160824,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54520UK",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,110.0,KG,20160824.0,,MD,GB,GB,2016,Q3,Adult
126815781,12681578,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 ANZ,,,,,,,,,,,QD,2016,Q3,Malaise,Malaise,2016,Q3,1,I,20160808.0,20160818.0,20160824,20160824,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54520UK",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,110.0,KG,20160824.0,,MD,GB,GB,2016,Q3,Adult
126824203,12682420,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,3,F,20160813.0,20160907.0,20160825,20160915,EXP,,JP-ASTRAZENECA-2016SE89566,ASTRAZENECA,,13324.0,DY,,M,Y,,,20160915.0,,MD,JP,JP,2016,Q3,Elderly
126824203,12682420,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,3,F,20160813.0,20160907.0,20160825,20160915,EXP,,JP-ASTRAZENECA-2016SE89566,ASTRAZENECA,,13324.0,DY,,M,Y,,,20160915.0,,MD,JP,JP,2016,Q3,Elderly
126824203,12682420,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,3,F,20160813.0,20160907.0,20160825,20160915,EXP,,JP-ASTRAZENECA-2016SE89566,ASTRAZENECA,,13324.0,DY,,M,Y,,,20160915.0,,MD,JP,JP,2016,Q3,Elderly
126824203,12682420,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,3,F,20160813.0,20160907.0,20160825,20160915,EXP,,JP-ASTRAZENECA-2016SE89566,ASTRAZENECA,,13324.0,DY,,M,Y,,,20160915.0,,MD,JP,JP,2016,Q3,Elderly
126824203,12682420,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,TABLET,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,3,F,20160813.0,20160907.0,20160825,20160915,EXP,,JP-ASTRAZENECA-2016SE89566,ASTRAZENECA,,13324.0,DY,,M,Y,,,20160915.0,,MD,JP,JP,2016,Q3,Elderly
126826371,12682637,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20150801.0,20160819.0,20160825,20160825,EXP,,GB-ASTRAZENECA-2016SE89853,ASTRAZENECA,,62.0,YR,,M,Y,87.0,KG,20160825.0,,OT,GB,GB,2016,Q3,Adult
126826371,12682637,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U, UNKNOWN,,202293.0,10.0,MG,TABLET,,2016,Q3,Hyperglycaemia,,2016,Q3,1,I,20150801.0,20160819.0,20160825,20160825,EXP,,GB-ASTRAZENECA-2016SE89853,ASTRAZENECA,,62.0,YR,,M,Y,87.0,KG,20160825.0,,OT,GB,GB,2016,Q3,Adult
126887081,12688708,9,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2016,Q3,Drug dose omission,,2016,Q3,1,I,,20160603.0,20160826,20160826,PER,,US-DRREDDYS-DRL/USA/16/0080382,DR REDDYS,,53.0,YR,,M,Y,109.0,KG,20160826.0,,CN,US,US,2016,Q3,Adult
126887081,12688708,9,C,dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2016,Q3,Product physical issue,,2016,Q3,1,I,,20160603.0,20160826,20160826,PER,,US-DRREDDYS-DRL/USA/16/0080382,DR REDDYS,,53.0,YR,,M,Y,109.0,KG,20160826.0,,CN,US,US,2016,Q3,Adult
126918511,12691851,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,TABLET,,2016,Q3,Necrotising fasciitis,,2016,Q3,1,I,,20160819.0,20160827,20160827,EXP,,AU-ASTRAZENECA-2016SE89419,ASTRAZENECA,,67.0,YR,,M,Y,,,20160827.0,,OT,AU,AU,2016,Q3,Elderly
127080602,12708060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Ketosis,,2016,Q3,2,F,20160410.0,20160906.0,20160901,20160914,EXP,,IN-ASTRAZENECA-2016SE91837,ASTRAZENECA,,62.0,YR,,M,Y,72.0,KG,20160914.0,,MD,IN,IN,2016,Q3,Adult
127080602,12708060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Urinary tract infection,,2016,Q3,2,F,20160410.0,20160906.0,20160901,20160914,EXP,,IN-ASTRAZENECA-2016SE91837,ASTRAZENECA,,62.0,YR,,M,Y,72.0,KG,20160914.0,,MD,IN,IN,2016,Q3,Adult
127096841,12709684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,U, (UNKNOWN),,202293.0,10.0,MG,TABLET,,2016,Q3,Diabetic ketoacidotic hyperglycaemic coma,,2016,Q3,1,I,20160817.0,20160825.0,20160902,20160902,EXP,,GB-ASTRAZENECA-2016SE91695,ASTRAZENECA,,70.0,YR,,M,Y,,,20160902.0,,MD,GB,GB,2016,Q3,Elderly
127096841,12709684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,U, (UNKNOWN),,202293.0,10.0,MG,TABLET,,2016,Q3,Renal failure,,2016,Q3,1,I,20160817.0,20160825.0,20160902,20160902,EXP,,GB-ASTRAZENECA-2016SE91695,ASTRAZENECA,,70.0,YR,,M,Y,,,20160902.0,,MD,GB,GB,2016,Q3,Elderly
127148701,12714870,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1675.0,MG,Y,U,,,,5.0,MG,TABLET,QD,2016,Q3,Ketoacidosis,,2016,Q3,1,I,20160627.0,20160630.0,20160905,20160905,EXP,,DE-ASTRAZENECA-2016SE72164,ASTRAZENECA,,39.0,YR,,M,Y,80.7,KG,20160905.0,,MD,DE,DE,2016,Q3,Adult
127195162,12719516,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,2,F,,20160905.0,20160907,20160915,EXP,,IT-TEVA-688548ACC,TEVA,MATTEO M. SYNERGISTIC ACTION OF INCRETINS AND GLIFLOZINE: A WINNING STRATEGY. SODC DIABETOLOGY. 2016 JAN 01;16:79-79.,66.0,YR,,M,Y,,,20160915.0,,MD,IT,IT,2016,Q3,Elderly
127283791,12728379,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Acute kidney injury,,2016,Q3,1,I,,20160901.0,20160909,20160909,EXP,,GB-ASTRAZENECA-2016SE94130,ASTRAZENECA,,70.0,YR,,M,Y,65.0,KG,20160909.0,,PH,GB,GB,2016,Q3,Elderly
127283791,12728379,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,,20160901.0,20160909,20160909,EXP,,GB-ASTRAZENECA-2016SE94130,ASTRAZENECA,,70.0,YR,,M,Y,65.0,KG,20160909.0,,PH,GB,GB,2016,Q3,Elderly
127522781,12752278,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,840.0,MG,N,,,,,5.0,MG,TABLET,BID,2016,Q3,Ketosis,,2016,Q3,1,I,20160907.0,20160907.0,20160915,20160915,EXP,,HU-ASTRAZENECA-2016SE95626,ASTRAZENECA,,12093.0,DY,,M,Y,,,20160915.0,,MD,HU,HU,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Dizziness,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Major depression,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Morbid thoughts,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Panic reaction,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Personality disorder,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Pollakiuria,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127627561,12762756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q3,Thirst,,2016,Q3,1,I,20160625.0,20160912.0,20160920,20160920,EXP,,GB-ASTRAZENECA-2016SE96946,ASTRAZENECA,,68.0,YR,,M,Y,,,20160920.0,,PH,GB,GB,2016,Q3,Elderly
127645222,12764522,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,Y,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Fixed drug eruption,,2016,Q3,2,F,,20160912.0,20160920,20160923,EXP,,PT-ASTRAZENECA-2016SE97355,ASTRAZENECA,,63.0,YR,,M,Y,,,20160923.0,,OT,IT,IT,2016,Q3,Adult
127645222,12764522,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,Y,,,202293.0,10.0,MG,TABLET,QD,2016,Q3,Fixed drug eruption,,2016,Q3,2,F,,20160912.0,20160920,20160923,EXP,,PT-ASTRAZENECA-2016SE97355,ASTRAZENECA,,63.0,YR,,M,Y,,,20160923.0,,OT,IT,IT,2016,Q3,Adult
127649111,12764911,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q3,Rash macular,,2016,Q3,1,I,,20160909.0,20160921,20160921,EXP,,GB-CONCORDIA PHARMACEUTICALS INC.-GSH201609-004659,CONCORDIA,,67.0,YR,,F,Y,,,20160920.0,,OT,GB,GB,2016,Q3,Elderly
127757921,12775792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q3,Diarrhoea,,2016,Q3,1,I,20160823.0,20160915.0,20160923,20160923,EXP,,GB-ASTRAZENECA-2016SE98424,ASTRAZENECA,,59.0,YR,,F,Y,79.0,KG,20160923.0,,MD,GB,GB,2016,Q3,Adult
127759031,12775903,10,C,Dapagliflozin metformin,,2,Oral,10-1000MG,,,,,,,,,,TABLETS,,2016,Q3,Asthenia,,2016,Q3,1,I,201608.0,20160914.0,20160923,20160923,PER,,US-CELGENEUS-USA-2016093566,CELGENE,,73.0,YR,,F,Y,69.92,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127759031,12775903,10,C,Dapagliflozin metformin,,2,Oral,10-1000MG,,,,,,,,,,TABLETS,,2016,Q3,Blood immunoglobulin G decreased,,2016,Q3,1,I,201608.0,20160914.0,20160923,20160923,PER,,US-CELGENEUS-USA-2016093566,CELGENE,,73.0,YR,,F,Y,69.92,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127759031,12775903,10,C,Dapagliflozin metformin,,2,Oral,10-1000MG,,,,,,,,,,TABLETS,,2016,Q3,Tremor,,2016,Q3,1,I,201608.0,20160914.0,20160923,20160923,PER,,US-CELGENEUS-USA-2016093566,CELGENE,,73.0,YR,,F,Y,69.92,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127759031,12775903,10,C,Dapagliflozin metformin,,2,Oral,10-1000MG,,,,,,,,,,TABLETS,,2016,Q3,White blood cell count decreased,,2016,Q3,1,I,201608.0,20160914.0,20160923,20160923,PER,,US-CELGENEUS-USA-2016093566,CELGENE,,73.0,YR,,F,Y,69.92,KG,20160923.0,,MD,US,US,2016,Q3,Elderly
127760391,12776039,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5370.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Pericarditis,,2016,Q3,1,I,20160830.0,20160919.0,20160923,20160923,EXP,,IN-ASTRAZENECA-2016SF00874,ASTRAZENECA,,23391.0,DY,,M,Y,,,20160923.0,,MD,IN,IN,2016,Q3,Elderly
127760391,12776039,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5370.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Pericarditis,,2016,Q3,1,I,20160830.0,20160919.0,20160923,20160923,EXP,,IN-ASTRAZENECA-2016SF00874,ASTRAZENECA,,23391.0,DY,,M,Y,,,20160923.0,,MD,IN,IN,2016,Q3,Elderly
127779101,12777910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160905.0,20160915.0,20160924,20160924,EXP,,GB-ASTRAZENECA-2016SE98352,ASTRAZENECA,,58.0,YR,,M,Y,,,20160925.0,,OT,GB,GB,2016,Q3,Adult
127847011,12784701,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2016,Q3,Diabetic foot,,2016,Q3,1,I,2016.0,20160919.0,20160927,20160927,EXP,,GB-ASTRAZENECA-2016SF00133,ASTRAZENECA,,43.0,YR,,M,Y,,,20160927.0,,MD,GB,GB,2016,Q3,Adult
127912041,12791204,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q3,Abdominal distension,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q3,Fatigue,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q3,Glycosylated haemoglobin increased,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q3,High density lipoprotein decreased,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127912041,12791204,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q3,Somnolence,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11938,AUROBINDO,FEDERICA D^ANGELO. DAPAGLIFLOZIN: INNOVATION AND THERAPEUTIC EFFICACY CLINICAL CASE. 2016;16:88-89,65.0,YR,,F,Y,78.0,KG,20160929.0,,OT,IT,IT,2016,Q3,Elderly
127917331,12791733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9220.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160902.0,20160920.0,20160929,20160929,EXP,,US-ASTRAZENECA-2016SF02319,ASTRAZENECA,,21517.0,DY,,F,Y,,,20160929.0,,MD,US,US,2016,Q3,Elderly
127982591,12798259,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160903.0,20160922.0,20160930,20160930,EXP,,GB-ASTRAZENECA-2016SF01492,ASTRAZENECA,,55.0,YR,,M,Y,70.0,KG,20160930.0,,MD,GB,GB,2016,Q3,Adult
108752646,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,,10.0,MG,TABLET,QD,2016,Q4,Cardiac failure,,2016,Q4,6,F,20140701.0,20161130.0,20150227,20161213,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20161214.0,,MD,US,US,2016,Q4,Elderly
108752646,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,,10.0,MG,TABLET,QD,2016,Q4,Cellulitis,,2016,Q4,6,F,20140701.0,20161130.0,20150227,20161213,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20161214.0,,MD,US,US,2016,Q4,Elderly
108752646,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,,10.0,MG,TABLET,QD,2016,Q4,Hyponatraemia,,2016,Q4,6,F,20140701.0,20161130.0,20150227,20161213,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20161214.0,,MD,US,US,2016,Q4,Elderly
108752646,10875264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,,10.0,MG,TABLET,QD,2016,Q4,Respiratory failure,,2016,Q4,6,F,20140701.0,20161130.0,20150227,20161213,EXP,,US-ASTRAZENECA-2014SE56638,ASTRAZENECA,,27766.0,DY,,M,Y,,,20161214.0,,MD,US,US,2016,Q4,Elderly
109051024,10905102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3440.0,MG,D,,,,,10.0,MG,TABLET,QD,2016,Q4,Obstructive uropathy,,2016,Q4,4,F,20150226.0,20161021.0,20150311,20161026,EXP,,US-ASTRAZENECA-2015SE20925,ASTRAZENECA,,28621.0,DY,,M,Y,,,20161026.0,,MD,US,US,2016,Q4,Elderly
109051024,10905102,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3440.0,MG,D,,,,,10.0,MG,TABLET,QD,2016,Q4,Obstructive uropathy,,2016,Q4,4,F,20150226.0,20161021.0,20150311,20161026,EXP,,US-ASTRAZENECA-2015SE20925,ASTRAZENECA,,28621.0,DY,,M,Y,,,20161026.0,,MD,US,US,2016,Q4,Elderly
111237204,11123720,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Purpura,,2016,Q4,4,F,20140614.0,20161206.0,20150519,20161209,EXP,,CA-ASTRAZENECA-2015SE45036,ASTRAZENECA,,68.0,YR,,F,Y,,,20161209.0,,MD,CA,CA,2016,Q4,Elderly
111237204,11123720,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Purpura,,2016,Q4,4,F,20140614.0,20161206.0,20150519,20161209,EXP,,CA-ASTRAZENECA-2015SE45036,ASTRAZENECA,,68.0,YR,,F,Y,,,20161209.0,,MD,CA,CA,2016,Q4,Elderly
1117939915,11179399,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2016,Q4,Basal cell carcinoma,,2016,Q4,15,F,20150713.0,20161206.0,20150611,20161210,EXP,,PHHO2015IT009351,NOVARTIS,,81.0,YR,,M,Y,50.0,KG,20161210.0,,MD,IT,IT,2016,Q4,Elderly
1117939915,11179399,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2016,Q4,Pneumonia,,2016,Q4,15,F,20150713.0,20161206.0,20150611,20161210,EXP,,PHHO2015IT009351,NOVARTIS,,81.0,YR,,M,Y,50.0,KG,20161210.0,,MD,IT,IT,2016,Q4,Elderly
1117939915,11179399,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2016,Q4,Squamous cell carcinoma of lung,,2016,Q4,15,F,20150713.0,20161206.0,20150611,20161210,EXP,,PHHO2015IT009351,NOVARTIS,,81.0,YR,,M,Y,50.0,KG,20161210.0,,MD,IT,IT,2016,Q4,Elderly
113217532,11321753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2016,Q4,Urosepsis,,2016,Q4,2,F,20141203.0,20161019.0,20150729,20161025,EXP,,US-ASTRAZENECA-2015SE00319,ASTRAZENECA,,71.0,YR,,M,Y,,,20161025.0,,CN,US,US,2016,Q4,Elderly
114421383,11442138,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,N,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,3,F,,20161017.0,20150901,20161026,EXP,,DK-ASTRAZENECA-2015SE81912,ASTRAZENECA,,44.0,YR,,M,Y,,,20161026.0,,OT,DK,DK,2016,Q4,Adult
114421383,11442138,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,N,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Lactic acidosis,,2016,Q4,3,F,,20161017.0,20150901,20161026,EXP,,DK-ASTRAZENECA-2015SE81912,ASTRAZENECA,,44.0,YR,,M,Y,,,20161026.0,,OT,DK,DK,2016,Q4,Adult
114421383,11442138,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,N,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,3,F,,20161017.0,20150901,20161026,EXP,,DK-ASTRAZENECA-2015SE81912,ASTRAZENECA,,44.0,YR,,M,Y,,,20161026.0,,OT,DK,DK,2016,Q4,Adult
114421383,11442138,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,N,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Lactic acidosis,,2016,Q4,3,F,,20161017.0,20150901,20161026,EXP,,DK-ASTRAZENECA-2015SE81912,ASTRAZENECA,,44.0,YR,,M,Y,,,20161026.0,,OT,DK,DK,2016,Q4,Adult
126084952,12608495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,420.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Accident,,2016,Q4,2,F,20160712.0,20161104.0,20160729,20161110,EXP,,GB-ASTRAZENECA-2016SE79234,ASTRAZENECA,,62.0,YR,,M,Y,68.0,KG,20161110.0,,PH,GB,GB,2016,Q4,Adult
126084952,12608495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,420.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,20160712.0,20161104.0,20160729,20161110,EXP,,GB-ASTRAZENECA-2016SE79234,ASTRAZENECA,,62.0,YR,,M,Y,68.0,KG,20161110.0,,PH,GB,GB,2016,Q4,Adult
126084952,12608495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,420.0,MG,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Hypophagia,,2016,Q4,2,F,20160712.0,20161104.0,20160729,20161110,EXP,,GB-ASTRAZENECA-2016SE79234,ASTRAZENECA,,62.0,YR,,M,Y,68.0,KG,20161110.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Abnormal loss of weight,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Accident,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Arthralgia,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Blood creatine phosphokinase increased,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Chromaturia,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Cranial nerve disorder,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Diarrhoea,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Dysphagia,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Eczema,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Mobility decreased,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Muscular weakness,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Myositis,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126183522,12618352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Respiratory failure,,2016,Q4,2,F,20160514.0,20161108.0,20160803,20161116,EXP,,GB-ASTRAZENECA-2016SE81091,ASTRAZENECA,,52.0,YR,,M,Y,91.6,KG,20161117.0,,PH,GB,GB,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Cardiovascular disorder,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Cardiovascular insufficiency,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Cerebral artery occlusion,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Condition aggravated,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Death,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Endotracheal intubation,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Ischaemic stroke,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Metabolic acidosis,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Pulmonary embolism,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126201695,12620169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2016,Q4,Respiratory fatigue,,2016,Q4,5,F,20160427.0,20161028.0,20160803,20161104,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50284DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161104.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Cardiovascular disorder,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Cardiovascular insufficiency,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Condition aggravated,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Death,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Endotracheal intubation,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Metabolic acidosis,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Pulmonary embolism,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126458864,12645886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,,,,,2016,Q4,Respiratory fatigue,,2016,Q4,4,F,20160427.0,20161028.0,20160811,20161108,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52132DE",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,,,20161108.0,,MD,DE,DE,2016,Q4,Adult
126623622,12662362,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2280.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q4,Vertebrobasilar insufficiency,,2016,Q4,2,F,20160617.0,20161011.0,20160817,20161018,EXP,,PL-ASTRAZENECA-2016SE86112,ASTRAZENECA,,19463.0,DY,,M,Y,,,20161018.0,,MD,PL,PL,2016,Q4,Elderly
126825385,12682538,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2016,Q4,Blood bicarbonate decreased,,2016,Q4,5,F,,20161021.0,20160825,20161027,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20161027.0,,CN,IT,IT,2016,Q4,Adult
126825385,12682538,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2016,Q4,Blood lactic acid increased,,2016,Q4,5,F,,20161021.0,20160825,20161027,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20161027.0,,CN,IT,IT,2016,Q4,Adult
126825385,12682538,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,5,F,,20161021.0,20160825,20161027,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20161027.0,,CN,IT,IT,2016,Q4,Adult
126825385,12682538,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2016,Q4,Ketonuria,,2016,Q4,5,F,,20161021.0,20160825,20161027,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20161027.0,,CN,IT,IT,2016,Q4,Adult
126825385,12682538,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2016,Q4,Metabolic acidosis,,2016,Q4,5,F,,20161021.0,20160825,20161027,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069074,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,,,20161027.0,,CN,IT,IT,2016,Q4,Adult
126888925,12688892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1150.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Cardiac arrest,,2016,Q4,5,F,20160809.0,20161031.0,20160825,20161105,EXP,,JP-ASTRAZENECA-2016SE89841,ASTRAZENECA,,15394.0,DY,,M,Y,,,20161105.0,,MD,JP,JP,2016,Q4,Elderly
126888925,12688892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1150.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic hyperglycaemic coma,,2016,Q4,5,F,20160809.0,20161031.0,20160825,20161105,EXP,,JP-ASTRAZENECA-2016SE89841,ASTRAZENECA,,15394.0,DY,,M,Y,,,20161105.0,,MD,JP,JP,2016,Q4,Elderly
127342976,12734297,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,470.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Coma,,2016,Q4,6,F,20160827.0,20161221.0,20160912,20161223,EXP,,PL-ASTRAZENECA-2016SE96594,ASTRAZENECA,,20419.0,DY,,F,Y,,,20161223.0,,MD,PL,PL,2016,Q4,Elderly
127342976,12734297,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,470.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,6,F,20160827.0,20161221.0,20160912,20161223,EXP,,PL-ASTRAZENECA-2016SE96594,ASTRAZENECA,,20419.0,DY,,F,Y,,,20161223.0,,MD,PL,PL,2016,Q4,Elderly
127729112,12772911,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7990.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Thoracic vertebral fracture,,2016,Q4,2,F,20160615.0,20161012.0,20160922,20161020,EXP,,CA-ASTRAZENECA-2016SE98129,ASTRAZENECA,,65.0,YR,,F,Y,,,20161020.0,,MD,CA,CA,2016,Q4,Elderly
127760392,12776039,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5370.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Pleuropericarditis,,2016,Q4,2,F,20160830.0,20161207.0,20160923,20161209,EXP,,IN-ASTRAZENECA-2016SF00874,ASTRAZENECA,,23391.0,DY,,M,Y,,,20161209.0,,MD,IN,IN,2016,Q4,Elderly
127760392,12776039,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5370.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Pleuropericarditis,,2016,Q4,2,F,20160830.0,20161207.0,20160923,20161209,EXP,,IN-ASTRAZENECA-2016SF00874,ASTRAZENECA,,23391.0,DY,,M,Y,,,20161209.0,,MD,IN,IN,2016,Q4,Elderly
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Asthma,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Confusional state,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Cough,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Dysgeusia,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Dysphagia,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Dyspnoea,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Ear discomfort,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Ear disorder,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Ear pain,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Memory impairment,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Nasal congestion,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Nasal discomfort,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Nasal disorder,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Pruritus,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127804122,12780412,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2016,Q4,Sinusitis,,2016,Q4,2,F,2013.0,20161025.0,20160926,20161101,EXP,,GB-SA-2016SA170383,AVENTIS,,52.0,YR,A,M,Y,94.5,KG,20161101.0,,MD,GB,GB,2016,Q4,Adult
127873294,12787329,6,C,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2016,Q4,Bronchitis,,2016,Q4,4,F,20160831.0,20161201.0,20160927,20161212,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20161210.0,,PH,US,US,2016,Q4,Adult
127873294,12787329,6,C,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2016,Q4,Fatigue,,2016,Q4,4,F,20160831.0,20161201.0,20160927,20161212,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20161210.0,,PH,US,US,2016,Q4,Adult
127873294,12787329,6,C,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2016,Q4,Pain,,2016,Q4,4,F,20160831.0,20161201.0,20160927,20161212,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20161210.0,,PH,US,US,2016,Q4,Adult
127873294,12787329,6,C,Dapagliflozin,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,TABLET,,2016,Q4,Psoriatic arthropathy,,2016,Q4,4,F,20160831.0,20161201.0,20160927,20161212,EXP,,US-UCBSA-2016035654,UCB,,44.0,YR,,F,Y,,,20161210.0,,PH,US,US,2016,Q4,Adult
127917332,12791733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9220.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,20160902.0,20161121.0,20160929,20161128,EXP,,US-ASTRAZENECA-2016SF02319,ASTRAZENECA,,21507.0,DY,,F,Y,,,20161129.0,,MD,US,US,2016,Q4,Elderly
127999163,12799916,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q4,Craniocerebral injury,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q4,Macular oedema,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
127999163,12799916,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2016,Q4,Skin ulcer,,2016,Q4,3,F,2010.0,20161028.0,20160930,20161108,EXP,,ES-NOVOPROD-511118,NOVO NORDISK,,75.0,YR,E,M,Y,,,20161108.0,,MD,ES,ES,2016,Q4,Elderly
128125611,12812561,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,650.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Ketoacidosis,,2016,Q4,1,I,20160823.0,20160927.0,20161005,20161005,EXP,,GB-ASTRAZENECA-2016SF03164,ASTRAZENECA,,56.0,YR,,M,Y,95.3,KG,20161005.0,,PH,GB,GB,2016,Q4,Adult
128125611,12812561,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,650.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Lower urinary tract symptoms,,2016,Q4,1,I,20160823.0,20160927.0,20161005,20161005,EXP,,GB-ASTRAZENECA-2016SF03164,ASTRAZENECA,,56.0,YR,,M,Y,95.3,KG,20161005.0,,PH,GB,GB,2016,Q4,Adult
128125611,12812561,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,650.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Malaise,,2016,Q4,1,I,20160823.0,20160927.0,20161005,20161005,EXP,,GB-ASTRAZENECA-2016SF03164,ASTRAZENECA,,56.0,YR,,M,Y,95.3,KG,20161005.0,,PH,GB,GB,2016,Q4,Adult
128125611,12812561,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,650.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Pyrexia,,2016,Q4,1,I,20160823.0,20160927.0,20161005,20161005,EXP,,GB-ASTRAZENECA-2016SF03164,ASTRAZENECA,,56.0,YR,,M,Y,95.3,KG,20161005.0,,PH,GB,GB,2016,Q4,Adult
128187391,12818739,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20160927.0,20161006,20161006,EXP,,IT-ASTRAZENECA-2016SF03581,ASTRAZENECA,,61.0,YR,,M,Y,,,20161006.0,,OT,IT,IT,2016,Q4,Adult
128310561,12831056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5425.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Dizziness,,2016,Q4,1,I,20160823.0,20160929.0,20161007,20161007,EXP,,GB-ASTRAZENECA-2016SF04293,ASTRAZENECA,,49.0,YR,,F,Y,90.0,KG,20161008.0,,PH,GB,GB,2016,Q4,Adult
128310561,12831056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5425.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Hyperhidrosis,,2016,Q4,1,I,20160823.0,20160929.0,20161007,20161007,EXP,,GB-ASTRAZENECA-2016SF04293,ASTRAZENECA,,49.0,YR,,F,Y,90.0,KG,20161008.0,,PH,GB,GB,2016,Q4,Adult
128310561,12831056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5425.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Lethargy,,2016,Q4,1,I,20160823.0,20160929.0,20161007,20161007,EXP,,GB-ASTRAZENECA-2016SF04293,ASTRAZENECA,,49.0,YR,,F,Y,90.0,KG,20161008.0,,PH,GB,GB,2016,Q4,Adult
128310561,12831056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5425.0,MG,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Palpitations,,2016,Q4,1,I,20160823.0,20160929.0,20161007,20161007,EXP,,GB-ASTRAZENECA-2016SF04293,ASTRAZENECA,,49.0,YR,,F,Y,90.0,KG,20161008.0,,PH,GB,GB,2016,Q4,Adult
128344403,12834440,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,20161004.0,20161029.0,20161010,20161103,EXP,,IN-ASTRAZENECA-2016SF06029,ASTRAZENECA,,24081.0,DY,,M,Y,,,20161103.0,,MD,IN,IN,2016,Q4,Elderly
128344403,12834440,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Pyrexia,,2016,Q4,3,F,20161004.0,20161029.0,20161010,20161103,EXP,,IN-ASTRAZENECA-2016SF06029,ASTRAZENECA,,24081.0,DY,,M,Y,,,20161103.0,,MD,IN,IN,2016,Q4,Elderly
128344403,12834440,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,20161004.0,20161029.0,20161010,20161103,EXP,,IN-ASTRAZENECA-2016SF06029,ASTRAZENECA,,24081.0,DY,,M,Y,,,20161103.0,,MD,IN,IN,2016,Q4,Elderly
128344403,12834440,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Pyrexia,,2016,Q4,3,F,20161004.0,20161029.0,20161010,20161103,EXP,,IN-ASTRAZENECA-2016SF06029,ASTRAZENECA,,24081.0,DY,,M,Y,,,20161103.0,,MD,IN,IN,2016,Q4,Elderly
128425672,12842567,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Autoimmune hepatitis,,2016,Q4,2,F,20161004.0,20161011.0,20161013,20161017,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-083639,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,67.3,KG,20161017.0,,OT,KR,KR,2016,Q4,Elderly
128503391,12850339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293,1.0,DF,TABLET,QD,2016,Q4,Enuresis,,2016,Q4,1,I,,20161007.0,20161014,20161014,EXP,,GB-ASTRAZENECA-2016SF06737,ASTRAZENECA,,35.0,YR,,F,Y,,,20161014.0,,PH,GB,GB,2016,Q4,Adult
128503391,12850339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293,1.0,DF,TABLET,QD,2016,Q4,Nocturia,,2016,Q4,1,I,,20161007.0,20161014,20161014,EXP,,GB-ASTRAZENECA-2016SF06737,ASTRAZENECA,,35.0,YR,,F,Y,,,20161014.0,,PH,GB,GB,2016,Q4,Adult
128509232,12850923,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293,,,TABLET,,2016,Q4,Atrial fibrillation,,2016,Q4,2,F,20160927.0,20161122.0,20161014,20161130,EXP,,JP-ASTRAZENECA-2016SF06709,ASTRAZENECA,,73.0,YR,,M,Y,,,20161130.0,,MD,JP,JP,2016,Q4,Elderly
128607731,12860773,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,U,,,202293.0,10.0,MG,TABLET,,2016,Q4,Blood bilirubin increased,,2016,Q4,1,I,20160620.0,20161011.0,20161019,20161019,EXP,,DE-ASTRAZENECA-2016SF07994,ASTRAZENECA,,69.0,YR,,M,Y,68.0,KG,20161019.0,,,DE,DE,2016,Q4,Elderly
128607731,12860773,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,U,,,202293.0,10.0,MG,TABLET,,2016,Q4,Hepatic enzyme increased,,2016,Q4,1,I,20160620.0,20161011.0,20161019,20161019,EXP,,DE-ASTRAZENECA-2016SF07994,ASTRAZENECA,,69.0,YR,,M,Y,68.0,KG,20161019.0,,,DE,DE,2016,Q4,Elderly
128607731,12860773,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,U,,,202293.0,10.0,MG,TABLET,,2016,Q4,Transaminases increased,,2016,Q4,1,I,20160620.0,20161011.0,20161019,20161019,EXP,,DE-ASTRAZENECA-2016SF07994,ASTRAZENECA,,69.0,YR,,M,Y,68.0,KG,20161019.0,,,DE,DE,2016,Q4,Elderly
128718631,12871863,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2016,Q4,Headache,,2016,Q4,1,I,20160913.0,20161013.0,20161021,20161021,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201610004628,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20161020.0,,CN,GB,GB,2016,Q4,Adult
128733831,12873383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q4,Candida infection,,2016,Q4,1,I,,20161014.0,20161021,20161021,EXP,,GB-ASTRAZENECA-2016SF09351,ASTRAZENECA,,49.0,YR,,M,Y,124.0,KG,20161021.0,,MD,GB,GB,2016,Q4,Adult
128733831,12873383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q4,Pollakiuria,,2016,Q4,1,I,,20161014.0,20161021,20161021,EXP,,GB-ASTRAZENECA-2016SF09351,ASTRAZENECA,,49.0,YR,,M,Y,124.0,KG,20161021.0,,MD,GB,GB,2016,Q4,Adult
128746322,12874632,6,SS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q4,Gastritis,,2016,Q4,2,F,20160923.0,20161017.0,20161021,20161025,EXP,,MX-ASTRAZENECA-2016SF09212,ASTRAZENECA,,27315.0,DY,,F,Y,,,20161025.0,,MD,MX,MX,2016,Q4,Elderly
128750181,12875018,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20161003.0,20161014.0,20161023,20161023,EXP,,GB-ASTRAZENECA-2016SF08871,ASTRAZENECA,,55.0,YR,,M,Y,80.0,KG,20161024.0,,OT,GB,GB,2016,Q4,Adult
128768151,12876815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,,,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20161013.0,20161024,20161024,EXP,,GB-ASTRAZENECA-2016SF08853,ASTRAZENECA,,71.0,YR,,F,Y,,,20161024.0,,OT,GB,GB,2016,Q4,Elderly
128838752,12883875,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2016,Q4,Eczema,,2016,Q4,2,F,20160619.0,20161025.0,20161025,20161107,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-087739,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20161107.0,,PH,BR,BR,2016,Q4,Elderly
128875903,12887590,2,SS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q4,Acute kidney injury,,2016,Q4,3,F,20160707.0,20161129.0,20161026,20161206,EXP,,PL-ASTRAZENECA-2016SF08081,ASTRAZENECA,,25033.0,DY,,F,Y,,,20161206.0,,MD,PL,PL,2016,Q4,Elderly
128875903,12887590,2,SS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q4,Atrial fibrillation,,2016,Q4,3,F,20160707.0,20161129.0,20161026,20161206,EXP,,PL-ASTRAZENECA-2016SF08081,ASTRAZENECA,,25033.0,DY,,F,Y,,,20161206.0,,MD,PL,PL,2016,Q4,Elderly
128875903,12887590,2,SS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q4,Bladder neoplasm,,2016,Q4,3,F,20160707.0,20161129.0,20161026,20161206,EXP,,PL-ASTRAZENECA-2016SF08081,ASTRAZENECA,,25033.0,DY,,F,Y,,,20161206.0,,MD,PL,PL,2016,Q4,Elderly
128875903,12887590,2,SS,DAPAGLIFLOZIN CODE NOT BROKEN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2016,Q4,Urinary tract infection,,2016,Q4,3,F,20160707.0,20161129.0,20161026,20161206,EXP,,PL-ASTRAZENECA-2016SF08081,ASTRAZENECA,,25033.0,DY,,F,Y,,,20161206.0,,MD,PL,PL,2016,Q4,Elderly
128890101,12889010,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20161013.0,20161027,20161027,EXP,,AU-ASTRAZENECA-2016SF08854,ASTRAZENECA,COORAY SD.,51.0,YR,,M,Y,,,20161027.0,,OT,AU,AU,2016,Q4,Adult
128967092,12896709,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,20161008.0,20161021.0,20161031,20161031,EXP,,GB-ASTRAZENECA-2016SF11939,ASTRAZENECA,,59.0,YR,,F,Y,72.0,KG,20161101.0,,PH,GB,GB,2016,Q4,Adult
128967092,12896709,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Gastroenteritis,,2016,Q4,2,F,20161008.0,20161021.0,20161031,20161031,EXP,,GB-ASTRAZENECA-2016SF11939,ASTRAZENECA,,59.0,YR,,F,Y,72.0,KG,20161101.0,,PH,GB,GB,2016,Q4,Adult
128967541,12896754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20161021.0,20161031,20161031,EXP,,GB-ASTRAZENECA-2016SF11935,ASTRAZENECA,,59.0,YR,,F,Y,71.9,KG,20161031.0,,MD,GB,GB,2016,Q4,Adult
129128611,12912861,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20160901.0,20161025.0,20161104,20161104,EXP,,GB-ASTRAZENECA-2016SF12728,ASTRAZENECA,,82.0,YR,,M,Y,71.0,KG,20161104.0,,PH,GB,GB,2016,Q4,Elderly
129128611,12912861,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Syncope,,2016,Q4,1,I,20160901.0,20161025.0,20161104,20161104,EXP,,GB-ASTRAZENECA-2016SF12728,ASTRAZENECA,,82.0,YR,,M,Y,71.0,KG,20161104.0,,PH,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Balance disorder,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Cerebrovascular accident,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Confusional state,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Dizziness postural,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Gait disturbance,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Nystagmus,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129137531,12913753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Paraesthesia,,2016,Q4,1,I,,20161028.0,20161106,20161106,EXP,,GB-ASTRAZENECA-2016SF14261,ASTRAZENECA,,73.0,YR,,F,Y,,,20161106.0,,MD,GB,GB,2016,Q4,Elderly
129149214,12914921,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1290.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Laryngitis,,2016,Q4,4,F,20161023.0,20161223.0,20161106,20161228,EXP,,MX-ASTRAZENECA-2016SF13754,ASTRAZENECA,,19202.0,DY,,F,Y,,,20161228.0,,MD,MX,MX,2016,Q4,Elderly
129288061,12928806,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Abnormal loss of weight,,2016,Q4,1,I,20160910.0,20161102.0,20161110,20161110,EXP,,GB-ASTRAZENECA-2016SF15874,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20161110.0,,MD,GB,GB,2016,Q4,Adult
129288061,12928806,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Hemiparesis,,2016,Q4,1,I,20160910.0,20161102.0,20161110,20161110,EXP,,GB-ASTRAZENECA-2016SF15874,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20161110.0,,MD,GB,GB,2016,Q4,Adult
129288061,12928806,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Hypoaesthesia,,2016,Q4,1,I,20160910.0,20161102.0,20161110,20161110,EXP,,GB-ASTRAZENECA-2016SF15874,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20161110.0,,MD,GB,GB,2016,Q4,Adult
129288061,12928806,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Transient ischaemic attack,,2016,Q4,1,I,20160910.0,20161102.0,20161110,20161110,EXP,,GB-ASTRAZENECA-2016SF15874,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20161110.0,,MD,GB,GB,2016,Q4,Adult
129309091,12930909,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Abdominal pain,,2016,Q4,1,I,20160919.0,20161102.0,20161110,20161110,EXP,,GB-ASTRAZENECA-2016SF15895,ASTRAZENECA,,66.0,YR,,M,Y,,,20161110.0,,OT,GB,GB,2016,Q4,Elderly
129350891,12935089,4,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Unknown,,,,,, UNKNOWN,,,10.0,MG,,QD,2016,Q4,Lactic acidosis,,2016,Q4,1,I,,20160209.0,20161113,20161113,PER,,DK-LUPIN PHARMACEUTICALS INC.-2016-00703,LUPIN,"STORGAARD H, BAGGER J, KNOP F, VILSBOLL T, RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2016;118 (2):168-170.",44.0,YR,,M,Y,,,20161111.0,,OT,DK,DK,2016,Q4,Adult
129350891,12935089,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Unknown,10MG,,,,, UNKNOWN,,,,,,,2016,Q4,Lactic acidosis,,2016,Q4,1,I,,20160209.0,20161113,20161113,PER,,DK-LUPIN PHARMACEUTICALS INC.-2016-00703,LUPIN,"STORGAARD H, BAGGER J, KNOP F, VILSBOLL T, RUNGBY J. DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES AFTER INITIATION OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR TREATMENT. BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2016;118 (2):168-170.",44.0,YR,,M,Y,,,20161111.0,,OT,DK,DK,2016,Q4,Adult
129357912,12935791,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1275.0,MG,Y,U,,,,5.0,MG,TABLET,QD,2016,Q4,Transient ischaemic attack,,2016,Q4,2,F,20161027.0,20161109.0,20161114,20161117,EXP,,US-ASTRAZENECA-2016SF14848,ASTRAZENECA,,14825.0,DY,,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Elderly
129421051,12942105,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9330.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q4,Osteoarthritis,,2016,Q4,1,I,20160902.0,20161103.0,20161114,20161114,EXP,,CA-ASTRAZENECA-2016SF17175,ASTRAZENECA,,68.0,YR,,F,Y,,,20161114.0,,MD,CA,CA,2016,Q4,Elderly
129421051,12942105,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9330.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q4,Osteoarthritis,,2016,Q4,1,I,20160902.0,20161103.0,20161114,20161114,EXP,,CA-ASTRAZENECA-2016SF17175,ASTRAZENECA,,68.0,YR,,F,Y,,,20161114.0,,MD,CA,CA,2016,Q4,Elderly
129467122,12946712,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,2,F,,20161114.0,20161116,20161129,EXP,,PHJP2016JP032381,NOVARTIS,"UENO S, HAMAMOTO Y, KUBOTA S, OKAMOTO S, OKAMURA K, SAKURAMACHI Y ET AL.. A CASE OF MEN TYPE 1 IN WHICH WEIGHT REDUCTION FOR REMOVAL OF RIGHT ADRENAL TUMOR WAS DIFFICULT. THE JAPANESE JOURNAL OF ENDOCRINOLOGY/THE 26TH JES CLINICAL UPDATE ON ENDOCRINOL. 2016;92:490",43.0,YR,,F,Y,95.7,KG,20161129.0,,OT,JP,JP,2016,Q4,Adult
129467122,12946712,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2016,Q4,Neoplasm progression,,2016,Q4,2,F,,20161114.0,20161116,20161129,EXP,,PHJP2016JP032381,NOVARTIS,"UENO S, HAMAMOTO Y, KUBOTA S, OKAMOTO S, OKAMURA K, SAKURAMACHI Y ET AL.. A CASE OF MEN TYPE 1 IN WHICH WEIGHT REDUCTION FOR REMOVAL OF RIGHT ADRENAL TUMOR WAS DIFFICULT. THE JAPANESE JOURNAL OF ENDOCRINOLOGY/THE 26TH JES CLINICAL UPDATE ON ENDOCRINOL. 2016;92:490",43.0,YR,,F,Y,95.7,KG,20161129.0,,OT,JP,JP,2016,Q4,Adult
129467122,12946712,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2016,Q4,Product use issue,,2016,Q4,2,F,,20161114.0,20161116,20161129,EXP,,PHJP2016JP032381,NOVARTIS,"UENO S, HAMAMOTO Y, KUBOTA S, OKAMOTO S, OKAMURA K, SAKURAMACHI Y ET AL.. A CASE OF MEN TYPE 1 IN WHICH WEIGHT REDUCTION FOR REMOVAL OF RIGHT ADRENAL TUMOR WAS DIFFICULT. THE JAPANESE JOURNAL OF ENDOCRINOLOGY/THE 26TH JES CLINICAL UPDATE ON ENDOCRINOL. 2016;92:490",43.0,YR,,F,Y,95.7,KG,20161129.0,,OT,JP,JP,2016,Q4,Adult
129467122,12946712,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2016,Q4,Weight loss poor,,2016,Q4,2,F,,20161114.0,20161116,20161129,EXP,,PHJP2016JP032381,NOVARTIS,"UENO S, HAMAMOTO Y, KUBOTA S, OKAMOTO S, OKAMURA K, SAKURAMACHI Y ET AL.. A CASE OF MEN TYPE 1 IN WHICH WEIGHT REDUCTION FOR REMOVAL OF RIGHT ADRENAL TUMOR WAS DIFFICULT. THE JAPANESE JOURNAL OF ENDOCRINOLOGY/THE 26TH JES CLINICAL UPDATE ON ENDOCRINOL. 2016;92:490",43.0,YR,,F,Y,95.7,KG,20161129.0,,OT,JP,JP,2016,Q4,Adult
129498511,12949851,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, DAILY",,,Y,,,,,10.0,MG,TABLET,QD,2016,Q4,Metabolic acidosis,,2016,Q4,1,I,20160530.0,20161115.0,20161117,20161117,EXP,,AU-009507513-1611AUS007850,MERCK,,65.0,YR,,F,Y,,,20161117.0,,OT,AU,AU,2016,Q4,Elderly
129539801,12953980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20161001.0,20161111.0,20161118,20161118,EXP,,GB-ASTRAZENECA-2016SF20972,ASTRAZENECA,,43.0,YR,,M,Y,,,20161118.0,,PH,GB,GB,2016,Q4,Adult
129539801,12953980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Eating disorder,,2016,Q4,1,I,20161001.0,20161111.0,20161118,20161118,EXP,,GB-ASTRAZENECA-2016SF20972,ASTRAZENECA,,43.0,YR,,M,Y,,,20161118.0,,PH,GB,GB,2016,Q4,Adult
129539801,12953980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Fluid intake reduced,,2016,Q4,1,I,20161001.0,20161111.0,20161118,20161118,EXP,,GB-ASTRAZENECA-2016SF20972,ASTRAZENECA,,43.0,YR,,M,Y,,,20161118.0,,PH,GB,GB,2016,Q4,Adult
129539801,12953980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Malaise,,2016,Q4,1,I,20161001.0,20161111.0,20161118,20161118,EXP,,GB-ASTRAZENECA-2016SF20972,ASTRAZENECA,,43.0,YR,,M,Y,,,20161118.0,,PH,GB,GB,2016,Q4,Adult
129539801,12953980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Respiratory rate increased,,2016,Q4,1,I,20161001.0,20161111.0,20161118,20161118,EXP,,GB-ASTRAZENECA-2016SF20972,ASTRAZENECA,,43.0,YR,,M,Y,,,20161118.0,,PH,GB,GB,2016,Q4,Adult
129708942,12970894,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Overdose,,2016,Q4,2,F,20160417.0,20161122.0,20161123,20161128,EXP,,US-ASTRAZENECA-2016SE75812,ASTRAZENECA,,16650.0,DY,,M,Y,,,20161128.0,,MD,US,US,2016,Q4,Elderly
129741571,12974157,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,,QD,2016,Q4,Circulatory collapse,,2016,Q4,1,I,20160821.0,20161122.0,20161125,20161125,EXP,GB-MHRA-EYC 00148711,GB-ROCHE-1858556,ROCHE,,50.0,YR,,F,Y,80.0,KG,20161125.0,,MD,GB,GB,2016,Q4,Adult
129753412,12975341,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Blood ketone body,,2016,Q4,2,F,20160902.0,20161130.0,20161125,20161208,EXP,,GB-NOVOPROD-519980,NOVO NORDISK,,64.0,YR,A,F,Y,91.0,KG,20161208.0,,OT,GB,GB,2016,Q4,Adult
129760241,12976024,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2016,Q4,Ketoacidosis,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,ES-ASTRAZENECA-2016SF24724,ASTRAZENECA,,40.0,YR,,M,Y,,,20161126.0,,MD,ES,ES,2016,Q4,Adult
129760241,12976024,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,TABLET,,2016,Q4,Prostate cancer,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,ES-ASTRAZENECA-2016SF24724,ASTRAZENECA,,40.0,YR,,M,Y,,,20161126.0,,MD,ES,ES,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Acrochordon,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Diabetic neuropathy,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Gastrointestinal disorder,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Glycosylated haemoglobin increased,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Hypertension,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Insulin resistance,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Retinopathy proliferative,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Sleep apnoea syndrome,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129760271,12976027,5,SS,Dapagliflozin,DAPAGLIFLOZIN,1,Subcutaneous,10 MG ONCE DAILY,,,U,,,,,10.0,MG,,,2016,Q4,Weight decreased,,2016,Q4,1,I,,20161118.0,20161126,20161126,EXP,,GB-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00576,SCIEGEN,,52.0,YR,,M,Y,139.0,KG,20161126.0,,OT,GB,GB,2016,Q4,Adult
129906911,12990691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,N,,,,202293.0,5.0,MG,TABLET,,2016,Q4,Blood creatinine increased,,2016,Q4,1,I,,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25239,ASTRAZENECA,,61.0,YR,,M,Y,129.0,KG,20161201.0,,MD,GB,GB,2016,Q4,Adult
129906911,12990691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,N,,,,202293.0,5.0,MG,TABLET,,2016,Q4,Dyspnoea,,2016,Q4,1,I,,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25239,ASTRAZENECA,,61.0,YR,,M,Y,129.0,KG,20161201.0,,MD,GB,GB,2016,Q4,Adult
129906911,12990691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,N,,,,202293.0,5.0,MG,TABLET,,2016,Q4,Feeling hot,,2016,Q4,1,I,,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25239,ASTRAZENECA,,61.0,YR,,M,Y,129.0,KG,20161201.0,,MD,GB,GB,2016,Q4,Adult
129906911,12990691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,N,,,,202293.0,5.0,MG,TABLET,,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,1,I,,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25239,ASTRAZENECA,,61.0,YR,,M,Y,129.0,KG,20161201.0,,MD,GB,GB,2016,Q4,Adult
129906911,12990691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,N,,,,202293.0,5.0,MG,TABLET,,2016,Q4,Hyperhidrosis,,2016,Q4,1,I,,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25239,ASTRAZENECA,,61.0,YR,,M,Y,129.0,KG,20161201.0,,MD,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Glucose urine present,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Oral candidiasis,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Perianal erythema,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Perineal pain,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Pyelonephritis acute,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Vulvovaginal candidiasis,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Vulvovaginal erythema,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Vulvovaginal pain,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129912211,12991221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2270.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Vulvovaginal pruritus,,2016,Q4,1,I,20160509.0,20161123.0,20161201,20161201,EXP,,GB-ASTRAZENECA-2016SF25247,ASTRAZENECA,,55.0,YR,,F,Y,105.0,KG,20161201.0,,PH,GB,GB,2016,Q4,Adult
129935042,12993504,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,245.0,MG,Y,,,,202293.0,5.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,20160829.0,20161210.0,20161202,20161213,EXP,,US-ASTRAZENECA-2016SE92896,ASTRAZENECA,,38.0,YR,,F,Y,,,20161213.0,,MD,US,US,2016,Q4,Adult
129961261,12996126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1250.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Renal tubular acidosis,,2016,Q4,1,I,20160322.0,20161125.0,20161202,20161202,EXP,,GB-ASTRAZENECA-2016SF25950,ASTRAZENECA,,61.0,YR,,M,Y,86.0,KG,20161203.0,,PH,GB,GB,2016,Q4,Adult
129961261,12996126,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1250.0,MG,Y,U,,,,10.0,MG,TABLET,QD,2016,Q4,Urine ketone body present,,2016,Q4,1,I,20160322.0,20161125.0,20161202,20161202,EXP,,GB-ASTRAZENECA-2016SF25950,ASTRAZENECA,,61.0,YR,,M,Y,86.0,KG,20161203.0,,PH,GB,GB,2016,Q4,Adult
129972651,12997265,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U, MR680,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20161109.0,20161128.0,20161205,20161205,EXP,,GB-ASTRAZENECA-2016SF26500,ASTRAZENECA,,63.0,YR,,F,Y,,,20161205.0,,PH,GB,GB,2016,Q4,Adult
129972651,12997265,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U, MR680,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Myalgia,,2016,Q4,1,I,20161109.0,20161128.0,20161205,20161205,EXP,,GB-ASTRAZENECA-2016SF26500,ASTRAZENECA,,63.0,YR,,F,Y,,,20161205.0,,PH,GB,GB,2016,Q4,Adult
130056821,13005682,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20161116.0,20161128.0,20161207,20161207,EXP,,GB-ASTRAZENECA-2016SF26390,ASTRAZENECA,,64.0,YR,,F,Y,,,20161207.0,,OT,GB,GB,2016,Q4,Adult
130075262,13007526,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Arrhythmia,,2016,Q4,2,F,,20161205.0,20161207,20161213,EXP,,PL-ASTRAZENECA-2016SF28278,ASTRAZENECA,,55.0,YR,,M,Y,138.0,KG,20161213.0,,MD,PL,PL,2016,Q4,Adult
130091101,13009110,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20161125.0,20161129.0,20161208,20161208,EXP,,GB-ASTRAZENECA-2016SF27647,ASTRAZENECA,,57.0,YR,,F,Y,,,20161208.0,,OT,GB,GB,2016,Q4,Adult
130091101,13009110,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20161125.0,20161129.0,20161208,20161208,EXP,,GB-ASTRAZENECA-2016SF27647,ASTRAZENECA,,57.0,YR,,F,Y,,,20161208.0,,OT,GB,GB,2016,Q4,Adult
130202793,13020279,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2180.0,MG,,,,,,10.0,MG,TABLET,QD,2016,Q4,Pneumonia,,2016,Q4,3,F,20161112.0,20161223.0,20161212,20161226,EXP,,RU-ASTRAZENECA-2016SF31008,ASTRAZENECA,,24302.0,DY,,F,Y,,,20161226.0,,MD,RU,RU,2016,Q4,Elderly
130205861,13020586,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2016,Q4,Pancreatic carcinoma,,2016,Q4,1,I,,20161130.0,20161212,20161212,EXP,GB-MHRA-TPP3142548C2199432YC1479725187335,GB-ELI_LILLY_AND_COMPANY-GB201611011098,ELI LILLY AND CO,,63.0,YR,,M,Y,66.0,KG,20161212.0,,CN,GB,GB,2016,Q4,Adult
130308721,13030872,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2016,Q4,Blister,,2016,Q4,1,I,,20161201.0,20161215,20161215,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107065,BRISTOL MYERS SQUIBB,LTO. A CASE OF BULLOUS PEMPHIGOID WHICH DEVELOPED AFTER ADMINISTRATION OF DPP-4 INHIBITOR. 54TH KYUSHU LOCAL MEETING OF THE JAPAN DIABETES SOCIETY. 2016;144,82.0,YR,,F,Y,,,20161215.0,,MD,JP,JP,2016,Q4,Elderly
130308721,13030872,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2016,Q4,Erythema,,2016,Q4,1,I,,20161201.0,20161215,20161215,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107065,BRISTOL MYERS SQUIBB,LTO. A CASE OF BULLOUS PEMPHIGOID WHICH DEVELOPED AFTER ADMINISTRATION OF DPP-4 INHIBITOR. 54TH KYUSHU LOCAL MEETING OF THE JAPAN DIABETES SOCIETY. 2016;144,82.0,YR,,F,Y,,,20161215.0,,MD,JP,JP,2016,Q4,Elderly
130308721,13030872,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2016,Q4,Pemphigoid,,2016,Q4,1,I,,20161201.0,20161215,20161215,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107065,BRISTOL MYERS SQUIBB,LTO. A CASE OF BULLOUS PEMPHIGOID WHICH DEVELOPED AFTER ADMINISTRATION OF DPP-4 INHIBITOR. 54TH KYUSHU LOCAL MEETING OF THE JAPAN DIABETES SOCIETY. 2016;144,82.0,YR,,F,Y,,,20161215.0,,MD,JP,JP,2016,Q4,Elderly
130308721,13030872,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2016,Q4,Rash,,2016,Q4,1,I,,20161201.0,20161215,20161215,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107065,BRISTOL MYERS SQUIBB,LTO. A CASE OF BULLOUS PEMPHIGOID WHICH DEVELOPED AFTER ADMINISTRATION OF DPP-4 INHIBITOR. 54TH KYUSHU LOCAL MEETING OF THE JAPAN DIABETES SOCIETY. 2016;144,82.0,YR,,F,Y,,,20161215.0,,MD,JP,JP,2016,Q4,Elderly
130377501,13037750,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Hyperosmolar hyperglycaemic state,,2016,Q4,1,I,20160602.0,20161208.0,20161217,20161217,EXP,,GB-ASTRAZENECA-2016SF30353,ASTRAZENECA,,53.0,YR,,M,Y,139.0,KG,20161217.0,,MD,GB,GB,2016,Q4,Adult
130380021,13038002,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,10.0,MG,TABLET,QD,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,,20161209.0,20161218,20161218,EXP,,US-ASTRAZENECA-2016SF32265,ASTRAZENECA,,37.0,YR,,F,Y,,,20161218.0,,OT,US,US,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Malaise,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Myalgia,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Peripheral circulatory failure,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Pulse absent,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Rhabdomyolysis,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130494882,13049488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Sepsis,,2016,Q4,2,F,20161203.0,20161222.0,20161221,20161227,EXP,GB-MHRA-EYC 00150161,GB-PFIZER INC-2016581751,PFIZER,,53.0,YR,,M,Y,120.0,KG,20161227.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Malaise,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Myalgia,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Peripheral circulatory failure,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Pulse absent,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130504551,13050455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,20161203.0,20161214.0,20161221,20161221,EXP,,"GB-WARNER CHILCOTT, LLC-1061101",WARNER CHILCOTT,,53.0,YR,,M,Y,120.27,KG,20161221.0,,PH,GB,GB,2016,Q4,Adult
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Atrial fibrillation,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Fall,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Lower respiratory tract infection,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Metabolic acidosis,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130569771,13056977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,TABLET,,2016,Q4,Sepsis,,2016,Q4,1,I,20160805.0,20161214.0,20161222,20161222,EXP,,GB-ASTRAZENECA-2016SF32341,ASTRAZENECA,,70.0,YR,,M,Y,,,20161223.0,,OT,GB,GB,2016,Q4,Elderly
130601031,13060103,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,8640.0,MG,,U,,,,10.0,MG,TABLET,QD,2016,Q4,Renal cancer,,2016,Q4,1,I,20161022.0,20161216.0,20161223,20161223,EXP,,US-ASTRAZENECA-2016SF34192,ASTRAZENECA,,22987.0,DY,,M,Y,,,20161223.0,,MD,US,US,2016,Q4,Elderly
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Autoimmune disorder,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Malaise,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Myalgia,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Peripheral circulatory failure,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Pulse absent,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Rhabdomyolysis,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130620191,13062019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2016,Q4,Sepsis,,2016,Q4,1,I,20161203.0,20161214.0,20161226,20161226,EXP,GB-MHRA-EYC 00150161,GB-DRREDDYS-GER/UKI/16/0085642,DR REDDYS,,53.0,YR,,M,Y,120.0,KG,20161226.0,,PH,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Malaise,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Myalgia,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Peripheral circulatory failure,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Pulse absent,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Renal failure,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130677011,13067701,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Rhabdomyolysis,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-108766,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20161228.0,,CN,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Malaise,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Myalgia,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Peripheral circulatory failure,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Pulse absent,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
130679741,13067974,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,U,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,20161203.0,20161214.0,20161228,20161228,EXP,,GB-AUROBINDO-AUR-APL-2016-15681,AUROBINDO,,53.0,YR,,M,Y,120.0,KG,20161228.0,,PH,GB,GB,2016,Q4,Adult
